UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549




FORM 10-K



(Mark one)
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31 2020, 2023

OR

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to __________________

Commission file number    number: 001-34170

MicroVision, Inc.

(Exact name of registrant as specified in its charter)

Delaware

91-1600822

  (State(State or Other Jurisdiction
of Incorporation or Organization)
(I.R.S. Employer
Identification Number)

6244 185th Avenue

18390 NE Suite 100
68th Street

Redmond, Washington98052

(Address of Principal Executive Offices, including Zip Code)

(425)936-6847

(425) 936-6847
(Registrant'sRegistrant’s Telephone Number, including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

Common Stock, $0.001 par value per share

MVIS

MVIS

The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x Noo

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o Nox

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesx No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files. files). Yesx No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large“large accelerated filer," "accelerated” “accelerated filer," "smaller” “smaller reporting company"company” and "emerging“emerging growth company"company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer¨

Accelerated filer¨

Non-accelerated filerx

Smaller reporting companyx

Emerging growth company¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant has filed a report on and attestation to its management'smanagement’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ¨

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes oNox

The aggregate market value of common stock held by non-affiliates of the registrant as of June 30, 20202023 was approximately $208.0$859.3 million (based upon the closing price of $1.36$4.58 per share for the registrant'sregistrant’s common stock as reported by the Nasdaq Global Market on that date).

The number of shares of the registrant'sregistrant’s common stock outstanding as of March 9, 2021February 26, 2024 was 157,327,415.195,267,385.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant'sregistrant’s definitive Proxy Statement to be filed with the Securities and Exchange Commission pursuant to Regulation 14A in connection with the registrant's 2021registrant’s 2024 Annual Meeting of Shareholders (the "2021“2024 Proxy Statement"Statement”) are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein.



MICROVISION, INC.
INC
.

ANNUAL REPORT ON FORM 10-K

FOR THE YEAR ENDED DECEMBER 31, 20202023

TABLE OF CONTENTS

Part I.

Page

Page

   Item 1.

Business

1

   Item 1A.

Risk Factors

Part I.

5

Item 1.Business3
Item 1A.Risk Factors8
Item 1B.

Unresolved Staff Comments

13

18

   Item 2.

Properties

13

Item 3.

1C.

Legal Proceedings

Cybersecurity

14

18

Item 2.Properties19
Item 3.Legal Proceedings20
Item 4.

Mine Safety Disclosures

14

20

Item 4A.

Executive Officers of the Registrant

14

20

Part II.

Part II.
Item 5.

Market for Registrant'sRegistrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

15

21

   Item 6.

Selected Financial Data

15

Item 6.

Reserved22
Item 7.

Management'sManagement’s Discussion and Analysis of Financial Condition and Results of Operations

15

22

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

22

28

Item 8.

Financial Statements and Supplementary Data

24

29

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

46

56

Item 9A.

Controls and Procedures

46

56

   Item 9B.

Other Information

46

Part III.

Item 9B.

Other Information

58

Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections58
Part III.
Item 10.

Directors, Executive Officers and Corporate Governance

46

58

   Item 11.

Executive Compensation

46

Item 11.

Executive Compensation58
Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

47

58

Item 13.

Certain Relationships and Related Transactions and Director Independence

47

59

Item 14.

Principal Accounting Fees and Services

47

59

Part IV.

Part IV.
Item 15.

Exhibits, Financial Statement Schedules

48

59

Item 16.

Form 10-K Summary

49

62

Signatures

50Signatures

63

i


2

PART I.

Preliminary Note Regarding Forward-Looking Statements

This Annual Report contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"“Exchange Act”), and is subject to the safe harbor created by those sections. Such statements may include, but are not limited to, projections of revenues, income or loss, capital expenditures, plans for product development and cooperative arrangements, acquisition activity and related integration efforts, technology development by third parties, future operations, financing needs or plans of MicroVision, Inc. ("(“we," "our,"” “our,” or "us"“us”), as well as assumptions relating to the foregoing. The words "anticipate," "could," "would," "believe," "estimate," "expect," "goal," "may," "plan," "project," "will,"“anticipate,” “could,” “would,” “believe,” “estimate,” “expect,” “goal,” “may,” “plan,” “project,” “will,” and similar expressions identify forward-looking statements. Factors that could cause actual results to differ materially from those projected in our forward-looking statements include risk factors identified below in Item 1A.

ITEM 1. BUSINESS

ITEM 1. BUSINESSOverview

Overview

MicroVision, Inc. is developing a global developer and supplier of lidar sensorhardware and software solutions focused primarily on automotive lidar and advanced driver-assistance systems (ADAS) markets where we can deliver safe mobility at the speed of life. We offer a suite of light detection and ranging, or lidar, sensors and perception and validation software to be used in automotive safetyOEMs, for ADAS and autonomous driving applications.vehicle (AV) applications, as well as to complementary markets for non-automotive applications including industrial, robotics and smart infrastructure. Our long history of developing and commercializing the core components of our lidar sensor uses our pioneeringhardware and related software, combined with the experience of the team acquired from Ibeo Automotive Systems (Ibeo) with automotive-grade qualification, gives us a compelling advantage as a development and commercial partner.

Founded in 1993, MicroVision, Inc. is a pioneer in laser beam scanning, (LBS) technology. Ouror LBS technology, which is based on our patented expertise in micro-electromechanical systems, that include micro-electrical mechanical systems (MEMS),or MEMS, laser diodes, opto-mechanics, electronics, algorithms and software and how those elements are packaged into a small form factor. OurThroughout our history, we have combined our proprietary technology with our development expertise to create innovative solutions to address existing and emerging market needs, such as augmented reality microdisplay engines; interactive display modules; consumer lidar components; and, most recently, automotive lidar sensors and software solutions for the automotive market.

In January, 2023, we acquired certain strategic assets of Germany-based Ibeo, which was founded in 1998 as a lidar hardware and software provider. Ibeo developed and launched the first lidar sensor to be automotive qualified for serial production with a Tier 1 automotive supplier and that is currently available in passenger cars by premium OEMs. Ibeo developed software solutions, including perception and validation software, which are also utilizesused by premium OEMs. In addition, Ibeo sold its products for non-automotive uses such as industrial, smart infrastructure and robotics applications.

For the automotive market, our integrated solution combines our MEMS-based dynamic-range lidar sensor and perception software, to be integrated on our custom ASIC, targeted for sale to premium automotive OEMs and Tier 1 automotive suppliers. Our ADAS solution is intended to leverage edge computing and machine intelligence as part of the solution. Though automotive lidar iscustom ASICs to enable our priority now, we have developed solutions for Augmented Reality, Interactive Displays,hardware and Consumer Lidars.

We are developing our 1st generation lidar sensor, which we call Long Range Lidar (LRL), for OEM and Tier-1 automotive suppliersperception software to be incorporatedintegrated into automotive active collision avoidance systems and autonomous driving vehicles. This product will also be targeted for sales to technology companies focused on Mobility as a Service (MaaS). MaaS customers are currently major users of automotive lidar sensors.an OEM’s ADAS stack.

In addition to our dynamic-range and long-range MAVIN sensor and perception software solution for the automotive market, our product suite includes our short-range flash-based MOVIA lidar sensor, for automotive and industrial applications, including smart infrastructure, robotics, and other commercial segments. Also, our validation software tool, the MOSAIK suite, is used by OEMs and other customers including Tier 1s for validating vehicle sensors for ADAS and AV applications. The tool includes software that automates the manual data classification or annotation process, significantly reducing the time and resources required by OEMs to validate their ADAS and AV systems.

3

In the recent past, we have developed micro-display concepts and designs that could be utilizedfor use in head-mounted Augmented Reality (AR)augmented reality, or AR, headsets and have developed a 1440i MEMS module that can support augmented realitysupporting AR headsets. We have also developed aan interactive display solution targeted at the smart speakers market which we call an Interactive Display module. This display is designed to project onto a countertop, tabletop or a wall from inside a smart speaker. The user can then touch the projected image on any surface on which the display is visible and it will behave like a touchscreen, as on a tablet or smartphone. Lastly, we have developed a small consumer lidar sensor which we call Consumer Lidar, for use indoors with smart home systems. This allows

We completed the acquisition of assets from Ibeo Automotive Systems GmbH, which we refer to throughout this report as Ibeo, on January 31, 2023 pursuant to the terms and subject to the conditions of the Asset Purchase Agreement, dated December 1, 2022, and amended as of January 31, 2023, by and between our wholly owned subsidiary, MicroVision GmbH organized under the laws of The Federal Republic of Germany, and Ibeo for a smart home systempurchase price of EUR 15.0 million, or approximately $16.3 million, subject to understand what is happeningpotential reduction on the terms set forth in the homeAsset Purchase Agreement. Pursuant to the Asset Purchase Agreement, the purchase price also included advanced funds to Ibeo so that it could continue its operations while in insolvency during the period between signing and then enableclosing. Specifically, we advanced to Ibeo EUR 3.9 million, or approximately $4.1 million in December 2022; EUR 2.7 million, or approximately $3.0 million in January 2023; and EUR 0.6 million, or approximately $0.7 million in February 2023 shortly after the smart homeclosing. These fund advances included amounts related to respondheadcount reductions carried out by Ibeo management, decreasing the number of employees to transfer in an appropriate way.connection with the acquisition to approximately 250 employees. These headcount reduction costs of approximately EUR 2.3 million, or approximately $2.5 million, were reimbursed to MicroVision by way of deduction from the purchase price in accordance with the Asset Purchase Agreement.

For

Although our development and productization efforts are now solely focused on our lidar sensors and related software solutions, our revenue in the past few years, our strategy has beenfiscal year ended December 31, 2023 was largely derived from one customer, Microsoft Corporation, related to sell AR displays or components Interactive Displays, or Consumer Lidars to original equipment manufacturers (OEMs) and original design manufacturers (ODMs)that we developed for incorporation into their products. However, while we do have a well-knownhigh-definition display system. Our arrangement with this customer for one of these products which generatesgenerated royalty income, the volume of sales and resulting royalties from that product arewhich will not significant, andcontinue in future periods.

To date, we have been unable to secure additional customers at the scale needed to successfully launch one of our products.

As a result, since February 2020, we have focused our attention on strategic alternatives, including a potential sale or merger of the Company, sale of part of the Company, strategic minority investment, as well as licensing and other transactions. We currently have no agreements or commitments to engage in any specific strategic transactions, and our exploration of various strategic alternatives may not result in any specific action or transaction. We may be unable to identify, successfully negotiate with and consummate a suitable transaction with a buyer or other strategic partner on favorable terms, on the timeline we expect, or at all. If we determine to engage in a strategic transaction, we cannot predict the impact that such a transaction might have on our operations or stock price, and we cannot predict the impact on our stock price or operations if we fail to enter into such a transaction.

While we continue to pursue strategic alternatives, we plan to focus on increasing the value of the Company by completing development of our 1st Generation LRL module to a level that it would be ready to scale in the market. We believe our technology and designs for automotive lidar can be successful in the market, and our solutions will have features and performance that exceed market needs and competitive products and will provide us several sustainable strategic advantages in the market. In November 2020, we announced the results of initial product tests of our 1st Generation LRL module that demonstrated key features, including an ability to be immune to interference signals from other lidars, rogue malicious signals and interference caused by sunlight.

1


We believe we are on track to complete our A-Sample hardware along with selected benchmarked data in the April 2021 timeframe. These could be used for demonstration to interested parties. Following completion of the A-Sample hardware we will work to internally verify all features perform as expected. In addition to verification we will conduct reliability and compliance testing. It is possible the 1st Generation LRL could be available for sale, in small quantities, in the third or fourth quarter of 2021.

We have incurred substantialsignificant losses since inception and we expect to continue to incur significant losses in the near term. We have funded our operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a significant loss during the fiscal year ending December 31, 2021.lesser extent, from development contract revenues, product sales and licensing activities.

MicroVision, Inc. was founded in 1993 as a Washington corporation and reincorporated in 2003 under the laws of the State of Delaware. Our headquarters is located at 6244 185th Avenue18390 NE Suite 100,68th Street, Redmond, Washington 98052, and our telephone number is (425) 936-6847.

Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and all amendments to those reports are available free-of-charge from the investor page of our website, accessible at www.microvision.com, as soon as reasonably practicable after such material is electronically filed with the Securities and Exchange Commission (SEC). Copies of these filings may also be obtained by visiting the SEC'sSEC’s website, www.sec.gov, which contains current, quarterly and annual reports, proxy and information statements and other information regarding issuers that file electronically.

Impact

Our Industry and Market Strategy

We are developing lidar sensors and perception software to address the needs of COVID-19 on Our Business

On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which continuesLevel 2+, or L2+, and Level 3, or L3, advanced driver-assistance systems (ADAS) markets to be spread throughoutused in automotive safety and autonomous driving applications. Our micro-electromechanical systems, or MEMS-based high-speed lidar sensors, which we call MAVIN™, use our pioneering laser beam scanning (LBS) technology. Our solution-based development approach recognizes two key realities of the United StatesL2+ and L3 markets: that safety is mission critical and that OEMs require cost efficiency and integration adaptability. With these factors in mind, we believe that our best-in-class MAVIN lidar sensors support critical safety needs by providing the world. The impacthighest resolution at range and velocity of moving objects with a dynamic field of view while running at 30 hertz, thus enabling ADAS features, such as automatic emergency braking, forward collision warning, and automatic emergency steering, at higher speeds of operation than most competing products.

4

Moreover, we tailor our solution to meet the needs of OEMs, integrating our MEMS-based lidar and edge computing to support Highway Pilot capabilities up to 130km/h, save development cost and time for OEMs with no training required for our sensor-fused output, reduce system cost by requiring fewer and cheaper sensors and reduced processing, and enable seamless integration with an OEM’s existing architecture. Our unique solution for the L2+ and L3 markets, we believe, has the potential to achieve our goal of enabling mission-critical safety systems while solving for OEMs’ cost and integration objectives.

With this customer-centric approach, our go-to-market strategy depends on building partnerships with OEMs and Tier-1 automotive suppliers, as well as with silicon companies to support our solution on their compute platforms. Although we are working to establish direct marketing and co-development relationships with OEMs, we could also derive revenue directly from the COVID-19 outbreak is uncertain and may impact our business and results of operations and could impact our financial conditionTier-1 suppliers in the future. form of licensing revenue.

Our Technology and Competitive Strength

We are unablebelieve a significant competitive strength for us today is our long history of delivering LBS- and MEMS-based hardware and related firmware and software that meets reliability, predictability, and scalability standards of well-known OEMs and ODMs.

Core to accurately predict the full impactour automotive lidar sensors, custom ASICs and perception software is proprietary technology that COVID-19 may have due to numerous uncertainties, including the severity, duration and spread of the outbreak, and actions that may be taken by governmental authorities.

Several of the suppliers of components in our LBS modules have experienced closures orwe have been operating at reduced capacity, resulting in lower than planned product shipments. Continued disruptions to the supply chain could have a material impact on our future operating results.

As a result of the COVID-19 pandemic, including related governmental guidance or directives, we are still requiring most office-based employees to work remotely. We may experience reductions in productivitydeveloping, refining, productizing and disruptions to our business routines while our remote work policy remains in place, or if our employees become ill and are unable to work. This could have an adverse effect on the timing of our development activities, our ability to raise additional capital, our ability to enter into licensing agreements, or our ability to complete a potential sale or merger of the Company.

In April 2020, we received funds in the amount of $1.6 million pursuant to a loan under the Paycheck Protection Program of the 2020 CARES Act ("PPP") administered by the Small Business Administration. The loan has an interest rate of 0.98% and a term of 24 months. No payments are dueprotecting for the first 10 months following the 24-week covered period, although interest accrues during that period. Thereafter, the loan is repayable in monthly installments over the next 18 months to retire the loan plus accrued interest. Funds from the loan may only be used for certain purposes, including payroll, benefits, rent and utilities, and a portion of the loan used to pay certain costs may be forgivable, all as provided by the terms of the PPP. The CARES Act reduces the amount of the PPP loan that may be forgiven if the borrower reduces full-time equivalent employees during the covered period as compared to a base period. As of December 31, 2020, all of the funds received under the PPP had been used for qualified purposes. We intend to apply for partial forgiveness of the loan under PPP guidelines. Based on the terms of the PPP, we estimate the amount of the loan that will be forgiven will be approximately $690,000, subject to approval by our lender in accordance with PPP guidelines. The loan is evidenced by a promissory note, which contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. We may prepay the loan at any time prior to maturity with no prepayment penalties.

Technology

nearly 30 years. Our patented LBS technology combines a MEMS scanning mirror, laser diode light sources, electronics, and optics that are controlled using our proprietary system control algorithms along with edge computing and machine learning in some systems. The MEMS scanning mirror is a key component of our technology system and is one of our core competencies. Our MEMS scanning mirror is a silicon device that oscillates in a precisely controlled closed loop pattern so that we can place a pixel of light at a precise point. This allows us to generate a projected image pixel-by-pixel for use in lidar sensing and display. Scanning modules with our technology can be designed to operate in one of three different modes: lidar sensing only, display and lidar sensing combined, and display only. For applications that

2


include a projected display, our PicoP® scanning technology creates a brilliant, full color, high-contrast, uniform image over the entire field-of-view from a small and thin module with low power consumption. Our Consumer Lidar scanning module is small with high resolution, low power and low latency which are features that are important for its applications. We believe that our proprietary technology offers significant advantages over other lidar sensing systems and traditional displays.

For

Early applications of our proprietary technology included heads up displays for the U.S. military and automotive lidar, we believe that our sensor will meet the specifications set by OEM's, have high resolution within all range targets, collect large numbersystems. The contemplated uses of points per degree, have dynamic field of view that covers near, mid and far field of view in a single sensor, and provide clustered velocity data for objects in the fields of view at low latency. We also believe our solution will operate in full sunlight and in the presence of lidars in other nearby vehicles. In Augmented Reality (AR) applications, our technology enables high resolutionrequire incorporation of 1440i for large fields of view with low weight and low latency and persistence. Our Interactive Display gives an instant on and off, full color, focus-free, 720p projected image that is capable of responding as if it were a capacitance touch screen from any surface the projection can be seen on while maintaining Class 1 laser safety requirements. Our Consumer Lidar has a small size and is intended for use indoors with smart home systems. It is designed to enable a smart home system to understand what is happening in the home and respond in an appropriate way.

Markets for Our Technology

All of the uses of the technology that we have developed require that they become a component insideour components into the products of other companies.companies or partners. Most recently, our technology can be found in a Microsoft heads up display product. In the past, we have worked with other global brands to incorporate our core technology into their consumer products.

For

The MAVIN DR, our dynamic-range automotive lidar sensor is designed to, and we believe can, meet or exceed OEM specifications, performing to 220 meters of range with an output resolution of up to 15.0 million points per second. Our hardware delivers a high point cloud density for a single-channel sensor as compared to competitive products. In addition to providing a low-latency, high-resolution point cloud at range, our LRL sensor would be soldoutputs axial, lateral, and vertical components of velocity of moving objects in the field of view at 30 hertz. This allows our solution to support a detailed understanding of the velocity of moving objects in real time, enabling fast and accurate path planning and maneuvering of the vehicle. Further, our proprietary scan locking feature ensures that our sensor is immune from interference from sunlight and from other lidar sensors.

Our Products and Revenue Strategy

Following our acquisition of assets from Ibeo, our product suite includes our MEMS-based high-speed automotive Tier-1 manufacturers,lidar sensors, perception software, flash-based automotive lidar sensor, lidar sensors for non-automotive industrial markets, and reference and validation software. We also provide engineering services in connection with these hardware and software products.

5

Central to our development and commercialization efforts is our MAVIN DR dynamic view lidar system targeted for sale to automotive OEMs and MaaS technology companies. The sensor is targeted for Level 3 (L3) autonomous safetyTier 1 automotive suppliers. MAVIN DR combines short-, medium- and Level 4 (L4) autonomous driving applications.

For displays or components for the AR market, we would sell our displays or components to an OEM or ODM for them to incorporate into their product. Our AR technology provides for largelong-range sensing and fields of view ininto one form factor. Dynamic range is key to enabling ADAS features at highway speeds. At speeds of up to 1440i resolutions130 km/h (80 mph), ADAS systems need more time to make decisions and react in order to take proactive action and hence need resolution at range. Our MAVIN DR sensor produces an ultra-high-resolution point cloud showing drivable and non-drivable areas of the road ahead. With its low latency point cloud (30 hertz), we believe the MAVIN product line allows ADAS systems to respond more quickly, make split-second decisions and take action at high speeds.

Our perception software integrated with light weightour automotive lidar hardware, and eventually ported into our digital ASIC, is also targeted for sale to automotive OEMs and Tier 1 automotive suppliers. This perception software, included in our acquisition of assets from Ibeo, was developed in collaboration with an OEM customer and successfully passed through that OEM’s development qualification processes.

Also stemming from our acquisition of assets are our flash-based sensors, suitable for short- and mid-range use by customers in the automotive market, as well as non-automotive industrial markets. These solid-state sensors, comprising our MOVIA line of lidar sensors, are based on technology developed according to automotive-grade standards, featuring variable scan frequency, high resolution, a modular optics concept, and low latencypower consumption. The availability of our MOVIA sensors support a revenue strategy that includes royalty revenues from automotive production, as well as sales in multiple markets including industrial, smart infrastructure, robotics, and persistence.commercial vehicles.

The Interactive Display modules

Our acquisition allows us to offer a system solution for validating vehicle sensors for ADAS and AV applications. This system, which we would produce using our technology would be assembled inside a smart speakerhave branded MOSAIK, includes software that automates the manual data classification or other device. The customer for Interactive Display would be an electronics OEM or ODM.

Lastly, our Consumer Lidar would be soldannotation process. We believe the MOSAIK solution significantly reduces the time and resources required by OEMs to OEMs or ODMs to incorporate invalidate their overall smart home or smart home security product.

ProductsADAS and Services

AV systems. In 2019, our revenue was derived from the sale of components, from development contracts, and from royalty fees for LBS technology. Beginning in the third quarter of 2019 and through the end of February 2020, we were selling components to a high-definition display system that we developed for a well-known customer under a development agreement. The volume and resulting revenue and gross profit from this business was fairly low. Therefore, in March 2020, we transferred production of the componentsaddition to the customer. Starting in March 2020, we earned a royalty from the customer for each unit shipped, with amounts applied against the prepayment that we had previously received from the customer until the prepayment is exhausted. The valueauto-annotation software, sales of the royalty is approximately equal to the amount of gross profit we would have earned if we continued to produce and ship the components. We believe this arrangement will help us conserve cash, and still preservesvalidation solution may include our ability to experience financial benefits should the volume of components increase in the future.lidar sensors.

Research and Development

We believe our research and development efforts have earned us a leadership position in the field of lidar sensors, LBS technology and applications as applied to automotive, consumer electronics automotive and other markets. Our ability to attract customers and grow revenue will depend on our ability to maintain our LBS technology leadership, to continually improve performance, reduce costs, reduce the size of component parts and scanning modules,ensure functional safety and to increase the number of applications and products enabled by our LBS technology.

3


flexible design. Our research and development team isteams as of December 31, 2023 were located in Redmond, Washington, Hamburg, Germany and as of December 31, 2020, wasNuremberg, Germany and were comprised of 37approximately 270 engineering and technical staff in optics, software engineering, electrical engineering, product engineering, and MEMS design.

Sales and Marketing

Our sales and marketing approach is account based, business-to-business targeting of automotive OEMs and ODMs.Tier 1 suppliers and potential customers in several industrial markets. Our business development efforts are headed by executive management and business development representatives and are supported by engineers that assist customers during the design cycles of products. The engineers areWe have business development offices for our automotive and industrial solutions located in Redmond, Washington.Germany and the United States. We engage potential customers directly, participate in trade shows, and maintain a website.

Manufacturing

Manufacturing

We continue to invest in our manufacturing capabilities, evaluating long-term Tier 1 relationships and establishing new relationships with contract manufacturers, as we drive toward our goal of serving as a Tier 1 supplier to automotive OEM customers. While our current partner is manufacturing limited volumes and we are not otherwise manufacturing anyour products at significant volume at this time. Whentime, in the past, when we have produced products or components, in the past, our products were manufactured by a contract manufacturer based on our proprietary design, process, test, quality, and reliability standards and incorporated our LBS technology and included MEMS and ASICs that were produced to order by semiconductor foundries.

Our past manufacturing has not been subject to seasonal variations as our shipments have been relatively small and were in the early stages of product introduction. In the future, depending on our customers'customers’ product mix, we may be affected by seasonal fluctuations which could affect working capital demands.

While we are not currently having products produced, below describes how we had products produced in the past and is likely how it will be done again if we were to begin production. We provided forecasts that allow our contract manufacturers to stock component parts and other materials and plan capacity. Our contract manufacturers procured raw materials in volumes consistent with our forecasts, manufactured and/or assembled the products and performed tests according to our specifications. Products were shipped to our customers or shipped to our Redmond, Washington headquarters to be inventoried. We procured some specific components and either sold them or consigned them to our contract manufacturers. We held some inventories of these components. Our contract manufacturers procured additional raw materials we did not own until the finished goods were completed by our contract manufacturer. Title to the products transferred from our contract manufacturers to us and then to our customers when we completed our performance obligations. If raw materials were unused, or the products were not sold within specified periods of time, we may have incurred carrying charges or obsolete material charges for component parts that our contract manufacturers purchased to build products to meet our forecasts or customer orders.

Many of the raw materials used in our components are standard, to the consumer electronics industry. Ouralthough our MEMS, MEMS die, and ASICs have historically been manufactured to our specifications by separate single-source suppliers.

Human Factors, Ergonomics and Safety

6

We work with third party independent experts in the field of laser safety to assist in meeting safety specifications. In addition, we monitor developments in the area of permissible laser exposure limits as established by International Electrotechnical Commission (IEC) and others. Independent experts have concluded that laser exposure to the eye resulting from use of LBS devices under normal operating conditions would be below the calculated maximum permissible exposure level set by the IEC.

Competitive Conditions

The automotive

Many companies are attempting to develop lidar sensors and consumer display industries areADAS solutions; the competitive landscape is highly competitive. Potential products incorporating our LBS technology willcrowded and rapidly evolving. We compete with the products of other manufacturers or, in the case of our display technology, compete with established technologies, such as flat panel display devices, as well as companies developing new display and sensing technologies. Our competitors include companies such as Velodyne, Innoviz, Luminar Technologies, Aeva, Ouster, Quanergy, Texas Instruments, Intel, Bosch, Opus, Mirrorcle, Maradin, Himax, Pioneer, Sony (LCOS) and others,pureplay lidar developers, some of which have much greater financial, technicalrecently completed de-SPAC transactions raising significant capital. Some of these companies have announced partnerships with OEMs, Tier 1 suppliers, and other resourcescontract manufacturers that, even if nonexclusive, may appear more credible than us.we do in the marketplace. We also face competition from OEMs and Tier 1 suppliers that have internally developed lidar sensors. All of these OEMs and Tier 1s are significantly larger, more well-resourced, have long operating histories and enjoy relevant brand recognition. Many oflidar developers are also building ADAS solutions with which our competitors may be currently developing alternative lidar sensing or miniature display technologies.solution competes. Our competitors may succeed in developing innovative technologies and products that could render our technology or our proposed products commercially infeasible or technologically obsolete.

4


The lidar sensing and consumer display industries haveindustry has been characterized by rapid and significant technological advances. Our LBS technology system and potential products may not be competitive with such advances, and we may not have sufficient funds to invest in new technologies, products or processes. Although we believe our technology system and proposed products could deliver higher performance and have other advantages, manufacturers of competing technologies may develop improvements to their technology that could reduce or eliminate the anticipated advantages of our proposed products.

Lidar sensing is a new market, and we believe we are developing products that will have cost and performance benefits over what competitors may offer. However, manufacturers of competing technologies or products may develop improvements to the size, performance, and cost of their products, that could reduce or eliminate the anticipated advantages of our proposed products.

Intellectual Property and Proprietary Rights

We create intellectual property from three sources: internal research and development activities, technology acquisitions, and performance on development contracts. The inventions covered by our patent applications generally relate to systems controls in our LBS technology, component miniaturization, power reduction, feature enhancements, specific implementation of various system components, and design elements to facilitate mass production. Protecting these key-enabling technologies and components is a fundamental aspect of our strategy to penetrate diverse markets with unique products. As such, we intend to continue to develop our portfolio of proprietary and patented LBS technologies at the system, component, and process levels.

We believe our extensive patent portfolio is the largest, broadest, and earliest filed LBS technology portfolio. We currently have been granted over 450700 issued patents and pending patents worldwide.worldwide, including approximately 330 patents we acquired in the acquisition from Ibeo in January 2023. As our technology develops, we periodically review our patent portfolio and eliminate patents that are deemed of low value. Due to this ongoing portfolio management practice, the number of patents in our portfolio will vary at any given time.

Since our inception in 1993, we have acquired through portfolio purchases, patents that grant us exclusive rights to various LBS technologies. From time to time some of these patents may expire or be abandoned to better utilize resources expended to maintain and generate new intellectual property.

Our ability to compete effectively in automotive lidar AR, or any other market we may enter may depend, in part, on our ability and the ability of our licensors to maintain the proprietary nature of these technologies.

We also rely on unpatented proprietary technology. To protect our rights in these areas, we require all employees, and where appropriate, contractors, consultants, advisors and collaborators, to enter into confidentiality and non-compete agreements. There can be no assurance, however, that these agreements will provide meaningful protection for our trade secrets, know-how or other proprietary information in the event of any unauthorized use, misappropriation or disclosure of such trade secrets, know-how or other proprietary information.

We have registered the name "PicoP®"“MAVIN™,” “MOVIA™,” “MOSAIK™, “SAFE MOBILITY AT THE SPEED OF LIFE,” “PicoP®” and "MicroVision®"“MicroVision®” with the United States Patent and Trademark Office.Office and in various foreign countries.

Employees

7

As

Our Employees, People Operations and Workplace Safety

At the end of March 9, 2021,fiscal year 2023, throughout our global offices, we had 52approximately 340 predominantly full-time employees. NoneWe do not hire seasonal workers and none of our employees are represented by a labor union.union or works council.

Our principal human capital objectives with respect to our workforce are to attract, retain, motivate, and reward our employees to achieve positive results for our customers and us.for MicroVision. To achieve these objectives, our human capitalemployee benefit programs seek to (i) support skill building and prepare our employees for advancement through continuous learning, (ii) reward our employees through compensation awards and resources intended to motivate our employees and promote well-being, and (iii) continuously identify opportunities for development through regular employee input and engagement. We offer competitive compensation and benefits.

We also strive for continuous improvement in the diversity and inclusivity among our employees, management, and board of directors, and seek to promote job opportunities to a diverse pool of qualified candidates. We are also committed to providing an inclusive work environment free of discrimination or harassment of any kind, and is supported by policies, communications, and reporting and resolution resources.

Protecting the safety, health, and well-being of our employees is also a key priority.priority and we have implemented policies and practices to support this. Throughout the COVID-19 pandemic, we have remained focused on the health and safety of our employees by implementing newappropriate safety protocols.

We work with third party independent experts in the field of laser safety to assist in meeting safety specifications. In addition, we monitor developments in the area of permissible laser exposure limits as established by International Electrotechnical Commission (IEC) and others. Independent experts have implemented work-from-home procedures where possible, requiredconcluded that laser exposure to the wearingeye resulting from use of masks and physical distancing onLBS devices under normal operating conditions would be below the job, and increased cleaning procedures and provided cleaning supplies.calculated maximum permissible exposure level set by the IEC.

ITEM 1A. RISK FACTORS

ITEM 1A. RISK FACTORS

You should carefully consider the risks described below together with the other information set forth in this report, which could materially affect our business, financial condition and future results. The risks described below are not the only risks facing our company. Risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and operating results.

8

Risk Factors Related to Our Business and Industry

We have a history of operating losses and expect to incur significant losses in the future.

5


We have had substantial losses since our inception. We cannot assure you that we will ever become or remain profitable.

As of December 31, 2023, we had an accumulated deficit of $765.4 million.
We had an accumulated deficit of $586.2 million from inception through December 31, 2020, a net loss of $43.2 million in 2021, a net loss of $53.1 million in 2022, and a net loss of $82.8 million in 2023.

The likelihood of our success must be considered in light of the expenses, difficulties and delays frequently encountered by companies formed to develop and commercialize new technologies. In particular, our operations to date have focused primarily on research and development of our LBS technology system, including products built around that technology such as our automotive lidar sensor, and development of demonstration units. We are unable to accurately estimate future revenues and operating expenses based upon historical performance.

We cannot be certain that we will succeed in obtaining additional development revenue or commercializing our technology or products.products at scale. In light of these factors, we expect to continue to incur significant losses and negative cash flow at least through 20212024 and likely thereafter. There is significant risk that we will not achieve positive cash flow at any time in the future.

We were unable to secure a customer to launch one of our module products in 2020, as planned. As a result, we plan to focus our attention in the near term on strategic alternatives, including a potential sale or merger of the Company, sale of part of the Company, strategic minority investment, as well as licensing and other transactions. There is substantial risk that these efforts will be unsuccessful. Such efforts may also be impeded by the impact of COVID-19 on parties who might have otherwise been interested in pursuing a transaction or on economic and market conditions generally. We currently have no agreements or commitments to engage in any specific strategic transactions, and our exploration of various strategic alternatives may not result in any specific action or transaction. We may be unable to identify, successfully negotiate with and consummate a suitable transaction with a buyer or other strategic partner on favorable terms, on the timeline we expect, or at all. If we determine to engage in a strategic transaction, we cannot predict the impact that such a transaction might have on our operations or stock price, and we cannot predict the impact on our stock price or operations if we fail to enter into such a transaction.

COVID-19 has had an adverse effect on our business, and the future COVID-19 effects on our financial position and business prospects are uncertain.

On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which continues to be spread throughout the United States and the world. The impact from the COVID-19 outbreak is uncertain and may impact our business and results of operations and could impact our financial condition in the future. We are unable to accurately predict the full impact that COVID-19 may have due to numerous uncertainties, including the severity, duration and spread of the outbreak, and actions that may be taken by governmental authorities.

The adverse impacts of the pandemic on our business and future financial performance could include, but are not limited to:

We may require additional capital to fund our operations andat the level necessary to implement our business plan. If we do not obtain additional capital, we may be required to curtail our operations substantially. Raising additional capital maywill dilute the value of current shareholders' shares.shareholders’ investment in us.

Based on our current operating plan, and including $61.4 million raised under At-the-Market equity offering agreements with Craig-Hallum Capital Group since December 31, 2020, we anticipate that we have sufficient cash and cash equivalents to fund our operations for at least the next 12 months. We maywill, however, require additional capital to fund our operating plan past that time. We maywill seek to obtain additional capital through the issuance of equity or debt securities, development revenue, product sales and/or licensing activities. There can be no assurance that any such efforts to obtain additional capital would be successful.

6


While we continue to pursue strategic alternatives, we plan to focusWe are currently focused on developing and commercializing our automotive lidar module.solution. This would involveinvolves introducing new technologytechnologies into an emerging market which creates significant uncertainty about our ability to accurately project the amounts and timing of revenue, costs and cash flows. Our capital requirements will depend on many factors, including, but not limited to, the commercial success of our LBS modules,technologies, the rate at which OEMs and ODMs introduce productssystems incorporating our LBS technologyproducts and technologies and the market acceptance and competitive position of such products.systems. Our expenses have increased significantly as a result of the January 2023 Ibeo acquisition and related headcount increase. If revenues arecontinue to be less than we anticipate, if the mix of revenues and the associated margins vary from anticipated amounts, or if expenses exceed the amounts budgeted, we may require additional capital earlier than expected to fund our operations. In addition, our operating plan provides for the development of strategic relationships with suppliers of components, products and systems, and equipment manufacturers that may require additional investments by us.

Additional capital may not be available to us or, if available, may not be available on terms acceptable to us or on a timely basis. Raising additional capital may involve issuing securities with rights and preferences that are senior to our common stock and may dilute the value of our current shareholders' shares.shareholders’ investment in us. If adequate capital resources are not available on a timely basis, we may consider limiting our operations substantially and we may be unable to continue as a going concern. This limitation of operations could include reducing investments in our research and development projects, staff, operating costs, and capital expenditures which could jeopardize our ability to achieve our business goals or satisfy our customer requirements. In February 2020, we reduced headcount by approximately 60% following an OEM's decision not to incorporate our technology into its products. As a result, further cost reduction efforts may be particularly difficult to implement.

Qualifying a contract manufacturer or foundry for our products could cause us to experience delays that result in lost revenues and damaged customer relationships.

9

We rely on single or limited-source suppliers to manufacture our products. Establishing a relationship with a contract manufacturer or foundry is a time-consuming process, as our unique technology may require significant manufacturing process adaptation to achieve full manufacturing capacity. Accordingly, we may be unable to establish a relationship with a contract manufacturer at prices or on other terms that are acceptable to us.

Changes in our supply chain may result in increased cost and delay and may subject us to risks and uncertainties regarding, but not limited to, product warranty, product liability and quality control standards. The loss of any single or limited-source supplier, the failure of any of these suppliers to perform as expected or the disruption in the supply chain of components from these suppliers could cause significant delays in product deliveries, which may result in lost revenues and damaged customer relationships. To the extent that we are not able to establish a relationship with a contract manufacturer or foundry in a timely manner, we may be unable to meet contract or production milestones, which could have a material adverse effect on our financial condition, results of operations and cash flows.

Our success will depend, in part, on our ability to secure and retain significant third-party manufacturing resources.

Our success will depend, in part, on our ability to provide our components and future products in commercial quantities at competitive prices and on schedule. Accordingly, we will be required to obtain and retain access, through business partners or contract manufacturers, to manufacturing capacity and processes for the commercial production of our expected future products.

Our foreign contract manufacturers could experience severe financial difficulties or other disruptions in their business, and such continued supply could be significantly reduced or terminated. In addition, we cannot be certain that we will successfully obtain and retain access to needed manufacturing resources concurrent with a significant increase in our planned production levels. Future manufacturing limitations of our suppliers could constrain the number of products that we are able to develop and produce.

We are dependent on third parties in order to develop, manufacture, sell and market products incorporating our LBS technology, scanning modules, and the scanning module components.

Our business strategy for commercializing our technology in products incorporating LBS technology includes entering into development, manufacturing, licensing, sales and marketing arrangements with OEMs, ODMs and other third parties. These arrangements reduce our level of control over production and distribution and may subject us to risks and uncertainties regarding, but not limited to, product warranty, product liability and quality control standards.

7


We cannot be certain that we will be ableRisks Related to negotiate arrangements on acceptable terms, if at all, or that these arrangements will be successful in yielding commercially viable products. If we cannot establish these arrangements, we would require additional capital to undertake such activities on our ownFinancial Statements and would require extensive manufacturing, sales and marketing expertise that we do not currently possess and that may be difficult to obtain.Results

In addition, we could encounter significant delays in introducing our LBS technology or find that the development, manufacture or sale of products incorporating our technology would not be feasible. To the extent that we enter into development, manufacturing, licensing, sales and marketing or other arrangements, our revenues will depend upon the performance of third parties. We cannot be certain that any such arrangements will be successful.

We cannot be certain that our technology system or products incorporating our LBS technology will achieve market acceptance. If our technology system or products incorporating our technology do not achieve market acceptance, our revenues may not grow.

Our success will depend in part on customer acceptance of our LBS technology. Our technology may not be accepted by manufacturers who use lidar sensing and display technologies in their products, by systems integrators, OEMs, and ODMs who incorporate the scanning module components into their products or by end users of these products. To be accepted, our LBS technology must meet the expectations of our current and potential customers in the consumer electronics, automotive, and other markets. If our technology system or products incorporating our LBS technology do not achieve market acceptance, we may not be able to continue to develop our technology.

Future products incorporating our LBS technology and scanning modules are dependent on advances in technology by other companies.

Our LBS technology will continue to rely on technologies, such as laser diode light sources and other components that are developed and produced by other companies. The commercial success of certain future products incorporating our LBS technology will depend, in part, on advances in these and other technologies by other companies. We may,revenue is generated from time to time, contract with and support companies developing key technologies in order to accelerate the development of them for our or our customers' specific uses. There are no guarantees that such activities will result in useful technologies or products that will be profitable.

We are dependent on a small number of customers, forand losing a significant customer will have a negative impact on our revenue. Our quarterly performance may vary substantially and this variance, as well as general market conditions, may cause our stock price to fluctuate greatly and potentially expose us to litigation.

In 2020,2023, one commercial customer, Customer A accounted for $3.0$4.6 million in revenue, representing 97%63% of our total revenue. In 2019, onerevenue, a second commercial customer accounted for $7.7$0.8 million in revenue, representing 86%11% of our total revenue and a secondthird commercial customer accounted for $1.2$0.4 million in revenue, representing 13%5% of our total revenue. Our customers take timeIn 2022, Customer A accounted for $0.7 million in revenue, representing 100% of our total revenue. No revenue was recognized from this customer during the second half of 2022 or for the first three quarters of 2023 as no shipments of our components were reported by the customer during that period. In 2021, Customer A accounted for $2.5 million in revenue, representing 100% of our total revenue. Subsequent to obtain, and the loss of a significant customer couldfiscal year 2023, we do not expect to recognize further revenue from Customer A, which will negatively affect our future revenue. Our quarterly operating results may vary significantly based upon:

In one or more future quarters, our results of operations may fall below the expectations of securities analysts and investors and the trading price of our common stock may decline asstock.

The audit of our internal controls over financial reporting for fiscal year 2024 will include controls of our subsidiary, MicroVision GmbH, which became a consequence. In addition, following periodssignificant subsidiary upon the closing of volatilityour acquisition of assets from Ibeo in 2023. Accordingly, our internal control environment will become more complex and, therefore, the market pricerisk of a company's securities, shareholders often have instituted securities class action litigation against that company.material weakness in internal controls will be higher.

If we become involved in a class action suit, it could divert the attention of management and, if adversely determined, could require us to pay substantial damages.

8


We or our customers may fail to perform under open orders or agreements, which could adversely affect our operating results and cash flows.

We or our customers may be unable to meet the performance requirements and obligations under open orders or agreements, including performance specifications, milestones or delivery dates, required by such purchase orders or agreements. Furthermore, our customers may be unable or unwilling to perform their obligations thereunder on a timely basis, or at all if, among other reasons, our products and technologies do not achieve market acceptance, our customers' products and technologies do not achieve market acceptance or our customers otherwise fail to achieve their operating goals. To the extent we are unable to perform under such purchase orders or agreements or to the extent customers are unable or unwilling to perform, our operating results and cash flows could be adversely affected.

Our stock price has fluctuated in the past, has recently been volatile and may be volatile in the future, and as a result, investors in our common stock could incur substantial losses.

Our stock price has fluctuated significantly in the past, has recently been volatile, and may be volatile in the future. DuringOver the 12 months prior to the date of this report,52-week period ending February 26, 2024, our common stock has traded at a low of $0.15$1.82 and a high of $24.18. From the beginning of 2021 through March 9, 2021, our common stock has traded at a low of $4.86 and a high of $24.18.$8.20. We may incur rapid andcontinue to experience sustained depression or substantial decreasesvolatility in our stock price in the foreseeable future that are unrelated to our operating performance or prospects. For the fiscal year ended December 31, 2020,2023, we incurred a loss per share of $(0.10)$(0.45).

As a result of this volatility, investors may experience losses on their investment in our common stock. The market price for our common stock may be influenced by many factors, including the following:

investor reaction to our business strategy;
the success of competitive products or technologies;
strategic developments;
the timing and results of our development and commercialization efforts with respect to our lidar sensors and ADAS solutions;
changes in regulatory or industry standards applicable to our technologies;
variations in our or our competitors’ financial and operating results;
developments concerning our collaborations or partners;
developments or disputes with any third parties that supply, manufacture, sell or market any of our products;
developments or disputes concerning patents or other proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technology;
actual or perceived defects in any of our products, if commercialized, and any related product liability claims;
our ability or inability to raise additional capital and the terms on which we raise it;
declines in the market prices of stocks generally;
trading volume of our common stock;
sales of our common stock by us or our stockholders;
general economic, industry and market conditions; and
the effects of other events or factors, including war, terrorism and other international conflicts, public health issues including health epidemics or pandemics, such as the COVID-19 outbreak, and natural disasters such as fire, hurricanes, earthquakes, tornados or other adverse weather and climate conditions, whether occurring in the United States or elsewhere.

10

Since the stock price of our common stock has fluctuated in the past, has been recently volatilesuffered recent declines and may be volatile in the future, investors in our common stock could incur substantial losses. In the past, following periods of volatility in the market, securities class-action litigation has often been instituted against companies. Such litigation, if instituted against us, could result in substantial costs and diversion of management'smanagement’s attention and resources, which could materially and adversely affect our business, financial condition, results of operations and growth prospects. There can be no guarantee that our stock price will remain at current levels or that future sales of our common stock will not be at prices lower than those sold to investors.

9


Additionally, securities of certain companies have recentlyin the past few years experienced significant and extreme volatility in stock price due to short sellers of shares of common stock, known as a "short“short squeeze." These short squeezes have caused extreme volatility in both the stock prices of those companies and in the market, and have led to the price per share of those companies to trade at a significantly inflated rate that is disconnected from the underlying value of the company. Many investors who have purchased shares in those companies at an inflated rate face the risk of losing a significant portion of their original investment, as in many cases the price per share has declined steadily as interest in those stocks have abated. While we have no reason to believe our shares would be the target of a short squeeze, thereThere can be no assurance that weour shares will not be subject to a short squeeze in the future, and youinvestors may lose a significant portion or all of yourtheir investment if youthey purchase our shares at a rate that is significantly disconnected from our underlying value.

We may not be able

If we are unable to maintain our listing on The Nasdaq Global Market, and it maycould become more difficult to sell our stock in the public market.

Our common stock is listed on The Nasdaq Global Market. To maintain our listing on this market, we must meet Nasdaq'sNasdaq’s listing maintenance standards. If we are unable to continue to meet Nasdaq'sNasdaq’s listing maintenance standards for any reason, our common stock could be delisted from The Nasdaq Global Market. If our common stock were delisted, we may seek to list our common stock on The Nasdaq Capital Market, the NYSE American or on a regional stock exchange or, if one or more broker-dealer market makers comply with applicable requirements, the over-the-counter (OTC) market. Listing on such other market or exchange could reduce the liquidity of our common stock. If our common stock were to trade in the OTC market, an investor would find it more difficult to dispose of, or to obtain accurate quotations for the price of, the common stock.

A delisting from The Nasdaq Global Market and failure to obtain listing on another market or exchange would subject our common stock to so-called penny stock rules that impose additional sales practice and market-making requirements on broker-dealers who sell or make a market in such securities. Consequently, removal from The Nasdaq Global Market and failure to obtain listing on another market or exchange could affect the ability or willingness of broker-dealers to sell or make a market in our common stock and the ability of purchasers of our common stock to sell their securities in the secondary market.

On March 9, 2021,February 26, 2024, the closing price of our common stock was $14.08$2.09 per share.

Our lack of financial and technical resources relative to our competitors may limit our revenues, potential profits, overall market share or value.

Our products and potential products incorporating our LBS technology willsolutions compete with established manufacturersother pureplay lidar developers, many of existing productswhich have recently gone public through de-SPAC transactions and companies developing new technologies. Many of our competitorstherefore have substantially greater financial technical and other resources than we have. We also face competition from OEMs and Tier 1 suppliers that have internally developed lidar sensors. All of these OEMS and Tier 1s are significantly larger, more well-resourced, have long operating histories and enjoy relevant brand recognition. Because of their greater resources, our competitors may develop or commercialize products or technologies that may be superiormore quickly than us and have access to our own. The introduction of superior competing products or technologiesmore entrenched sales channels. This imbalance in financial resources and access could result for us in reduced revenues, lower margins or loss of market share, any of which could reduce the value of our business. Additionally, for a variety of reasons, customers may choose to purchase from suppliers that have substantially greater financial technical or other resources than we have.

We

11

Risks Related to Our Operations

Difficulty in qualifying a contract manufacturer, Tier 1 partner, or foundry for our products, or experiencing changes in our supply chain, could cause delays that may result in lost future revenues and damaged customer relationships.

Historically, we have relied on single or limited-source suppliers to manufacture our products. Establishing and maintaining a relationship with a contract manufacturer, automotive Tier 1 partner, or foundry is a time-consuming process, as our unique technologies may require significant manufacturing process adaptation to achieve full manufacturing capacity. To the extent that we are not be able to keep upestablish or maintain a relationship with rapid technological change and our financial results may suffer.

The automotive lidar and consumer display industries have been characterized by rapidly changing technology, accelerated product obsolescence and continuously evolving industry standards. Our success will depend upon our ability to further develop our LBS technology system and to cost effectively introduce new products and featuresa contract manufacturer, Tier 1 partner, or foundry in a timely manner or at prices or on other terms that are acceptable to us, we may be unable to meet evolving customer requirementscontract or production milestones. Moreover, changes in our supply chain could result in increased cost and compete with competitors'delay and subject us to risks and uncertainties regarding, but not limited to, product advances. We may not succeedwarranty, product liability and quality control standards. The loss of any single or limited-source supplier, the failure of any of these suppliers to perform as expected or the disruption in the supply chain of components from these efforts due to:

The occurrencemarketing or other arrangements, our revenues will depend upon the performance of third parties. We cannot be certain that any of the above factors could result in decreased revenues, market share and value of our business.such arrangements will be successful.

We could face lawsuits related to our use of LBS technology or other technologies. Defending these suitstechnologies, which would be costly, and time-consuming. Anany adverse outcome in any such matter, could limit our ability to commercialize our technology or products incorporating our LBS technology, reduce our revenues and increase our operating expenses.products.

10


We are aware of several patents held by third parties that relate to certain aspects of light scanning displays, and 3D sensing products.products, and other technologies that are core to our sensor hardware. These patents could be used as a basis to challenge the validity, limit the scope or limit our ability to obtain additional or broader patent rights of our patents. A successful challenge to the validity of our patents could limit our ability to commercialize our technology or products incorporating our LBS technology and, consequently, materially reduce our ability to generate revenues. Moreover, we cannot be certain that patent holders or other third parties will not claim infringement by us with respect to current and future technology. Because U.S. patent applications are held and examined in secrecy, it is also possible that presently pending U.S. applications willcould eventually be issued with claims that willcould be infringed by our products or our technology.

The defense and prosecution of a patent suit would be costly and time-consuming, even if the outcome were ultimately favorable to us. An adverse outcome in the defense of a patent suit could subject us to significant costs, require others and us to cease selling products incorporating our technology, require us to cease licensing our technology or require disputed rights to be licensed from third parties. Such licenses, if available, would increase our operating expenses. Moreover, if claims of infringement are asserted against our future co-development partners or customers, those partners or customers may seek indemnification from us for any damages or expenses they incur.

12

If we fail to manage expansion effectively, our revenue and expenses could be adversely affected.

Our ability to successfully offer products incorporating LBS technologyour technologies and implement our business plan in a rapidly evolving market requires an effective planning and management process. The growth in business and relationships with customers and other third parties has placed, and will continue to place, a significant strain on our management systems and resources. We will need to continue to improve our financial and managerial controls, reporting systems and procedures, and will need to continue to train and manage our work force. FollowingWe continue to strengthen our substantial reductioncompliance programs, including our compliance programs related to product certifications (in particular, certifications applicable to the automotive market), export controls, privacy and cybersecurity and anti-corruption. We may not be able to implement improvements in headcountan efficient or timely manner and may discover deficiencies in February 2020, the risks associated with strained resources are heightened.

If we fail to adequately reduceexisting controls, programs, systems and control our manufacturing, supply chain and operating costs,procedures, which could have an adverse effect on our business, reputation and financial condition,results.

We target customers that are large companies with substantial negotiating power and operating results couldpotentially competitive internal solutions; if we are unable to sell our products to these customers, our prospects will be adversely affected.

We incur significant costs related

Our potential customers, automotive OEMs in particular, are large, multinational companies with substantial negotiating power relative to procuring componentsus and, increasing our production capabilitiesin some instances, may have internal solutions that are competitive to manufacture our products. WeThese large, multinational companies also have significant resources, which may experience delays, cost overrunsallow them to acquire or other unexpected costs associateddevelop competitive technologies either independently or in partnership with others. Accordingly, even after investing significant resources to develop a product, we may not secure a series production award or, even after securing a series production award, may not be able to commercialize a product on profitable terms. If our products are not selected by these large companies or if these companies develop or acquire competitive technology or negotiate terms that are disadvantageous to us, it will have an increase in production. If we are unsuccessful in our efforts to reduce and control our manufacturing, supply chain and operating costs and keep costs aligned with the levels of revenues we generate,adverse effect on our business and financial condition could suffer.prospects.

Our technology and products incorporating our LBS technology may be subject to future environmental, health and safety regulations that could increase our development and production costs.

Our technology and products incorporating our LBS technology could become subject to future environmental, health and safety regulations or amendments that could negatively impact our ability to commercialize our technology and products incorporating our LBS technology.products. Compliance with any such current or new regulations would likely increase the cost to develop and producecommercialize products, incorporating our LBS technology, and violations may result in fines, penalties or suspension of production. If we become subject to any environmental, health, or safety laws or regulations that require us to cease or significantly change our operations to comply, our business, financial condition and operating results could be adversely affected.

Our operating results may be adversely impacted by worldwide political and economic uncertainties and specific conditions in the markets we address.

In

At various times in our history, including in the recent past, general worldwide economic conditions have experienced a downturndownturns due to slower economic activity, concerns about inflation, increased energy costs, decreased consumer confidence, reduced corporate profits and capital spending, and adverse business conditions. Any continuation or worsening of the current global economic and financial conditions could materially adversely affect: (i) our ability to raise, or the cost of, needed capital, (ii) demand for our current and future products, and (iii) our ability to commercialize products. Additionally, the outbreaks of wars or infectious diseases, including COVID-19as recently experienced, may cause an unexpected downturndeterioration in economic conditions. We cannot predict the timing, strength, or duration of any economic slowdown or subsequent economic recovery, worldwide, regionally or in the display industry.automotive or technology industries.

Because we have recently expanded and plan to continue expanding our international operations and using foreign suppliers and manufacturers, our operating results could be harmed by economic, political, regulatory and other factors in foreign countries.

11


WeDuring 2021, we established an office in Germany and on January 31, 2023 we completed our acquisition of certain assets of Ibeo, with the result that we now have more employees and operations in Germany than in the U.S. In addition, we currently use foreign suppliers and partners and plan to continue to use foreign suppliersdo so to manufacture current and future components and products, where appropriate. These international operations are subject to inherent risks, which may adversely affect us, including, but not limited to:

Our suppliers'manufacturing partners’ facilities could be damaged or disrupted by a natural disaster or labor strike, either of which would materially affect our financial position, results of operations and cash flows.

A major catastrophe, such as an earthquake, monsoon, flood, infectious disease including the COVID-19 virus, or other natural disaster, labor strike, or work stoppage at our suppliers'suppliers’ or manufacturers partners’ facilities or our customers, could result in a prolonged interruption of our business. A disruption resulting from any one of these events could cause significant delays in product shipments and the loss of sales and customers, which could have a material adverse effect on our financial condition, results of operations, and cash flows.

If we are unable to obtain effective intellectual property protection for our products, processes and technology, we may be unable to compete with other companies.

Intellectual property protection for our products, processes and technology is important and uncertain. If we do not obtain effective intellectual property protection for our products, processes and technology, we may be subject to increased competition. Our commercial success will depend, in part, on our ability to maintain the proprietary nature of our LBS technology and other key technologies by securing valid and enforceable patents and effectively maintaining unpatented technology as trade secrets.

We protect our proprietary LBS technology by seeking to obtain United States and foreign patents in our name, or licenses to third party patents, related to proprietary technology, inventions, and improvements that may be important to the development of our business. However, our patent position involves complex legal and factual questions. The standards that the United States Patent and Trademark Office and its foreign counterparts use to grant patents are not always applied predictably or uniformly and can change.

14

Additionally, the scope of patents is subject to interpretation by courts and their validity can be subject to challenges and defenses, including challenges and defenses based on the existence of prior art. Consequently, we cannot be certain as to the extent to which we will be able to obtain patents for our new products and technology or the extent to which the patents that we already own, protect our products and technology. Reduction in scope of protection or invalidation of our licensed or owned patents, or our inability to obtain new patents, may enable other companies to develop products that compete directly with ours on the basis of the same or similar technology.

We also rely on the law of trade secrets to protect unpatented know-how and technology to maintain our competitive position. We try to protect this know-how and technology by limiting access to the trade secrets to those of our employees, contractors and partners, with a need-to-know such information and by entering into confidentiality agreements with parties that have access to it, such as our employees, consultants and business partners. Any of these parties could breach the agreements and disclose our trade secrets or confidential information, or our competitors might learn of the information in some other way. If any trade secret not protected by a patent were to be disclosed to or independently developed by a competitor, our competitive position could be negatively affected.

We could be subject to significant product liability claims that could be time-consuming and costly, divert management attention and adversely affect our ability to obtain and maintain insurance coverage.

We could be subject to product liability claims if any of the product applications are alleged to be defective or cause harmful effects. For example, because some of the scanning modules incorporating our LBS technology could scan a low power beam of colored light into the user'suser’s eye, the testing, manufacture, marketing and sale of these products involve an inherent risk that product liability claims will be asserted against us.

12


Additionally, any misuse of our technology or products incorporating our LBS technology by end users or third parties that obtain access to our technology, could result in negative publicity and could harm our brand and reputation. Product liability claims or other claims related to our products or our technology, regardless of their outcome, could require us to spend significant time and money in litigation, divert management time and attention, require us to pay significant damages, harm our reputation or hinder acceptance of our products. Any successful product liability claim may prevent us from obtaining adequate product liability insurance in the future on commercially desirable or reasonable terms. An inability to obtain sufficient insurance coverage at an acceptable cost or otherwise to protect against potential product liability claims could prevent or inhibit the commercialization of our products and our LBS technology.

Our contracts and collaborative research and development agreements have long sales cycles, which makes it difficult to plan our expenses and forecast our revenues.

Our contracts and collaborative research and development agreements have long sales cycles that involve numerous steps including determining the product application, exploring the technical feasibility of a proposed product, evaluating the costs of manufacturing a product or qualifying a contract manufacturer for production. Typically, these contracts and agreements involve several face-to-face meetings before they conclude. Infectious diseases including COVID-19 may delay face-to-face meetings and closing contracts and agreements. Our long sales cycle, which can last several years, makes it difficult to predict the quarter in which revenue recognition will occur. Delays in entering into contracts and collaborative research and development agreements could cause significant variability in our revenues and operating results for any particular period.

Our contracts and collaborative research and development agreements may not lead to any product or any products that will be profitable.

Our contracts and collaborative research and development agreements, including without limitation, those discussed in this document, are exploratory in nature and are intended to develop new types of products for new applications. Our efforts may prove unsuccessful and these relationships may not result in the development of any product or any products that will be profitable.

Our operations could be adversely impacted by information technology system failures, network disruptions, or cyber security breaches.incidents.

We rely on information technology systems to process, transmit, store, and protect electronic data between our employees, our customers, manufacturing partners and our suppliers. Our systems and the third parties we rely on for related services are vulnerable to damageactual or interruptionsattempted cybersecurity incidents, such as attacks by hackers, acts of vandalism, malware, social engineering, denial or degradation of service attacks, computer viruses, software bugs or vulnerabilities, supply chain attacks, phishing attacks, ransomware attacks, misplaced or lost data, human errors, malicious insiders or other similar events. Such systems are also susceptible to other disruptions due to events beyond our control, including, but are not limited to, natural disasters, power loss, and telecommunications failures, computer viruses, hacking, or other cyber security issues.failures. Our system redundancy may be inadequate and our disaster recovery planning may be ineffective or insufficient to account for all eventualities. Additionally,

As security incidents have become more prevalent across industries we will need to continually examine, modify and update our systems. These updates or improvements may require implementation costs. In addition, we may not be able to monitor and react to all developments in a timely manner. The measures we do adopt may prove ineffective.

Any failure, or perceived failure, by us to comply with current and future regulatory or customer-driven privacy, data protection, and information security requirements, or to prevent or mitigate cyber incidents, could harm our business and expose us to potential litigation, liability, remediation costs, investigation costs, loss of revenue, damage to our reputation and loss of customers. While we maintain insurance coverage to address certain aspects of cyber risks. Suchrisks, such insurance coverage may be insufficient to cover all losses or all claims that may arise, should such an event occur.

15

We, and certain of our third-party vendors, collect and store personal information in connection with human resources operations and other aspects of our business. While we obtain assurances that any third parties we provide data to will protect this information and, where we believe appropriate, monitor the protections employed by these third parties, there is a risk the confidentiality of data held by us or by third parties may be compromised and expose us to liability for such breach.

Loss of any of our key personnel could have a negative effect on the operation of our business.

Our success depends on our executive officers and other key personnel and on the ability to attract and retain qualified new personnel. Achievement of our business objectives will require substantial additional expertise in the areas of sales and marketing, research and product development and manufacturing. Competition for qualified personnel in these fields is intense, and the inability to attract and retain additional highly skilled personnel, or the loss of key personnel, could hinder our ability to compete effectively in the LBSautomotive or technology markets and adversely affect our business strategy execution and results of operations.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.Risks Related to Development for the Automotive Industry

ITEM 2. PROPERTIES

If our products and solutions are not selected for inclusion in ADAS systems by automotive OEMs or automotive Tier 1 suppliers, our future prospects will be materially and adversely affected.

Automotive OEMs and Tier 1 suppliers design and develop ADAS technology over several years, undertaking extensive testing and qualification processes prior to selecting a product such as our lidar sensors and software for use in a particular system, product or vehicle model because such products will function as part of a larger system or platform and must meet certain other specifications. We have invested and will continue to invest significant time and resources to have our products considered and possibly selected by OEMs or Tier 1 suppliers for use in a particular system, product or vehicle model, which is known as a “series production win” or a “series production award.” In July 2017,the case of ADAS technology, a series production award would mean that our lidar sensor and/or ADAS solution had been selected for use in a particular vehicle model. However, if we are unable to achieve a series production award with respect to a particular vehicle model, we may not have an opportunity to supply our products to the automotive OEM for that vehicle model for a period of many years. In many cases, this period can be as long as five to seven or more years. If our products are not selected by an automotive OEM or our suppliers for one vehicle model or if our products are not successful in that vehicle model, it is unlikely that our product will be deployed in other vehicle models of that OEM. If we fail to win a significant number of vehicle models from one or more of automotive OEMs or their suppliers, our future business prospects will be materially and adversely affected.

The complexity of our products and the limited visibility into the various environmental and other conditions under which potential customers may use the products could result in unforeseen delays or expenses from undetected defects, errors or reliability issues in hardware or software which could reduce the market adoption of our products, damage our reputation with prospective customers, expose us to product liability and other claims, and adversely affect our operating costs.

Our products are highly technical and complex and require high standards to manufacture and may experience defects, errors or reliability issues at various stages of development. We may be unable to timely manufacture or release products, or correct problems that have arisen or correct such problems to the customer’s satisfaction. Additionally, undetected errors, defects or security vulnerabilities could result in serious injury to the end users or bystanders of technology incorporating our products, inability of customers to commercialize technology incorporating our products, litigation against us, negative publicity and other consequences. These risks are particularly prevalent in the highly competitive ADAS market. These problems may also result in claims, including class actions, against us that could be costly to defend. Our reputation or brand may be damaged as a result of these problems and potential customers may be reluctant to buy our products, which could adversely affect our financial results.

16

Adverse conditions in the automotive industry or the global economy more generally could have adverse effects on our results of operations.

While we make our strategic planning decisions based on the assumption that the markets we are targeting will grow, our business is dependent, in large part on, and directly affected by, business cycles and other factors affecting the global automobile industry and global economy generally. Automotive production and sales are highly cyclical and depend on general economic conditions and other factors, including consumer spending and preferences, changes in interest rates and credit availability, consumer confidence, fuel costs, fuel availability, environmental impact, governmental incentives and regulatory requirements, and political volatility, especially in energy-producing countries and growth markets. In addition, automotive production and sales can be affected by our automotive OEM customers’ ability to continue operating in response to challenging economic conditions and in response to labor relations issues, regulatory requirements, trade agreements and other factors. The volume of automotive production in North America, Europe and the rest of the world has fluctuated, sometimes significantly, from year to year, and we expect such fluctuations to give rise to fluctuations in the demand for our products. Any significant adverse change in any of these factors may result in a reduction in automotive sales and production by our automotive OEM customers and could have a material adverse effect on our business, results of operations and financial condition.

Developments in alternative technology may adversely affect the demand for our lidar technology.

Significant developments in alternative technologies, such as cameras and radar, may materially and adversely affect our business prospects in ways we do not currently anticipate. Existing and other camera and radar technologies may emerge as OEMs’ preferred alternative to our solution, which would result in the loss of competitiveness of our lidar solution. Our R&D efforts may not be sufficient to adapt to these changes in technology and our solution may not compete effectively with these alternative systems.

ADAS features may be delayed in adoption by OEMs, which would negatively impact our business prospects.

The ADAS market is fast evolving and there is generally a lack of an established regulatory framework. Vehicle regulators globally continue to consider new and enhanced emissions requirements, including electrification, to meet environmental and economic needs as well as pursue new safety standards to address emerging traffic risks. To control new vehicle prices, among other concerns, OEMs may need to dedicate technology and cost additions to new vehicle designs to meet these emissions and safety requirements and postpone the consumer cost pressures of new ADAS features. As additional safety requirements are imposed on vehicle manufacturers, our business prospects may be materially impacted.

Because the lidar and ADAS markets are rapidly evolving, it is difficult to forecast customer adoption rates, demand, and selling prices for our products and solutions.

We are pursuing opportunities in rapidly evolving markets, including technological and regulatory changes, and it is difficult to predict the timing and size of the opportunities. For example, lidar-based ADAS solutions require complex technology and because these automotive systems depend on technology from many companies, commercialization of ADAS products could be delayed or impaired on account of certain technological components of ours or others not being ready to be deployed in vehicles. In addition, the selling prices we are able to ultimately charge in the future for the products we are currently developing may be less than what we currently project. Our future financial performance will depend on our ability to make timely investments in the correct market opportunities. If one or more of these markets experience a shift in prospective customer demand, our products may not compete as effectively, if at all, and they may not be designed into commercialized products. Given the evolving nature of the markets in which we operate, it is difficult to predict customer demand or adoption rates for our products, selling prices or the future growth of our target markets. If demand does not develop or if we cannot accurately forecast it, the size of our markets, inventory requirements or future financial results will be adversely affected.

Because lidar is new in the markets we are seeking to enter, our market forecasts may not materialize as anticipated.

Our market opportunity estimates and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not materialize as anticipated. These forecasts and estimates relating to the expected size and growth of the markets for lidar-based technology may prove to be inaccurate. Even if these markets experience the forecasted growth we anticipate, we may not grow our business at similar rates, or at all. Our future growth is subject to many factors, including market adoption of our products, which is subject to many risks and uncertainties. Accordingly, we cannot assure you that these forecasts will not be materially inaccurate.

17

ITEM 1B.UNRESOLVED STAFF COMMENTS

None.

ITEM 1C. CYBERSECURITY

Risk Management and Strategy

Our Cybersecurity Processes

We continue to strengthen our cybersecurity measures to safeguard our information systems based on industry standards. Our measures include policies to promote internal compliance by our employees, policies and procedures to regularly evaluate the security of our information systems and implementation of third-party products, including intrusion prevention and detection solutions, multifactor identification and anti-virus software, to help detect and protect against potential cybersecurity threats. We educate our staff on cybersecurity matters with periodic risk awareness information, phishing awareness campaigns, and training materials. Moreover, given the rapid growth of our global operations in 2023 due to the Ibeo acquisition, and our expectations for near- and long-term strategic growth, our Information Technology, or IT, team is prioritizing enhancements to our response system and continuity plans.

A key dimension to the security and effectiveness of our information system is our compliance with standards that are unique to the industries in which we operate. For instance, it is critical that our information system achieves TISAX certification. Established by the German Association of the Automotive Industry, Trusted Information Security Assessment Exchange, or TISAX, is a globally recognized assessment and exchange mechanism for information security in the automotive industry. Automotive OEMs rely on the TISAX label to ensure that suppliers and partners have a solid information security management system in place. To successfully complete the TISAX assessment process in our German and U.S. operations, we are actively evaluating our cybersecurity measures and seeking enhancements, including engaging a third-party auditor and global standardization of our cybersecurity training program, to ensure a comprehensive and robust system.

We evaluate our third-party information system providers, as well as any other provider that may have access to our data, for their maturity and reliability, and as a matter of policy we choose to only work with reputable vendors.

Risks from Cybersecurity Threats

We have not encountered cybersecurity incidents that have materially affected or are reasonably likely to materially affect us, including our operations or financial condition. Any material cybersecurity incident could have a material impact on our operations by causing a disruption to our ability to function as a global organization, by interrupting our internal and external communications and reporting or managing our operations. Refer to “Item 1A. Risk Factors” in this annual report on Form 10-K, including “Our operations could be adversely impacted by information technology system failures, network disruptions, or cybersecurity breaches,” for additional discussion about cybersecurity-related risks.

Governance

Board of Directors and Audit Committee

With delegated authority from our Board of Directors and in accordance with its charter, our Audit Committee is charged with the oversight of enterprise risk, including risk related to cybersecurity threats. Our Audit Committee Chair is expected to report regularly to our Board of Directors about our Audit Committee’s oversight of enterprise risk. Beginning in 2024, our Audit Committee Chair will report quarterly to our Board of Directors specifically about our cybersecurity incident management and governance.

18

Management, and specifically our Chief Financial Officer, reports to our Audit Committee on cybersecurity, including initiatives and strategies, and incident reporting and any lessons learned. Beginning in 2024, our Chief Financial Officer will make this report on a quarterly basis. From time to time, management will also engage in informal discussions with members of the Audit Committee about our cybersecurity practices and risks, including informing our Audit Committee Chair in a timely manner about any cybersecurity incidents that management determines may have a significant impact on our operations or that may trigger any reporting obligations.

Our Audit Committee will conduct an annual review of our cybersecurity measures and the effectiveness of our risk management strategies.

Management

Anubhav Verma, joined MicroVision in 2021 as our Chief Financial Officer. He is an experienced risk management professional and currently oversees the Company’s accounting and finance strategies, including risk management. Mr. Verma also oversees our IT team and, with regular communication with the team, is responsible for approving the IT budget, hiring of IT personnel, including third-party consultants, and approving cybersecurity processes and other cybersecurity-related matters. Although we do not currently employ a chief information security officer, we are working with an outside consulting firm that is serving in this role and assisting our internal team with the primary responsibility of overseeing our cybersecurity measures and risks.

The day-to-day responsibility for assessing, monitoring and managing our cybersecurity risks resides with our IT team. Across the IT team we have employees who have in-depth knowledge and decades of cybersecurity industry experience, including prior experience with developing and overseeing cybersecurity polices and processes for companies required to comply with NIST SP800-171, cybersecurity standards for companies that store sensitive unclassified information on behalf of the United States government, and former Ibeo employees having experience with TISAX compliance. Yet, we recognize the evolving and increasing threat that cybersecurity will have on our operations. As part of our long-term growth strategy, we expect to establish a dedicated cybersecurity team to oversee our cybersecurity risk management.

The IT Team Director regularly meets with the Chief Financial Officer and as appropriate the Chief Executive Officer to discuss cybersecurity risks. This ensures that management is informed about our current cybersecurity measures and aware of any potential risks facing our operations. In the event of a cybersecurity incident, we have put in place a reporting structure to inform the Chief Financial Officer, Chief Executive Officer and General Counsel promptly of any incident so that they may assess the appropriate response to the incident and any reporting concerns that may be triggered by the incident.

ITEM 2.PROPERTIES

In September 2021, we entered into a 65 month facility lease amendment on 31,142approximately 16,681 square feet of combined use office, laboratory and manufacturing space at our headquarters facilitylocated in Redmond, Washington.Washington that we use primarily for general office space. The lease agreement includes extension and rent escalation provisions over theprovides for an initial term of the lease.128 months that commenced November 1, 2021.

13


ITEM 3. LEGAL PROCEEDINGSIn September 2021, we entered into a second lease on approximately 36,062 square feet of space located in Redmond, Washington that we use primarily for product testing and lab space. The lease provides for an initial term of 120 months and commenced on December 1, 2022.

In March 2019,April 2022, we filedentered into a Noticelease on approximately 3,533 square feet of Arbitrationspace located in Hong Kong against Ragentek asNuremberg, Germany that we use primarily for general office space for business development activities. The lease provides for a resultterm of its failure60 months that commenced May 1, 2022.

In September 2022, we entered into a second lease on approximately 3,810 square feet of space located in Nuremberg, Germany that we use primarily for product testing for engineering and development activities. The lease provides for a term of 60 months that commenced November 15, 2022.

19

In connection with our January 2023 acquisition of assets from Ibeo, we assumed three leases in Hamburg, Germany covering approximately 45,208 square feet of office space, garages to perform its obligations underhouse test and demonstration vehicles, space for IT network equipment, and long-range laser testing space.

In December 2023, we entered into a purchase order with us.  During 2019,lease on approximately 60,000 square feet of space located in Hamburg, Germany that we reached an agreement withwill use primarily for general office space and product testing. This lease is intended to replace the distributoroffice space described in our Ragentek contractthe immediately preceding paragraph. The lease provides for a term of 60 months and will commence on the final transaction pricedate the property is delivered to us, which is expected to occur between August 1, 2024 and December 31, 2024.

We believe that our facilities are adequate to meet our needs for the immediate future, and that, should it be needed, suitable additional or substitute space will be available to accommodate any such expansion of our operations. For a further description of our leased properties, see Note 11, Leases, of the units shipped to them. As part of the agreement reached in 2019, we agreed to return $432,000 of the original transaction pricenotes to our distributor. During 2020, payments totaling $332,000 were madeconsolidated financial statements included elsewhere in this Annual Report, which is incorporated by reference in response to the distributor and we settled all claims with Ragentek and our distributor. Per the terms of the agreement in 2020, the final $100,000 payment to our distributor was no longer required. Upon settlement we dismissed the arbitration.this item.

ITEM 3. LEGAL PROCEEDINGS

We are also subject to various claims and pending or threatened lawsuits in the normal course of business. We are not currently party to any other legal proceedings that management believes are reasonably possible to have a material adverse effect on our financial position, results of operations or cash flows.

ITEM 4. MINE SAFETY DISCLOSURES

ITEM 4.MINE SAFETY DISCLOSURES

Not applicable.

ITEM 4A. EXECUTIVE OFFICERS OF THE REGISTRANT

ITEM 4A.EXECUTIVE OFFICERS OF THE REGISTRANT

Executive officers are appointed by our Board of Directors and hold office until their successors are elected and duly qualified. The following persons serve as executive officers of MicroVision, Inc.:

Sumit Sharma, age 47,50, was appointed Chief Executive Officer in February 2020 and served as Chief Operating Officer from June 2018 to February 2020, after serving as Vice President of Product Engineering and Operations since February 2017 and Vice President and Senior Director of Operations since September 2015. Prior to MicroVision, from April 2015 to September 2015, he was a Product Development and Operations consultant at BlueMadison Consulting. From November 2013 to March 2015, he was the Senior Director, Advanced Manufacturing Operations and Technology Development at Jawbone. From March 2011 to October 2013, he was the Head of Manufacturing Operations for project GLASS at Google. Mr. Sharma has extensive experience in optics, wearable technology, product development and qualification for automotive industry. Mr. Sharma also has deep experience in global operations and developing strategic partnerships. A patent holder, Mr. Sharma received his baccalaureate degree in engineering from New Jersey Institute of Technology.

Stephen P. Holt,

Anubhav Verma, age 58,38, joined MicroVision in April 2013November 2021 as Chief Financial Officer. Prior to MicroVision, from May 2007October 2016 to May 2012,November 2021, he servedled several growth initiatives including M&A and Capital Market transactions as Chief Financial OfficerSenior Vice President Finance of PixelOptics, where he played a lead role in bringing the company's first electronic focusing eyewear productExela Technologies. From November 2013 to market. At this venture capital-backed start-up, Mr. Holt raised capital and negotiated strategic partner agreements to license technology in addition to implementing policies and procedures to create an infrastructure capable of supporting rapid growth while maintaining a strong internal control environment. From March 2006 to April 2007,October 2016, he was an Investment Professional of HandsOn Global Management driving end-to-end M&A deals including post-merger integration along with several rounds of capital market financings. From July 2009 to October 2013, he advised several Fortune 500 companies as an Investment Banker at Credit Suisse in their New York and Mumbai offices. Mr. Verma has extensive experience in Mergers and Acquisitions (M&A), Capital Markets and Strategic Finance roles for publicly listed and privately held companies. Mr. Verma received a Bachelor of Technology degree in engineering and a Masters of Technology degree in engineering from the Chief Financial OfficerIndian Institute of Interstate Distributors,Technology, Bombay.

20

Drew Markham, age 56, joined MicroVision in June 2021 as Vice President, General Counsel and Secretary. Before joining MicroVision, from January 2017 through June 2021, Ms. Markham was President at Avisé, a truckingsocial purpose corporation, where she was a legal consultant to publicly traded technology companies. From January 2013 to December 2016, she was Vice President, Deputy General Counsel & Assistant Secretary at RealNetworks, Inc. From June 1999 to December 2012, she was an attorney with Wilson Sonsini Goodrich & Rosati. Ms. Markham received her Juris Doctor degree from the University of Washington School of Law and transportation services company. From December 2003 to March 2006, he washer Bachelor of Science degree in Accounting from the Chief Financial OfficerUniversity of a group of companies consisting of Activelight, Boxlight, Cinelight and Projector Wholesale Supply. These companies were value-added resellers and distributors of audio-visual and projection equipment. Mr. Holt, a Certified Management Accountant, holds a B.S. from California State University, Chico and an M.B.A. from Santa Clara University.Florida.

14


PART II.

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock began trading publicly on August 27, 1996. Our common stock trades on The Nasdaq Global Market under the ticker symbol "MVIS."“MVIS.” We have never declared or paid cash dividends on our common stock. We currently anticipate that we will retain all future earnings to fund the operations of our business and do not anticipate paying dividends on the common stock in the foreseeable future.

As of March 9, 2021,February 26, 2024, there were approximately 115144 holders of record of 157,327,415195,267,385 shares of common stock outstanding. As many of our shares of common stock are held by brokerages and institutions on behalf of shareholders, we are unable to estimate the total number of beneficial holders of our common stock represented by these record holders.

ITEM 6. SELECTED FINANCIAL DATA

Not applicable.Stock Performance Graph

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

We are developing our 1st generation lidar sensor, which we call Long Range Lidar, for OEM and Tier-1 automotive suppliersThis performance graph shall not be deemed to be “soliciting material” or “filed” or incorporated intoby reference in future filings with the Securities and Exchange Commission, or subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

The following graph shows a comparison from 2018 through 2023 of the cumulative total return for our common stock, the Russell 2000 Index and the Dow Jones US Electronic and Electrical Equipment Index. Our prior annual reports had included cumulative total return from the NASDAQ Electrical Components Index, however it is not included on this graph because the index has been discontinued. The comparisons in the graph are historical and are not intended to forecast or be indicative of possible future performance of our common stock.

21

Recent Sales of Unregistered Securities

On November 21, 2023, pursuant to subscription agreements dated as of November 14, 2023, between us and each of the purchasers, we sold in the aggregate 50,761 shares of our common stock, par value $0.001 per share (“Common Stock”), at $1.97 per share, for an aggregate purchase price of approximately $0.1 million. The purchasers consisted of our Chief Executive Officer, Chief Financial Officer, General Counsel and certain members of our Board of Directors.

On March 13, 2023, pursuant to a subscription agreement dated as of March 13, 2023, we sold to our Chief Executive Officer 100,000 shares of Common Stock, at $2.14 per share, for an aggregate purchase price of $0.2 million.

The sales of our Common Stock described above were each undertaken in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2).

ITEM 6. RESERVED

ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONAND RESULTS OF OPERATIONS

The following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and the related notes included in Part II, Item 8 of this Form 10-K. The following discussion focuses on the results of our operations for the year ended December 31, 2023 compared to the year ended December 31, 2022. Similar discussion of the results of our operations for the year ended December 31, 2022 compared to the year ended December 31, 2021 can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2022.

22

Overview

Currently, our development and commercialization efforts are focused primarily on automotive active collision avoidancelidar and advanced driver-assistance systems (ADAS) markets where we can deliver safe mobility at the speed of life. Our integrated solution combines our lidar sensors, including our MEMS-based dynamic-range and autonomous driving vehicles. This product will alsoflash-based short/mid-range, with perception software, to be integrated on our custom ASIC, targeted for salessale to technology companies focused on Mobility as a Service (MaaS). MaaS customers are currently major users ofpremium automotive lidar sensors. ThoughOEMs and Tier 1 automotive suppliers.

Although automotive lidar is our priority now, we have developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

For In the recent past, few years, our strategy hashad been to sell AR displays or components, Interactive Displays, or Consumer Lidars to original equipment manufacturers (OEMs) and original design manufacturers (ODMs) for incorporation into their products. However, while we do have a well-known customer for one of these products which generates royalty income, the volume of sales and resulting royalties from that product are not significant, and we have been unable to secure additional customers to launch one of our products.

As discussed above, we plan to focus our attention on strategic alternatives, including a potential sale or merger of the Company, sale of part of the Company, strategic minority investment, as well as licensing and other transactions.

We have incurred substantial losses since inception and expect to incur a significant loss during the fiscal year ending December 31, 2021.2024. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from development contract revenues, product sales and licensing activities. There can be no assurance that additional capital will be available or that, if available, it will be available on terms acceptable to us on a timely basis. We cannot be certain that we will succeed in commercializing our technology or products.

Impact of COVID-19 on Our Business

On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which continues to be spread throughout the United States and the world. The impact from the COVID-19 outbreak is uncertain and may impact our business and results of operations and could impact our financial condition in the future. We are unable to accurately predict the full impact that COVID-19 may have due to numerous uncertainties, including the severity, duration and spread of the outbreak, and actions that may be taken by governmental authorities.

Several of the suppliers of components in our LBS modules have experienced closures or have been operating at reduced capacity, resulting in lower than planned product shipments. Continued disruptions to the supply chain could have a material impact on our future operating results.

As a result of the COVID-19 pandemic, including related governmental guidance or directives, we are still requiring most office-based employees to work remotely. We may experience reductions in productivity and disruptions to our

15


business routines while our remote work policy remains in place or if our employees become ill and are unable to work. This could have an adverse effect on the timing of our development activities, our ability to raise additional capital, our ability to enter into licensing agreements, or our ability to complete a potential sale or merger of the Company.

In April 2020, we received funds in the amount of $1.6 million pursuant to a loan under the Paycheck Protection Program of the 2020 CARES Act ("PPP") administered by the Small Business Administration. The loan has an interest rate of 0.98% and a term of 24 months. No payments are due for the first 10 months following the 24-week covered period, although interest accrues during that period. Thereafter, the loan is repayable in monthly installments over the next 18 months to retire the loan plus accrued interest. Funds from the loan may only be used for certain purposes, including payroll, benefits, rent and utilities, and a portion of the loan used to pay certain costs may be forgivable, all as provided by the terms of the PPP. The CARES Act reduces the amount of the PPP loan that may be forgiven if the borrower reduces full-time equivalent employees during the covered period as compared to a base period. As of December 31, 2020, all of the funds received under the PPP had been used for qualified purposes. We intend to apply for partial forgiveness of the loan under PPP guidelines. Based on the terms of the PPP, we estimate the amount of the loan that will be forgiven will be approximately $690,000, subject to approval by our lender in accordance with PPP guidelines. The loan is evidenced by a promissory note, which contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. We may prepay the loan at any time prior to maturity with no prepayment penalties.

Key accounting policies and estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that materially affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities. We evaluate our estimates on a continuous basis. We base our estimates on historical data, terms of existing contracts, our evaluation of trends in the consumer display and 3D sensing industries, information provided by our current and prospective customers and strategic partners, information available from other outside sources and on various other assumptions we believe to be reasonable under the circumstances. The results form the basis for making judgments regarding the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We believe the following key accounting policies require significant judgments and estimates used in the preparation of our consolidated financial statements.

Revenue recognition

23

Revenues are recognized when control

Business combination

Our business combination is accounted for under the acquisition method. We allocate the fair value of purchase consideration to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The excess of the promised goods or services are transferred to our customers, in an amount that reflects the consideration that we expect to receive in exchange for those goods or services. We generate all of our revenue from contracts with customers.

Our contract revenue in a particular period is dependent upon when we enter into a contract, thefair value of the contracts we have entered into,underlying net assets acquired and liabilities assumed over the availabilitypurchase consideration is included in bargain purchase gain in the Consolidated Statement of technical resourcesOperations. Such valuations require management to perform workmake significant estimates and assumptions, especially with respect to intangible assets.

Intangible assets

Our intangible assets consist of acquired technology from the January 2023 Ibeo asset purchase and purchased patents. The estimated fair value of acquired technology was calculated through the income approach using the multi-period excess earnings and relief from royalty methodologies. The intangible assets are amortized using the straight-line method over their estimated period of benefit, ranging from one to seventeen years. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying value may not be recoverable. Recoverability of these assets is measured by comparison of their carrying values to the projected undiscounted net cash flows associated with the related intangible assets or group of assets over their remaining lives. Measurement of an impairment loss for our intangible assets is based on the contracts. We recognize contract revenue either at a point in time, or over time, depending upondifference between the characteristics of the individual contract. If control of the deliverable(s) occur over time, the revenue is recognized in proportion to the transfer of control. If control passes to the customer only upon completion and transferfair value of the asset revenue is recognized at the completion of the contract. In contracts that include significant customer acceptance provisions, we recognize revenue only upon acceptance of the deliverable(s).and its carrying value.

We identify each performance obligation in our development contracts at contract inception. The contracts generally include product development and customization specified by the customer. In contracts with multiple performance obligations, we identify each performance obligation and evaluate whether the performance obligations are distinct within the context of the contract. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Performance obligations that are not distinct at contract inception are combined.

If we identify multiple distinct performance obligations, we evaluate each performance obligation to determine if there is a stand-alone selling price. In instances where stand-alone selling price is not directly observable, such as when we do not sell the product or service separately, we determine the stand-alone selling price using information that may

16


include market conditions and other observable inputs. Judgment is required to determine the stand-alone selling price for each distinct performance obligation.

Our development contracts are primarily fixed-fee contracts. If control of deliverables occurs over time, we recognize revenue on fixed fee contracts on the proportion of total cost expended (under Topic 606, the `input method') to the total cost expected to complete the contract performance obligation. For contracts that require the input method for revenue recognition, the determination of the total cost expected to complete the performance obligations on fixed fee contracts involves significant judgment. We incorporate revisions to hour and cost estimates when the causal facts become known.

Share-based compensation

We issue share-based compensation to employees in the form of stock options, and restricted stock units (RSUs), and performance stock units (PSUs). We account for the share-based awards by recognizing the fair value of share-based compensation expense on a straight-line basis over the service period of the award, net of estimated forfeitures. The fair value of stock options is estimated on the grant date using the Black-Scholes option pricing model. The fair value of RSUs and non-executive PSUs is determined by the closing price of our common stock on the grant date or the period end date for the awards that are being measured by the service inception date. TheFor performance-based awards, expense is recognized when it is probable the performance criteria will be achieved. If the likelihood becomes improbable that the performance criteria will be achieved, the expense is reversed. Executive PSUs that have market-based performance criteria are valued using a binomial option pricing model using the following inputs: stock price, volatility, and risk-free interest rates. Changes in estimated inputs or using other option valuation methods may result in materially different option values and share-based compensation expense.

Leases

Leases

Significant judgment may be required when determining whether a contract contains a lease, the length of the lease term, the allocation of the consideration in a contract between lease and non-lease components, and the determination of the discount rate included in our office lease. We review the underlying objective of each contract, the terms of the contract, and consider our current and future business conditions when making these judgments.

Income taxes

Significant judgment is required in evaluating our tax position and in determining our provision for income taxes, our deferred tax assets and liabilities and any valuation allowance recorded against our net deferred tax assets. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. Based on our history of losses since inception, the available objective evidence creates sufficient uncertainty regarding the realizability of the deferred tax assets. Our actual tax exposure may differ from our estimates and any such differences may impact income our tax expense in the period in which such determination is made.

The key accounting policies described above are not intended to be a comprehensive list of all of our accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated by generally accepted accounting principles, with no need for us to apply judgment or make estimates. There are also areas in which our judgment in selecting any available alternative would not produce a materially different result to our financial statements. Additional information about our accounting policies, and other disclosures required by generally accepted accounting principles, are set forth in the notes to our financial statements.

Inflation has not had a material impact on our revenues or income from continuing operations over the three most recent fiscal years.

Results of Operations

YEAR ENDED DECEMBER 31, 20202023 COMPARED TO YEAR ENDED DECEMBER 31, 2019.2022.

Product revenue

      % of     % of      
      total     total      
   2020  revenue  2019  revenue  $ change  % change
(In thousands)                  
Product revenue $1,347   43.6  $5,345   60.2  $(3,998)  (74.8)

17


Revenue

  2023  2022  $ change  % change 
(In thousands)                
Revenue $7,259  $664   6,595   993.2 

Product revenue is revenue from sales of our products which

Revenues are LBS modules and their components. Revenue is recognized when control of the promised goods passesor services are transferred to our customers, in an amount that reflects the customer.

The decrease in product revenue for the year ended December 31, 2020 compared to the same period in 2019 was primarily due to reduced product shipments to a major technology company. Beginning in the third quarter of 2019 and through the end of February 2020, we were selling components to a high definition display systemconsideration that we developedexpect to receive in exchange for a customer under a development agreement. The volume and resulting revenue and gross profit from this business was fairly low. Therefore, in March 2020 we transferred production of the components to the customer. Starting in March 2020, we earn a royalty from the customer for each unit shipped.

Product revenue in 2019 included $1.2 million related to the sale of display modules that had been produced for Ragentek and delivered to our distributor in 2017. Our distributor made payments in excess of revenue recognized and Ragentek failed to meet their obligations under the March 2017 order. During 2019, the remaining units held by our distributor were sold to other customers and we reached an agreement with our distributor on the final transaction price of the units shipped to them.

Product revenue backlog at December 31, 2020 and 2019 was zero and $6.7 million, respectively. The December 31, 2019 backlog was primarily due to the production orders received from a major technology company under the product supply agreement signed in April 2017. The reduction in product backlog was due to the transferring of production to our customer.

License and royalty revenue

      % of     % of      
      total     total      
   2020  revenue  2019  revenue  $ change  % change
(In thousands)                  
License and royalty revenue $1,718   55.6  $99   1.1  $1,619   1,635.4 

License and royalty revenue is revenue under license agreements to our PicoP® scanning technology.those goods or services. We recognize revenue on upfront license fees at a point in time if the nature of the license granted is a right-to-use license, representing functional intellectual property with significant standalone functionality. If the nature of the license granted is a right-to-access license, representing symbolic intellectual property, which excludes significant standalone functionality, we recognize revenue over the period of time we have ongoing obligations under the agreement. We will recognize revenue from sales-based royalties on the basis of the quarterly reports provided by our customer as to the number of royalty-bearing products sold or otherwise distributed. In the event that reports are not received, we will estimate the number of royalty-bearing products sold by our customers.

In March 2020, we entered into an agreement for our customer to take over production of the components we had been producing for them. The agreement provides that, beginning in March 2020, we will earn a royalty on each component shipped that is approximately equal to the gross profit we would have earned if we continued to produce and ship the components. The increase in license and royalty revenue for the twelve months ended December 31, 2020 compared to the same period in 2019 was primarily due to this change, moving to a royalty arrangement from recognizing product revenue.

Contract revenue

      % of     % of      
      total     total      
   2020  revenue  2019  revenue  $ change  % change
(In thousands)                  
Contract revenue $25   0.8  $3,442   38.7  $(3,417)  (99.3)

Contract revenue includes revenue from performance on development contracts and the sale of prototype units and evaluation kits based on our PicoP® scanning module. Our contract revenue in a particular period is dependent upon when we enter into a contract, the value of the contracts we have entered into, and the availability of technical resources to perform work on the contracts. We recognize contract revenue either at a point in time, or over time, depending upon the characteristics of the individual contract. If control of the deliverable(s) occurtransfers over time, the revenue is recognized in proportion to the transfer of control. If control passes to the customer only upon completion

18


and transfer of the asset, revenue is recognized at the completion of the contract.

In contractsApril 2017, we signed a contract with Microsoft Corporation to develop an LBS display system; the contract terminated effective December 31,2023. Under the agreement, we received an upfront payment of $10.0 million. In March 2020, Microsoft took over production of components that include significant customer acceptance provisions, we recognizehad been producing for them. As a result, beginning in March 2020, we earned a royalty on each component shipped approximately equal to the gross profit we would have earned if we had continued to produce and ship the components. The increase in revenue only upon acceptance of the deliverable(s).

The decrease in contract revenue duringfor the year ended December 31, 20202023 compared to the same period in 20192022 was attributedprimarily due to decreased contract activity becausethe recognition of the remaining $4.6 million of revenue as we believe the likelihood of further deliveries under the contract is remote. We do not expect to recognize any further revenue in connection with this contract.

The remaining increase in revenue during the twelve months ended December 31, 2023 compared to the prior year was primarily a result of customer contracts assumed in connection with our April 2017 customer was completed in 2019. Our contractJanuary 2023 acquisition of assets from Ibeo.

The revenue backlog including orders for prototype units and evaluation kits, atduring the twelve months ended December 31, 2020 and 20192023 was zero.$3.1 million as compared to $0.0 million in 2022.

24

Cost of product revenue

      % of     % of      
      product     product      
   2020  revenue  2019  revenue  $ change  % change
(In thousands)                  
Cost of product revenue $1,394   103.5  $6,692   125.2  $(5,298)  (79.2)

     % of     % of       
  2023  revenue  2022  revenue  $ change  % change 
(In thousands)                        
Cost of revenue $2,772   38.2  $100   

n/a

  $2,672   2,672.0 

Cost of product revenue includes the direct and allocated indirect costs of products and services sold to customers. Direct costs include labor, materials, reserves for estimated warranty expenses, and other costs incurred directly, or charged to us by our contract manufacturers, in the manufacture of these products. Indirect costs include labor, manufacturing overhead, and other costs associated with operating our manufacturing capabilities and capacity. Manufacturing overheadcapabilities. Overhead includes the costs of procuring, inspecting and storing material, facility and other costs, and is allocated to cost of product revenue based on the proportion of indirect labor which supported productionrevenue activities.

Cost of product revenue can fluctuate significantly from period to period, depending on the product mix and volume, the level of manufacturing overhead expense and the volume of direct material purchased. CostThe increase in cost of product revenue was lower duringfor the twelve months ended December 31, 20202023 compared to the same period in 20192022 was primarily due to lower product shipments to a major technology company and lower inventory write-downs. Inventory write-downsthe amortization of $168,000 and $2.2 million were recordedintangible assets obtained in the twelve months ended December 31, 2020 and 2019, respectively.

Costacquisition of contract revenue

      % of     % of      
      contract     contract      
   2020  revenue  2019  revenue  $ change  % change
(In thousands)                  
Cost of contract revenue $  16.0  $1,872   54.4  $(1,868)  (99.8)

CostIbeo assets of contract revenue includes both the direct and allocated indirect costs of performing on contracts and producing prototype units and evaluation kits. Direct costs include labor,$1.4 million. The increase in 2023 was also driven by materials and other costs incurred directly in producing prototype units and evaluation kits or performing on a contract. Indirect costs include labor and other costs associated with operating our research and development department and building our technical capabilities and capacity. Cost of contractthe corresponding increase in revenue is determined by the level of direct and indirect costs incurred, which can fluctuate substantially from period to period.this year.

The decrease in the cost of contract revenue during the year ended December 31, 2020 compared to the same period in 2019 was attributed to reduced activity on the April 2017 development contract because the contract was completed in 2019.

Research and development expense

         2020  2019  $ change  % change
(In thousands)                  
Research and development expense       $9,840  $18,661  $(8,821)  (47.3)

  2023  2022  $ change  % change 
(In thousands)                
Research and development expense $56,707  $30,413  $26,294   86.5 

Research and development expense consists of compensation related costs of employees and contractors engaged in internal research and product development activities, direct material to support development programs, laboratory operations, outsourced development and processing work, and other operating expenses. We assign our research and development resources based on the business opportunity of the available projects, the skill mix of the resources available and the contractual commitments we have made to our customers. We believe that a substantial level of continuing research and development expenseexpenses will be required to further develop our scanning technology.

19


The decreaseincrease in research and development expense during the year ended December 31, 20202023 compared to the same period in 20192022 was attributableprimarily due to reduced personnel-related compensationthe Ibeo acquisition that resulted in higher salary and benefits expenses as a result of increased headcount of $21.2 million, increased depreciation expenses of $1.6 million, increased facilities and lower direct materials and subcontractor costs.information technology expenses of $1.6 million compared to the prior year.

Sales, marketing, general and administrative expense

         2020  2019  $ change  % change
(In thousands)                  
Sales, marketing, general and administrative expense       $5,917  $8,133  $(2,216)  (27.2)

  2023  2022  $ change  % change 
(In thousands)                
Sales, marketing, general and administrative expense $36,689  $24,041  $12,648   52.6 

Sales, marketing, general and administrative expense includes compensation and support costs for marketing, sales, management and administrative staff, and for other general and administrative costs, including legal and accounting services, consultants and other operating expenses.

The decreaseincrease in sales, marketing, general and administrative expense during the year ended December 31, 20202023 as compared to the same period in 20192022 was attributedprimarily due to lower personnel-related compensationthe Ibeo acquisition that resulted in increased salary and benefits expenses and loweras a result of increased headcount of approximately $7.0 million, increased professional and outside services costs. At the end of 2020 there were no sales or marketing personnel$1.3 million incurred in connection with the Company.

Income taxesIbeo acquisition, increased non-cash compensation expense of $1.1 million, increased depreciation expense of $1.1 million and increased purchased labor of $0.7 million.

No provision for income taxes has been recorded because we have experienced

25

Bargain purchase gain, net losses from inception throughof tax

  2023  2022  $ change  % change 
(In thousands)            
Bargain purchase gain, net of tax $1,669  $-  $1,669   - 

During the twelve months ended December 31, 2020. At2023, we recorded a bargain purchase gain related to the acquisition of assets from Ibeo. The bargain purchase gain represents the excess of the fair value of the underlying net assets acquired and liabilities assumed over the purchase consideration paid in the transaction.

Other income (expense), net

  2023  2022  $ change  % change 
(In thousands)            
Other income (expense), net $5,510  $799  $4,711   589.6 

The increase in other income during the twelve months ended December 31, 2020,2023 compared to the same period in 2022 is due to a payment of $3.0 million as an incentive to terminate our previous building lease. The remainder of the increase is primarily due to income from investment securities.

Income taxes

During the years ended December 31, 2023 and 2022, we recognized tax expense of $1.1 million and $0.0 million, respectively, mainly related to income in foreign jurisdictions offset, partially offset by a deferred income tax benefit generated by the reduction to a deferred tax liability created as a result of the acquisition of Ibeo in Q2 2023. The change in income tax expense during the year ended December 31, 2023 was largely the result of profitability in foreign jurisdictions related to the Ibeo acquisition. As of December 31, 2023, we had net operating loss carryforwards of approximately $396.6$463.1 million for federal income tax reporting purposes. In addition, we have research and development tax credits of $8.8$10.1 million. During 2020, $28.42023, $23.1 million federal net operating losses and $0.3 million general business credits expired unused. A majority of the net operating loss carryforwards and research and development credits available to offset future taxable income, if any, will expire in varying amounts from 20212024 to 2040,2043, if not previously used.

In certain circumstances, as specified in the Internal Revenue Code, a 50% or more ownership change by certain combinations of our shareholders during any three-year period would result in a limitation on our ability to use a portion of our net operating loss carryforwards.

We recognize interest accrued and penalties related to unrecognized tax benefits in tax expense. We did not have any unrecognized tax benefits at December 31, 20202023 or at December 31, 2019.2022.

Liquidity and Capital Resources

We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from development contract revenues, product sales, and licensing activities. At December 31, 2020,2023, we had $16.9$45.2 million in cash and cash equivalents.

equivalents and $28.6 million in investment securities. We also have approximately $19.0 million availability left on our existing $35.0 million ATM facility that was put in place in the third quarter of 2023. Based on our current operating plan for 2024 and including $61.4 million received in 2021 under At-the-Market equity offering agreements with Craig-Hallum Capital Group,beyond, we anticipate that we have sufficient cash and cash equivalents to fund our operations for at least the next 12 months. We may require additional capital to fund our operating plan past that time. We may obtain additional capital through the issuance of equity or debt securities, and/or licensing activities. There can be no assurance that additional capital will be available to us or, if available, will be available on terms acceptable to us or on a timely basis. If adequate capital resources are not available on a timely basis, we intend to consider limiting our operations substantially. This limitation of operations could include further reductions in our research and development projects, staff, operating costs, and capital expenditures.

Operating activities

Cash used in operating activities totaled $16.1$67.1 million during 2020,2023, compared to $24.0$38.0 million in 2019.2022. Cash used in operating activities resulted primarily from cash used to fund our net loss, after adjusting for non-cash charges such as share-based compensation, depreciation and amortization charges and changes in operating assets and liabilities. The changes in cash used in operating activities were primarily attributed to reducedthe Ibeo acquisition that resulted in increased operating expenses to support the development of our lidar sensors. During the second half of 2023, we made a payment of $3.1 million to our contract manufacturing partner in connection with the buildup of MOVIA sensor inventory for direct sales to both automotive and non-automotive customers. Moreover, we expect to make additional payments to this partner totaling approximately $6.2 million over the timingfirst six months of 2024 in line with agreed-upon deliveries.

20


payments received from customers during the year ended December 31, 2020 compared to the year ended December 31, 2019.

Investing activities

Cash provided by investing activities totaled $123,000$21.8 million in 2020,2023, compared to cash used in investing activities of $745,000$38.1 million in 2019. 2022. During the yeartwelve months ended December 31, 2020,2023, we purchased short-term investment securities totaling $41.7 million and sold fixed assets to our customer for $525,000 as part of our agreement with them to take over production ofshort-term investment securities totaling $76.7 million. During the componentstwelve months ended December 31, 2022, we had been producing.purchased short-term investment securities totaling $90.2 million and sold short-term investment securities totaling $60.6 million. Purchases of property and equipment during the twelve months ended December 31, 20202023 and 20192022 were $402,000$2.0 million and $745,000,$4.4 million, respectively. During the twelve months ended December 31, 2023, we made payments totaling $11.2 million related to the acquisition of Ibeo assets. We expect to make the final payment related to the Ibeo acquisition of approximately $3.0 million and we expect restricted cash of $3.3 million to be released from escrow to Ibeo during the first quarter of 2024. In 2022, operating funds advanced to Ibeo during the pre-closing period totaling $4.1 million were included in cash used in investing activities.

Financing activities

Cash provided by financing activities totaled $27.0$72.4 million in 2020,2023, compared to $16.9$14.3 million in 2019. Principal2022. During the year ended December 31, 2022, we made principal payments under finance leases were $29,000long-term debt totaling $0.4 million related to the loan under the Paycheck Protection Program of the 2020 CARES Act (PPP) administered by the Small Business Administration compared to $0.5 million in 2020 and $20,000 in 2019.the prior year. Proceeds received from stock option exercises totaled $0.3 million during 2023 compared to $0.7 million during 2022.

26

The following is a list of our financing activities during 20202023 and 2019.

In addition to the $6.1 million received in January 2021 for the 1.0 million shares of common stock that were issued in December 2020 under the ATM equity offering agreement with Craig-Hallum, we have raised an additional $55.3 million in 2021. Please see Note 17 Subsequent Events for additional details.2022.

21


In August 2023, we entered into a $35.0 million ATM equity offering agreement with Craig-Hallum. Under the agreement, we are able, at our discretion, to offer and sell shares of our common stock having an aggregate value of up to $35.0 million through Craig-Hallum. As of December 31, 2023, we had completed sales under such sales agreement, having sold 6.1 million shares for net proceeds of $15.5 million. As of December 31, 2023, we have approximately $19.0 million available under this ATM agreement.
In June 2023, we entered into a $45.0 million ATM equity offering agreement with Craig-Hallum. Under the agreement, we were able, at our discretion, to offer and sell shares of our common stock having an aggregate value of up to $45.0 million through Craig-Hallum. As of June 30, 2023, we had completed sales under such sales agreement, having sold 10.9 million shares for net proceeds of $43.9 million. No further shares are available for sales under this agreement.
In June 2021, we entered into a $140.0 million ATM equity offering agreement with Craig-Hallum. Under the agreement we were able, at our discretion, to offer and sell shares of our common stock having an aggregate value of up to $140.0 million through Craig-Hallum. As of December 31, 2022, we had issued 8.3 million shares of our common stock for net proceeds of $81.8 million under this ATM agreement. During the quarter ended March 31, 2023, we issued 5.0 million shares of our common stock for net proceeds of $12.5 million under the agreement. The sales agreement was terminated in June 2023.

Our capital requirements will depend on many factors, including, but not limited to, the rate at which OEMs and ODMsother potential customers introduce products incorporating our LBS technology and the market acceptance and competitive position of such products. Our ability to raise capital will depend on numerous factors, including the following:

Perceptions of our ability to continue as a going concern;
Market acceptance of products incorporating our technology;
Changes in evaluations and recommendations by any securities analysts following our stock or our industry generally;
Announcements by other companies in our industry;
Changes in business or regulatory conditions;
Announcements or implementation by our competitors of technological innovations or new products;
The status of particular development programs and the timing of performance under specific development agreements;
Economic and stock market conditions;
The cost of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;
Our ability to establish cooperative development or licensing arrangements; or
Other factors unrelated to our company or industry.

If we are successful in establishing OEM or ODM co-development and joint venture arrangements, we expect our partners to fundmay receive full or partial funding for certain non-recurring engineering costs for technology development and/or for product development. Nevertheless, we expect our capital requirements to remain high as we expand our activities and operations with the objective of commercializing our LBS technology.

27

Contractual obligations

The following table lists our contractual obligations as of December 31, 20202023 (in thousands):

   Payments Due By Period
   ‹ 1 year  1-3 years  3-5 years  > 5 years  Total
Contractual Obligations               
Open purchase obligations * $701  $138  $ $ $839 
Minimum payments under finance leases  35   46       81 
Minimum payments under operating leases  676   871       1,547 
Minimum payments under long-term liabilities  445   1,158       1,603 
  $1,857  $2,213  $ $ $4,070 

  Payments Due By Period 
Contractual Obligations < 1 year  1-3 years  3-5 years  > 5 years  Total 
Open purchase obligations * $10,414  $320  $-  $-  $10,734 
Minimum payments under finance leases  -   -   -   -   - 
Minimum payments under operating leases+  2,951   6,819   6,686   8,527   24,983 
  $13,365  $7,139  $6,686  $8,527  $35,717 

* Open purchase obligations represent commitments to purchase materials, capital equipment, maintenance agreements and other goods used in the normal operation of our business.

+ License and royalty obligations continue throughMinimum payments under operating leases included payments associated with the livesforward-starting lease of the underlying patents, which is currently through at leastMicroVision GmbH with a target commencement date of August 1, 2024.

Recent accounting pronouncements

See Note 2, "Summary“Summary of significant accounting policies," in the Notes to the consolidated financial statements found in Part II, Item 8 of this Form 10-K.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate and Market Liquidity Risks

As of December 31, 2020,2023, all of our cash and cash equivalents have variable interest rates. Therefore,rates; however, we believe our exposure to market and interest rate risks is not material. Due to the generally short-term maturities of our investment securities, we believe that the market risk arising from our holdings of these financial instruments is not significant. We do not believe that inflation has had a material effect on our business, financial condition or results of operations; however, we do anticipate our labor costs to increase as a result of inflationary pressures.

22


Our investment policy generally directs that the investment managers should select investments to achieve the following goals: principal preservation, adequate liquidity, and return. As of December 31, 2020,2023, our cash and cash equivalents are comprised of short-term highly rated (A rated securities and above) money market savings accounts.accounts and our short-term investments are comprised of highly rated corporate and government debt securities (A rated securities and above). The values of cash and cash equivalents and investment securities, available-for-sale as of December 31, 2020,2023, are as follows (in thousands):

   Amount  Percent 
Cash and cash equivalents $16,862   100%
Less than one year     
  $16,862   100%

  Amount  Percent 
Cash and cash equivalents $45,167   61.2%
Less than one year  28,611   38.8 
  $73,778   100.0%

Foreign Exchange Rate Risk

Our major contract and collaborative research and development agreements, product sales, and licensing activity payments are currently made in U.S. dollars. However,dollars or Euros. Changes in the future werelative value of the U.S. dollar to the Euro and other currencies may enter into contracts or collaborative researchaffect revenue and development agreementsother operating results as expressed in U.S. dollars. In addition, our international subsidiary financial statements are denominated in Euros. As such, the consolidated financial statements will continue to remain subject to the impact of foreign currencies that may subject uscurrency translation as our international operations continue to foreign exchange rate risk. We have entered into purchase orders and supply agreements in foreign currencies in the past and may enter into such arrangements, from time to time, in the future. We believe our exposure to currency fluctuations related to these arrangements is not material.expand. We may enter into foreign currency hedges to offset material exposure to currency fluctuations when we can adequately determine the timing and amounts of the exposure.

23


ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX TO FINANCIAL STATEMENTS

28
 

ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Page

Report of Independent Registered Public Accounting Firm (Moss Adams LLP, Seattle, Washington, PCAOB ID:659)

25

30

Consolidated Balance Sheets as of December 31, 20202023 and 20192022

26

31

Consolidated Statements of Operations for the years ended December 31, 20202023, 2022 and 20192021

27

32

Consolidated Statements of Shareholders'Comprehensive Loss for the years ended December 31, 2023, 2022 and 2021

33
Consolidated Statements of Shareholders’ Equity (Deficit) for the years ended December 31, 20202023, 2022 and 20192021

28

34

Consolidated Statements of Cash Flows for the years ended December 31, 20202023, 2022 and 20192021

29

35

Notes to Consolidated Financial Statements

30

36

29
 

24


Report of Independent Registered Public Accounting Firm

To the Shareholders and the Board of Directors of

MicroVision, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of MicroVision, Inc. (the "Company"“Company”) as of December 31, 20202023 and 2019,2022, the related consolidated statements of operations, shareholders'comprehensive loss, shareholders’ equity (deficit), and cash flows for each of the three years thenin the period ended December 31, 2023, and the related notes and schedule (collectively referred to as the "financial statements"“consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 20202023 and 2019,2022, and the results of its operations and its cash flows for each of the three years thenin the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 29, 2024, expressed an unqualified opinion on the Company’s internal control over financial reporting.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company'sCompany’s management. Our responsibility is to express an opinion on the Company'sCompany’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB")PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

Critical

The critical audit matters are mattersmatter communicated below is a matter arising from the current period audit of the consolidated financial statements that werewas communicated or required to be communicated to the audit committee and that (1) relaterelates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are noThe communication of critical audit matters.matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Business Combination – Valuation of Acquired Intangible Assets

As described in Note 3 to the consolidated financial statements, the Company acquired certain net assets of Ibeo Automotive Systems (Ibeo), a lidar hardware and software provider based in Hamburg, Germany for total consideration of approximately EUR 20.0 million or $21.6 million, subject to settlement of working capital adjustments. The acquisition was accounted for as a business combination and included acquired intangible assets.

We identified the business combination, and in particular, the valuation of acquired intangible assets, as a critical audit matter because determining the fair value of acquired intangible assets required management to use complex valuation models based on underlying assumptions to estimate future cash flows. This, in turn, required significant and subjective auditor judgment, including the need to involve fair value specialists, in performing procedures and evaluating audit evidence obtained.

The primary procedures we performed to address this critical audit matter included:

Testing the design, implementation, and operating effectiveness of internal controls over the valuation of acquired intangible assets, including controls surrounding the valuation methodology and selection of assumptions used in the determination of the fair value of acquired intangible assets.

● With the assistance of valuation specialists, testing the reasonableness of the valuation methodology, discount rate, royalty rate, contributory asset rate, internal rate of return, and weighted average cost of capital used to estimate the fair value of acquired intangible assets.

● Testing the significant assumptions used to estimate future cash flows by testing the underlying data to supporting the assumptions and comparing the assumptions to industry trends and subsequent results to evaluate the reasonableness of management’s estimates as of the date of the acquisition.

/s/ Moss Adams LLP

Seattle, Washington
March 15, 2021

February 29, 2024

We have served as the Company'sCompany’s auditor since 2012.

30

25


MicroVision, Inc.

Consolidated Balance Sheets

(In thousands)

   December 31,
   2020  2019
Assets      
Current assets      
     Cash and cash equivalents $16,862  $5,837 
     Accounts receivable    1,079 
     Inventory    192 
     Other current assets  698   729 
          Total current assets  17,560   7,837 
       
Property and equipment, net  1,883   1,849 
Operating lease right-of-use asset  946   1,308 
Restricted cash  435   435 
Intangible assets, net  164   221 
Other assets  18   186 
               Total assets $21,006  $11,836 
       
Liabilities and shareholders' equity (deficit)      
Current liabilities      
     Accounts payable $630  $1,871 
     Accrued liabilities  495   2,045 
     Deferred revenue    21 
     Contract liabilities  7,765   9,755 
     Other current liabilities    83 
     Current portion of long-term debt  431   
     Current portion of operating lease liability  676   656 
     Current portion of finance lease obligations  31   25 
          Total current liabilities  10,028   14,456 
       
Long-term debt, net of current portion  1,151   
Operating lease liability, net of current portion  774   1,348 
Finance lease obligations, net of current portion  44   
Total liabilities  11,997   15,813 
       
Commitments and contingencies (Note 13)      
       
Shareholders' equity (deficit)      
     Preferred stock, par value $0.001; 25,000 shares authorized; zero and      
          zero shares issued and outstanding, respectively    
     Common stock, par value $0.001; 210,000 shares authorized;      
          152,926 and 125,803 shares issued and outstanding at December 31,       
          2020 and 2019, respectively  153   126 
     Additional paid-in capital  601,224   568,496 
     Subscriptions receivable  (6,135)  
     Accumulated deficit  (586,233)  (572,599)
          Total shareholders' equity (deficit)  9,009   (3,977)
               Total liabilities and shareholders' equity (deficit) $21,006  $11,836 

 2023  2022 
  December 31, 
 2023  2022 
Assets        
Current assets        
Cash and cash equivalents $45,167  $20,536 
Investment securities, available-for-sale  28,611   62,173 
Restricted cash, current  3,263   - 
Accounts receivable, net of allowances  949   - 
Inventory  3,874   1,861 
Advance to Ibeo  -   4,132 
Other current assets  4,890   2,306 
Total current assets  86,754   91,008 
         
Property and equipment, net  9,032   6,830 
Operating lease right-of-use asset  13,758   14,579 
Restricted cash, net of current portion  961   1,418 
Intangible assets, net  17,235   75 
Other assets  1,895   1,086 
Total assets $129,635  $114,996 
         
Liabilities and shareholders’ equity        
Current liabilities        
Accounts payable $2,271  $2,061 
Accrued liabilities  8,640   2,058 
Accrued liability for Ibeo business combination  6,300   - 
Contract liabilities  300   4,601 
Current portion of operating lease liability  2,323   1,846 
Current portion of finance lease obligations  -   21 
Other current liabilities  669   839 
Total current liabilities  20,503   11,426 
         
Operating lease liability, net of current portion  12,714   13,829 
Other long-term liabilities  614   - 
Total liabilities  33,831   25,255 
         
Commitments and contingencies (Note 13)  -    -  
         
Shareholders’ equity        
Preferred stock, par value $0.001; 25,000 shares authorized; zero and zero shares issued and outstanding, respectively  -   - 
Common stock, par value $0.001; 310,000 shares authorized; 194,736 and 170,503 shares issued and outstanding at December 31, 2023 and 2022, respectively  195   171 
Additional paid-in capital  860,765   772,221 
Accumulated other comprehensive gain (loss)  210   (127)
Accumulated deficit  (765,366)  (682,524)
Total shareholders’ equity  95,804   89,741 
Total liabilities and shareholders’ equity $129,635  $114,996 

The accompanying notes are an integral part of these consolidated financial statements.statements

26


31

MicroVision, Inc.

Consolidated Statements of Operations

(In thousands, except per share data)

   Year Ended December 31,
   2020  2019
       
Product revenue $1,347  $5,345 
License and royalty revenue  1,718   99 
Contract revenue  25   3,442 
     Total revenue  3,090   8,886 
       
Cost of product revenue  1,394   6,692 
Cost of contract revenue    1,872 
     Total cost of revenue  1,398   8,564 
       
     Gross profit  1,692   322 
       
Research and development expense  9,840   18,661 
Sales, marketing, general and administrative expense  5,917   8,133 
Gain on disposal of fixed assets  (450)  
     Total operating expenses  15,307   26,794 
Loss from operations  (13,615)  (26,472)
       
Other expense, net  (19)  (11)
     Net loss $(13,634) $(26,483)
       
Net loss per share - basic and diluted $(0.10) $(0.24)
       
Weighted-average shares outstanding - basic and diluted  139,829   111,297 

  2023  2022  2021 
  Year Ended December 31, 
  2023  2022  2021 
          
Revenue $7,259  $664  $2,500 
             
Cost of revenue  2,772   100   2 
             
Gross profit  4,487   564   2,498 
             
Research and development expense  56,707   30,413   24,111 
Sales, marketing, general and administrative expense  36,689   24,041   22,256 
Gain on disposal of fixed assets  (34)  -   - 
Total operating expenses  93,362   54,454   46,367 
             
Loss from operations  (88,875)  (53,890)  (43,869)
             
Bargain purchase gain, net of tax  1,669   -   - 
Gain on debt extinguishment  -   -   692 
Other income (expense), net  5,510   799   (23)
             
Net loss before taxes $(81,696) $(53,091) $(43,200)
             
Income tax expense  (1,146)  -   - 
             
Net loss $(82,842) $(53,091) $(43,200)
             
Net loss per share - basic and diluted $(0.45) $(0.32) $(0.27)
             
Weighted-average shares outstanding - basic and diluted  182,802   165,958   160,662 

The accompanying notes are an integral part of these consolidated financial statements.

27


32

MicroVision, Inc.

Consolidated Statements of Shareholders' Equity (Deficit)
Comprehensive Loss

(In thousands)

        Additional        Total
  Common Stock  paid-in  Subscriptions  Accumulated  shareholders'
  Shares  Par value  capital  receivable  deficit  equity (deficit)
Balance at December 31, 2018 100,105  $100  $550,133  $ $(546,116) $4,117 
Share-based compensation expense 822     1,613       1,614 
Sales of common stock 24,876   25   16,750       16,775 
Net loss         (26,483)  (26,483)
Balance at December 31, 2019 125,803   126   568,496     (572,599)  (3,977)
Share-based compensation expense 201     1,252       1,252 
Exercise of options 693     999       1,000 
Sales of common stock 26,229   26   30,477   (6,135)    24,368 
Net loss         (13,634)  (13,634)
Balance at December 31, 2020 152,926  $153  $601,224  $(6,135) $(586,233) $9,009 

  2023  2022  2021 
  Year Ended December 31, 
  2023  2022  2021 
Net loss $(82,842) $(53,091) $(43,200)
             
Other comprehensive loss            
Unrealized gain (loss) on investment securities, available-for-sale  153   (108)  (19)
Unrealized gain on translation  184   -   - 
Comprehensive loss $(82,505) $(53,199) $(43,219)

The accompanying notes are an integral part of these consolidated financial statements.

28


33

MicroVision, Inc.

Consolidated Statements of Cash Flows
Shareholders’ Equity (Deficit)

(In thousands)

   Year Ended December 31,
   2020  2019
Cash flows from operating activities      
     Net loss $(13,634) $(26,483)
     Adjustments to reconcile net loss to net cash used in operations:      
          Depreciation and amortization  963   1,649 
          Impairment of intangible assets    160 
          Impairment of property and equipment    434 
          Gain on disposal of property and equipment  (450)  
          Share-based compensation expense  1,297   1,569 
          Non-cash interest expense  11   
          Inventory write-downs  168   2,203 
     Change in:      
          Accounts receivable  1,079   (603)
          Costs and estimated earnings in excess of billings on uncompleted contracts    987 
          Inventory  24   (1,286)
          Other current and non-current assets  154   1,911 
          Accounts payable  (1,387)  (268)
          Accrued liabilities  (1,550)  (3,379)
          Deferred revenue  (21)  21 
          Contract liabilities and other current liabilities  (2,073)  (316)
          Operating lease liabilities  (656)  (642)
               Net cash used in operating activities  (16,075)  (24,043)
       
Cash flows from investing activities      
     Proceeds on sale of property and equipment  525   
     Purchases of property and equipment  (402)  (745)
               Net cash provided by (used in) investing activities  123   (745)
       
Cash flows from financing activities      
     Principal payments under finance leases  (29)  (20)
     Proceeds from long-term debt  1,571   
     Net proceeds from issuance of common stock  25,435   16,879 
               Net cash provided by financing activities  26,977   16,859 
       
Change in cash, cash equivalents, and restricted cash  11,025   (7,929)
Cash, cash equivalents, and restricted cash at beginning of period  6,272   14,201 
Cash, cash equivalents, and restricted cash at end of period $17,297  $6,272 
       
Supplemental schedule of non-cash investing and financing activities      
       
     Issuance of common stock for subscriptions receivable $6,135  $
       
     Property and equipment acquired under finance leases $70  $
       
     Non-cash additions to property and equipment $116  $37 
       
     Issuance of common stock for commitment fee $ $535 
       
       
The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of
December 31, 2020 and December 31, 2019:      
   Year Ended December 31,
   2020` 2019
Cash and cash equivalents $16,862  $5,837 
Restricted cash  435   435 
Cash, cash equivalents and restricted cash $17,297  $6,272 

  Shares  Par value  capital  receivable  comprehensive loss  deficit  equity (deficit) 
        Additional     Accumulated     Total 
  Common Stock  paid-in  Subscriptions  other  Accumulated  shareholders’ 
  Shares  Par value  capital  receivable  comprehensive loss  deficit  equity (deficit) 
Balance at December 31, 2020  152,926   153   601,224   (6,135)  -   (586,233)  9,009 
Share-based compensation expense  2,365                  2   15,282   -                                       -   -                15,284 
Exercise of options  1,518   2   2,652   -   -   -   2,654 
Sales of common stock, net of issuance costs  7,554   7   122,884   6,135   -   -   129,026 
Net loss  -   -   -   -   -   (43,200)  (43,200)
Other comprehensive loss  -   -   -   -   (19)  -   (19)
Balance at December 31, 2021  164,363   164   742,042   -   (19)  (629,433)  112,754 
Share-based compensation expense  1,294   1   15,460   -   -   -   15,461 
Exercise of options  525   1   725   -   -   -   726 
Sales of common stock, net of issuance costs  4,321   5   13,994       -   -   13,999 
Net loss  -   -   -   -   -   (53,091)  (53,091)
Other comprehensive loss  -   -   -   -   (108)  -   (108)
Balance at December 31, 2022  170,503  $171  $772,221  $-   (127) $(682,524) $89,741 
Balance  170,503  $171  $772,221  $-   (127) $(682,524) $89,741 
Share-based compensation expense  1,946   2   16,139   -   -   -   16,141 
Exercise of options  191   -   175   -   -   -   175 
Sales of common stock, net of issuance costs  22,096   22   72,230   -   -   -   72,252 
Net loss  -   -   -   -   -   (82,842)  (82,842)
Other comprehensive gain  -   -   -   -   337   -   337 
Other comprehensive gain (loss)  -   -   -   -   337   -   337 
Balance at December 31, 2023  194,736  $195  $860,765  $-   210  $(765,366) $95,804 
Balance  194,736  $195  $860,765  $-   210  $(765,366) $95,804 

The accompanying notes are an integral part of these consolidated financial statements.

29


34

MicroVision, Inc.

Consolidated Statements of Cash Flows

(In thousands)

  2023  2022  2021 
  Year Ended December 31, 
  2023  2022  2021 
Cash flows from operating activities            
Net loss $(82,842) $(53,091) $(43,200)
Adjustments to reconcile net loss to net cash used in operations:            
Depreciation and amortization  7,864   2,246   1,464 
Impairment of property and equipment  12   64   882 
Bargain purchase gain  (1,669)  -   - 
Gain on disposal of fixed assets  (34)        
Share-based compensation expense  16,141   15,461   15,284 
Non-cash interest income  -   -   (10)
Inventory write-downs  76   87   48 
Net accretion of premium on short-term investments  (1,275)  21   86 
Gain on debt extinguishment  -   -   (692)
Change in:            
Accounts receivable  (949)  -   - 
Inventory  (892)  (168)  (1,828)
Other current and non-current assets  (2,096)  (217)  (2,552)
Accounts payable  942   (1,737)  2,520 
Accrued liabilities  6,571   888   675 
Contract liabilities and other current liabilities  (6,452)  (293)  (1,319)
Operating lease liabilities  (2,500)  (1,280)  (762)
Other long-term liabilities  13   -   - 
Net cash used in operating activities  (67,090)  (38,019)  (29,404)
             
Cash flows from investing activities            
Sales of investment securities  76,700   60,576   - 
Purchases of investment securities  (41,710)  (90,158)  (32,825)
Purchases of property and equipment  (1,935)  (4,359)  (2,493)
Advance to Ibeo  -   (4,132)  - 
Cash paid for Ibeo business combination  (11,233)  -   - 
Net cash provided by (used in) investing activities  21,822   (38,073)  (35,318)
             
Cash flows from financing activities            
Principal payments under finance leases  (21)  (26)  (28)
Principal payments under long-term debt  -   (392)  (488)
Payments received on subscriptions receivable  -   -   6,135 
Proceeds from stock option exercises  175   726   2,654 
Net proceeds from issuance of common stock  72,284   13,999   122,891 
Net cash provided by financing activities  72,438   14,307   131,164 
             
Effect of exchange rate changes on cash and cash equivalents  267   -   - 
             
Change in cash, cash equivalents, and restricted cash  27,437   (61,785)  66,442 
Cash, cash equivalents, and restricted cash at beginning of period  21,954   83,739   17,297 
Cash, cash equivalents, and restricted cash at end of period $49,391  $21,954  $83,739 
             
Supplemental schedule of non-cash investing and financing activities            
             
Non-cash additions to property and equipment $-  $764  $550 
             
Accrued liability for Ibeo business combination $6,300  $-  $- 
             
Acquisition of right-to-use asset operating lease $1,338  $10,184  $5,097 
             
Accrued financing fees $(32) $-  $- 
             
Currency gain in translation $184  $-  $- 
             
Unrealized gain in investment securities, available-for-sale $153  $(108 ) $(19 )

The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of December 31, 2023, 2022 and 2021:

   2023   2022   2021 
  Year Ended December 31, 
   2023   2022   2021 
Cash and cash equivalents $45,167  $20,536  $82,647 
Restricted cash  4,224   1,418   1,092 
Cash, cash equivalents and restricted cash $49,391  $21,954  $83,739 

The accompanying notes are an integral part of these consolidated financial statements.

35

MicroVision, Inc.

Notes to Consolidated Financial Statements

For the year ended December 31, 20202023

1. THE COMPANY AND LIQUIDITY

MicroVision, Inc. is developing aand commercializing lidar sensorsensors and software to be used in automotive safety and autonomous driving applications. Our dynamic-range lidar sensor uses our pioneering laser beam scanning (LBS) technology. Our LBS technology is based on our patented expertise in systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms and software, and how those elements are packaged into a small form factor. OurThis lidar sensor also utilizes edge computing and machine intelligence as part of the solutions.solution. Though automotive lidar is our priority now, we have developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

For

In the recent past, few years, our strategy had been to sell AR displays or components, Interactive Displays, or Consumer Lidars to original equipment manufacturers (OEMs)OEMs and original design manufacturers (ODMs)ODMs for incorporation into their products. However, while we do haveIn fiscal years 2021 and 2022, our sole customer was Microsoft Corporation; in 2023, this customer accounted for a well-knownsignificant portion of our total revenue. Our arrangement with this customer for one of these products which generatesgenerated royalty income,income; however, the volume of sales and resulting royalties from that product arearrangement were not significant, andsignificant. A few years ago, we have been unableshifted our focus to secure additional customers to launch one of our products. As a result, since February 2020, we have focused our attention on strategic alternatives, including a potential sale or merger of the Company, sale of part of the Company, strategic minority investment, as well as licensing and other transactions.

While we continue to pursue strategic alternatives, we plan to focus on increasingincrease the value of the Company by completing development of our 1st Generation LRLlong-range lidar module to a level that would be ready to scale in the market. We believe our technology and designs for automotive lidar can be successful in the market, and our solutions will have features and performance that exceed those of competitors and will provide a sustainable strategic advantage in the market.

We completed the acquisition of Ibeo Automotive Systems GmbH (“Ibeo”) assets on January 31, 2023 pursuant to the terms and subject to the conditions of the Asset Purchase Agreement, dated December 1, 2022, and amended as of January 31, 2023, by and between our wholly owned subsidiary, MicroVision GmbH organized under the laws of The Federal Republic of Germany, and Ibeo for a purchase price of EUR 15.0 million, or approximately $16.3 million, subject to potential reduction on the terms set forth in the Asset Purchase Agreement. Pursuant to the Asset Purchase Agreement, the purchase price also included advanced funds to Ibeo so that it could continue its operations while in insolvency during the period between signing and closing. Specifically, we advanced to Ibeo EUR 3.9 million, or approximately $4.1 million in December 2022; EUR 2.7 million, or approximately $3.0 million in January 2023; and EUR 0.6 million, or approximately $0.7 million in February 2023 shortly after the closing. These fund advances included amounts related to headcount reductions carried out by Ibeo management, decreasing the number of employees to transfer in connection with the acquisition to approximately 250 employees. These headcount reduction costs of EUR 2.3 million, or approximately $2.5 million, were reimbursed to MicroVision by way of deduction from the purchase price in accordance with the Asset Purchase Agreement.

We have incurred significant losses since inception.inception and expect to incur a significant loss during the fiscal year ending December 31, 2024. We have funded our operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from development contract revenues, product sales and licensing activities. Since 2010, there has been substantial doubt about our ability to continue as a going concern.

On October 8, 2020, we filed a Certificate of Amendment (the "Certificate of Amendment") to our Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to increase the authorized number of shares of our capital stock to 235,000,000 shares, consisting of (i) 210,000,000 shares of common stock, $.001 par value and (ii) 25,000,000 shares of preferred stock, $.001 par value. The Certificate of Amendment was effective upon the filing thereof with the Secretary of State of the State of Delaware.

In late 2020 and early 2021, the share price of our common stock on The Nasdaq Global Market has increased dramatically. With the availability of authorized shares of common stock, we have been able to raise net proceeds of $12.7 million through the issuance 2.1 million shares of our common stock and $48.7 million through the issuance of 2.5 million shares of our common stock, in January 2021 and February 2021, respectively, under the terms of At-the-Market (ATM) offering agreements with Craig-Hallum Capital Group (Craig-Hallum).

As a result of our recent financing activities, there is no longer substantial doubt about our ability to continue as a going concern.

At December 31, 2020,2023, we had $16.9total liquidity of $73.8 million including $45.2 million in cash and cash equivalents.equivalents and $28.6 million in short-term investment securities. As of December 31, 2023, we have approximately $19.0 million available under an existing ATM agreement. Based on our current operating plan, and including $61.4 million received in 2021 under ATM equity offering agreements with Craig-Hallum, we anticipate that we have sufficient cash and cash equivalents to fund our operations for at least the next 12 months. While we continue to pursue strategic alternatives, we mayWe will require additional capital to fund our operating plan past that time. We maywill seek to obtain additional capital through the issuance of equity or debt securities, product sales and/or licensing activities. There can be no assurance that any such efforts to obtain additional capital willwould be available to us or, if available, will be available on terms acceptable to us or on a timely basis. If adequate capital resources are not available on a timely basis, we intend to consider limiting our operations substantially. This limitation of operations could include further reductions in our research and development projects, staff, operating costs, and capital expenditures.successful.

30


2. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles of the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from our estimates. We have identified the following areas where estimates and assumptions have been made in preparing the financial statements: business combinations, valuation of intangibles, revenue recognition, inventory valuation, valuation of share-based payments, income taxes, depreciable lives assessment and related disclosure of contingent assets and liabilities.

36

Cash and cash equivalents and fair value of financial instruments

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three level fair value inputs hierarchy, and requires an entity to maximize the use of observable valuation inputs and minimize the use of unobservable inputs. We use market data, assumptions and risks we believe market participants would use in measuring the fair value of the asset or liability, including the risks inherent in the inputs and the valuation techniques.

Our financial instruments include cash and cash equivalents, investment securities, accounts receivable, accounts payable and accrued liabilities. The carrying value of our financial instruments approximates fair value due to their short maturities. Our cash equivalents are comprised of short-term highly rated (A rated securities and above) money market savings accounts.

Our short-term investment securities are primarily debt securities. The Company has classified its entire investment portfolio as available-for-sale. Available-for-sale securities are stated at fair value with unrealized gains and losses included in other comprehensive income (loss). Dividend and interest income are recognized when earned. Realized gains and losses are presented separately on the income statement.

Principles of Consolidation

The consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision GmbH. MicroVision GmbH is a wholly owned subsidiary of MicroVision, Inc. All material intercompany accounts and transactions have been eliminated in consolidation.

Business Combination

Our business combination is accounted for under the acquisition method. We allocate the fair value of purchase consideration to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The excess of the fair value of the underlying net assets acquired and liabilities assumed over the purchase consideration is included in bargain purchase gain in the Consolidated Statement of Operations. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets.

Foreign Currency Translation

The functional currency for our German operation is the Euro, which represents the currency of its primary economic environment. The results of operations for the German operation are translated from the local currency into U.S. dollars using the average exchange rates during each period. All assets and liabilities are translated using exchange rates at the end of each period, with foreign currency translation adjustments included as a component of other comprehensive loss. All equity transactions and certain assets are translated using historical rates. The consolidated financial statements are presented in U.S. dollars.

Segment Information

We determine operating segments based on how our chief operating decision maker (“CODM”) manages the business, makes operating decisions around the allocation of resources, and evaluates operating performance. Our CODM is our Executive Management team, who reviews our operating results on a consolidated basis. We operate as one segment, which relates to sale and servicing of lidar hardware and software. The profitability of our product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company.

Inventory

Inventory consists of raw materials, work in process and finished goods assemblies. Inventory is computed using the first-in, first-out (FIFO) method and is stated at the lower of cost and net realizable value. Management periodically assesses the need to account for obsolescence of inventory and adjusts the carrying value of inventory to its net realizable value when required.

Intangible assets

Our intangible assets consist exclusively of acquired technology from the January 2023 Ibeo asset purchase and purchased patents. As part of the Ibeo asset acquisition, we acquired primarily two intangible assets in the form of Perception software and Reference software with a useful life of 15 years and 8 years, respectively. The patentsestimated fair value of acquired technology was calculated through the income approach using the multi-period excess earnings and relief from royalty methodologies. The intangible assets are amortized using the straight-line method over their estimated period of benefit, ranging from one to seventeen years. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying value may not be recoverable. Recoverability of these assets is measured by comparison of their carrying values to the projected undiscounted net cash flows associated with the related intangible assets or group of assets over their remaining lives. Measurement of an impairment loss for our intangible assets is based on the difference between the fair value of the asset and its carrying value.

37

Property and equipment

Property and equipment is stated at cost and depreciated over the estimated useful lives of the assets (two to five years) using the straight-line method. Our property and equipment may include assets related to future product lines. As our production needs change, we periodically assess the remaining estimated useful life of our production equipment. If necessary, we adjust the depreciation on our production equipment to reflect the remaining estimated useful life. Leasehold improvements are depreciated over the shorter of estimated useful lives or the lease term. Costs for repairs and maintenance are charged to expense as incurred and expenditures for major improvements are capitalized at cost. Gains or losses on the disposition of assets are reflected in the income statements at the time of disposal.

Restricted cash

As

Restricted cash, current includes $3.3 million related to the Ibeo asset acquisition that has been withheld from the Purchase Price and held in escrow for a maximum period of 13 months post-Closing as partial security for potential claims arising out of or in connection with the Asset Purchase Agreement.

In addition, as of December 31, 20202023 and 2019,2022, restricted cash, net of current portion was in money market savings accounts and serveserves as collateral for $435,000 in irrevocable letters of credit.credit related to our facility lease agreements. The restricted cash balance at December 31, 2023 includes $0.7 million related to a letter of credit which is outstandingthat was issued in connection with a lease agreement entered into in September 2021 for our corporatecompany headquarters building in Redmond, Washington. The new lease commenced on December 1, 2022, and the required balance is requiredof the letter credit periodically decreases over the term of the 120-month lease. The restricted cash balance also includes $0.3 million related to a letter of credit that was issued in connection with a lease which expiresagreement entered into in March 2023.

LeasesSeptember 2021 for our general office and lab space in Redmond, Washington, and the required balance of the letter of credit periodically decreases over the term of the 120-month lease.

Leases

We determine if an arrangement is a lease at inception. On our balance sheet, our office lease is included in Operating lease right-of-use (ROU) asset, Current portion of operating lease liability and Operating lease liability, net of current portion. On our balance sheet, finance leases are included in Property and equipment, Current portion of finance lease obligations and Finance lease obligations, net of current portion.

31


ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. For leases that do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Significant judgment may be required when determining whether a contract contains a lease, the length of the lease term, the allocation of the consideration in a contract between lease and non-lease components, and the determination of the discount rate included in our office lease. We review the underlying objective of each contract, the terms of the contract, and consider our current and future business conditions when making these judgments.

Revenue recognition

The following is a description of principal activities from which we generate revenue. Revenues are recognized when control of the promised goods or services are transferred to our customers, in an amount that reflects the consideration that we expect to receive in exchange for those goods or services. We generate all of our revenue from contracts with customers.

We evaluate contracts based on the 5-step model as stated in Topic 606 as follows: (i) identify the contract, (ii) identify the performance obligations, (iii) determine the transaction price, (iv) allocate the transaction price, and (v) recognize revenue when (or as) performance obligations are satisfied.

A contract contains a promise (or promises) to transfer goods or services to a customer. A performance obligation is a promise (or a group of promises) that is distinct, as defined in the revenue standard.

38

The transaction price is the amount of consideration an entity expects to be entitled to from a customer in exchange for providing the goods or services. A number of factors should be considered to determine the transaction price, including whether there is variable consideration, a significant financing component, noncash consideration, or amounts payable to the customer. The determination of variable consideration will require a significant amount of judgment. In estimating the transaction price we will use either the expected value method or the most likely amount method.

The transaction price is allocated to the separate performance obligations in the contract based on relative standalone selling prices. Determining the relative standalone selling price can be challenging when goods or services are not sold on a standalone basis. The revenue standard sets out several methods that can be used to estimate a standalone selling price when one is not directly observable. Allocating discounts and variable consideration must also be considered. Allocating the transaction price can require significant judgement on our part.

Revenue is recognized when (or as) the customer obtains control of the good or service/performance obligations are satisfied. Topic 606 provides guidance to help determine if a performance obligation is satisfied at a point in time or over time. Where a performance obligation is satisfied over time, the related revenue is also recognized over time.

Product revenue

We sell our products to customers under a contract or by purchase order. We consider the sale of each individual item to be one performance obligation. The transaction price is generally either at stated product price per quantity or at a fixed amount at contract inception. Revenue is recognized under Topic 606 when the product is shipped to the customer because control passes to the customer at the point of shipment. Our product sales generally include acceptance provisions, however, because we generally can objectively determine that we have met agreed-upon customer specifications prior to shipment, control of the item passes at the time of shipment.

License and royalty revenue

We recognize revenue on upfront license fees at a point in time if the nature of the license granted is a right-to-use license, representing functional intellectual property with significant standalone functionality. If the nature of the license granted is a right-to-access license, representing symbolic intellectual property, which excludes significant standalone functionality, we recognize revenue over the period of time we have ongoing obligations under the

32


agreement. We will recognize revenue from sales-based royalties on the basis of the quarterly reports provided by our customer as to the number of royalty-bearing products sold or otherwise distributed. In the event that reports are not received, we will estimate the number of royalty-bearing products sold by our customers.

Contract revenue

Our contract revenue in a particular period is dependent upon when we enter into a contract, the value of the contracts we have entered into, and the availability of technical resources to perform work on the contracts. We recognize contract revenue either at a point in time, or over time, depending upon the characteristics of the individual contract. If control of the deliverable(s) occur over time, the revenue is recognized in proportion to the transfer of control. If control passes to the customer only upon completion and transfer of the asset, revenue is recognized at the completion of the contract. In contracts that include significant customer acceptance provisions, we recognize revenue only upon acceptance of the deliverable(s).

We identify each performance obligation in our development contracts at contract inception. The contracts generally include product development and customization specified by the customer. In contracts with multiple performance obligations, we identify each performance obligation and evaluate whether the performance obligations are distinct within the context of the contract. Performance obligations that are not distinct at contract inception are combined.

Our development contracts are primarily fixed-fee contracts. If control of deliverables occurs over time, we recognize revenue on fixed fee contracts on the proportion of total cost expended (under Topic 606, the `input method'‘input method’) to the total cost expected to complete the contract performance obligation. For contracts that require the input method for revenue recognition, the determination of the total cost expected to complete the performance obligations on fixed fee contracts involves significant judgment. We incorporate revisions to hour and cost estimates when the causal facts become known.

39

Cost of product revenue

Cost of product revenue includes the direct and allocated indirect costs of products sold to customers. Direct costs include labor, materials, reserves for estimated warranty expenses, and other costs incurred directly, or charged to us by our contract manufacturers in the manufacture of these products. Indirect costs include labor, manufacturing overhead, and other costs associated with operating our manufacturing capabilities and capacity. Manufacturing overhead includes the costs of procuring, inspecting and storing material, facility and other costs, and is allocated to cost of product revenue based on the proportion of indirect labor which supported production activities. The cost of product revenue can fluctuate significantly from period to period, depending on the product mix and volume, the level of manufacturing overhead expense and the volume of direct material purchased.

Cost of contract revenue

Cost of contract revenue includes both the direct and allocated indirect costs of performing on contracts and producing prototype units and evaluation kits based on our PicoP® scanning module.kits. Direct costs include labor, materials and other costs incurred directly in producing prototype units and evaluation kits or performing on a contract. Indirect costs include labor and other costs associated with operating our research and development department and building our technical capabilities and capacity. Cost of contract revenue is determined by the level of direct and indirect costs incurred, which can fluctuate substantially from period to period.

Our overhead, which includes the costs of procuring, inspecting and storing material, and facility and depreciation costs, is allocated to inventory, cost of product revenue, cost of contract revenue, and research and development expense based on the level of effort supporting production or research and development activity.

Concentration of credit risk and major customers and suppliers

Concentration of credit risk

Financial instruments that potentially subject us to a concentration of credit risk are primarily cash equivalents and accounts receivable. We typically do not require collateral from our customers. As of December 31, 2020,2023, our cash and cash equivalents are comprised of short-term highly rated (A rated securities and above) money market savings accounts.

33


Concentration of major customers and suppliers

In 2020,2023, one commercial customer (“Customer A”) accounted for $3.0$4.6 million in revenue, representing 97%63% of our total revenue. In 2019, onerevenue, a second commercial customer accounted for $7.7$0.8 million in revenue, representing 86%11% of our total revenue and a secondthird commercial customer accounted for $1.2$0.4 million in revenue, representing 13%5% of our total revenue. In 2022, Customer A accounted for $0.7 million in revenue, representing 100% of our total revenue. No revenue was recognized from Customer A during the second half of 2022 or the first three quarters of 2023 as no shipments of our components were reported by the customer during that period. In 2021, Customer A accounted for $2.5 million in revenue, representing 100% of our total revenue. Subsequent to fiscal year 2023, we do not expect to recognize further revenue from Customer A, which will negatively affect our future revenue.

A

Typically, a significant concentration of our components and the products we sellhave sold are currently manufactured and obtained from single or limited-source suppliers, which are primarily located in foreign countries.suppliers. The loss of any single or limited-source supplier, the failure of any of these suppliers to perform as expected, or the disruption in the supply chain of components from these suppliers could subject us to risks and uncertainties regarding,including, but not limited to, increased cost of sales, possible loss of revenues, or significant delays in product development or product deliveries, any of which could adversely affect our financial condition and operating results.

Income taxes

Deferred tax assets and liabilities are recorded for differences between the financial statement and tax bases of the assets and liabilities that will result in taxable or deductible amounts in the future, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is recorded for the amount of income tax payable for the period increased or decreased by the change in deferred tax assets and liabilities during the period.

40

Net loss per share

Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the periods. Net loss per share, assuming dilution, is calculated using the weighted-average number of common shares outstanding and the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities. Net loss per share, assuming dilution, is equal to basic net loss per share because the effect of dilutive securities outstanding during the periods, including options and warrants computed using the treasury stock method, is anti-dilutive.

The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):

   Year Ended December 31,
   2020  2019
Numerator:      
Net loss available for common shareholders $(13,634) $(26,483)
       
Denominator:      
Weighted-average common shares outstanding  139,829   111,297 
       
Net loss per share - basic and diluted $(0.10) $(0.24)

SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

             
  Year Ended December 31, 
 2023  2022  2021 
Numerator:            
Net loss available for common shareholders $(82,842) $(53,091) $(43,200)
             
Denominator:            
Weighted-average common shares outstanding  182,802   165,958   160,662 
             
Net loss per share - basic and diluted $(0.45) $(0.32) $(0.27)

During each of the years ended December 31, 20202023, 2022 and 2019,2021, we excluded the following securities from net loss per share as the effect of including them would have been anti- dilutive.anti-dilutive. The shares shown represent the number of shares of common stock which would be issued upon conversion in the respective years shown below (in thousands):

   Year Ended December 31,
   2020  2019
Options outstanding  3,281  5,104
Nonvested restricted stock units  1,982  1,215
   5,263  6,319

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

  2023  2022  2021 
  Year Ended December 31, 
  2023  2022  2021 
Options outstanding  752   945   1,533 
Nonvested restricted stock units  9,983   8,866   2,625 
 Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount  10,735   9,811   4,158 

Research and development

Research and development expense consists of compensation related costs of employees and contractors engaged in internal research and product development activities, direct material to support development programs, laboratory operations, outsourced development and processing work, and other operating expenses. We assign our research and development resources based on the business opportunity of the available projects, the skill mix of the resources available and the contractual commitments we have made to our customers. Research and development costs are

34


expensed as incurred. We believe that a substantial level of continuing research and development expense will be required to further develop our technology.

Share-based compensation

We issue share-based compensation to employees in the form of stock options and restricted stock units (RSUs), and performance stock units (PSUs). and stock options. We account for the share-based awards by recognizing the fair value of share-based compensation expense on a straight-line basis over the service period of the award, net of estimated forfeitures. The fair value of stock options is estimated on the grant date using the Black-Scholes option pricing model. The fair value of RSUs and non-executive PSUs is determined by the closing price of our common stock on the grant date. TheFor performance-based awards, expense is recognized when it is probable the performance criteria will be achieved. If the likelihood becomes improbable that the performance criteria will be achieved, the expense is reversed. Executive PSUs that have market-based performance criteria are valued using a binomial option pricing model using the following inputs: stock price, volatility, and risk-free interest rates. Changes in estimated inputs or using other option valuation methods may result in materially different option values and share-based compensation expense. The fair value of stock options is estimated on the grant date using the Black-Scholes option pricing model.

41

The following table summarizes the amount of share-based compensation expense by line item on the Statement of Operations (in thousands):

   Year Ended December 31,
   2020  2019
Cost of product revenue $ $26 
Research and development expense  699   379 
Sales, marketing, general and administrative expense  598   1,209 
  $1,297  $1,614 

Reclassifications

SCHEDULE OF SHARE-BASED COMPENSATION EXPENSE

  2023  2022  2021 
  Year Ended December 31, 
  2023  2022  2021 
Research and development expense  6,531   6,933   6,125 
Sales, marketing, general and administrative expense  9,610   8,528   9,159 
Total Share-based compensation expense $16,141  $15,461  $15,284 

Reclassifications

Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. These reclassifications had no impact on net loss, shareholders'shareholders’ equity or cash flows, as previously reported.

Recent accounting pronouncements

3. BUSINESS COMBINATION

On January 31, 2023, we completed the acquisition of certain net assets of Ibeo, a lidar hardware and software provider based in Hamburg, Germany. The purpose of the acquisition was to acquire certain Ibeo assets, primarily intellectual property, and personnel, to enable us to expand our technology and product portfolio and diversify our revenue profile.

Total consideration related to this transaction was approximately EUR 20.0 million or $21.6 million, consisting of approximately (i) EUR 7.0 million or $7.6 million in cash paid at closing, (ii) EUR 6.6 million or $7.1 million in cash advanced to Ibeo prior to closing, (iii) EUR 3.0 million or $3.3 million held in escrow for 13 months to be available to cover properly established claims by MicroVision, (iv) EUR 0.6 million or $0.7 million in costs paid on behalf of the seller, and (v) EUR 2.7 million or approximately $3.0 million after calculating the deduction in purchase price agreed between both the parties. The remaining balance of approximately EUR 2.7 million is expected to be paid during the first quarter of 2024. In addition, we incurred $0.6 million of acquisition-related costs associated with the acquisition during the twelve months ended December 2019,31, 2023, which were included in Sales, marketing, general and administrative expense. We incurred $0.5 million of acquisition-related costs associated with the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2019-12 (ASU 2019-12) Simplifyingacquisition during the Accountingthree twelve months ended December 31, 2022.

The accrued liability for Income Taxes. The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, Income Taxes. The amendments also improve consistent application of and simplify generally accepted accounting principles for other areas of Topic 740 by clarifying and amending existing guidance. The new guidance will be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. We do not expect that the adoption of this standard will have a material impactIbeo business combination on our balance sheet in the amount of $6.3 million includes $3.3 million that was withheld from the Purchase Price and held in escrow for a maximum period of 13 months post-Closing as partial security for potential claims arising out of or in connection with the Asset Purchase Agreement is intended to be released and $3.0 million holdback amount that is expected to be paid in first quarter of 2024.

The transaction has been accounted for as a business combination. The results of operations for the acquisition are included in our consolidated financial statements.statements from the date of acquisition onwards.

3.

The following table summarizes the final purchase price allocation to assets acquired and liabilities assumed (in thousands):

SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED

     Weighted Average 
  Amount  Useful Life (in years) 
Purchase consideration:        
Cash paid at closing(1) $8,245     
Payable to Ibeo(2)  6,246     
Advances to Ibeo(3)  7,120     
Total purchase consideration $21,611     
         
Inventory $1,197     
Other current assets  703     
Operating lease right-of-use asset  234     
Property and equipment, net  5,330     
Intangible assets:        
Acquired technology  17,987   13 
Order backlog  26   1 
Contract liabilities  (1,178)    
Operating lease liabilities  (234)    
Deferred tax liabilities  (785)    
Total identifiable net assets $23,280     
Bargain purchase gain(4)  (1,669)    

(1)Represents $7.6 million in cash paid at closing and $0.7 million in cash paid shortly after close.
(2)Recorded as accrued liability to Ibeo in our consolidated balance sheet. Pursuant to the terms of the Asset Purchase Agreement, $3.3 million will be withheld from the Purchase Price and held in escrow for a maximum period of 13 months post-closing as partial security for potential claims arising out of or in connection with the Asset Purchase Agreement and $3.0 million holdback amount is expected to be paid in first quarter of 2024.
(3)Represents $4.1 million and $3.0 million in cash advanced to Ibeo in December 2022 and January 2023, respectively.
(4)The bargain purchase gain represents the excess of the fair value of the underlying net assets acquired and liabilities assumed over the purchase consideration and is included in bargain purchase gain in the Consolidated Statement of Operations. The bargain purchase gain was attributable to the negotiation process with Ibeo during its insolvency proceedings resulting in cash consideration paid being less than the fair value of the net assets acquired.

42

The estimated fair value of acquired technology was calculated through the income approach using the multi-period excess earnings and relief from royalty methodologies. The estimated fair value of the order backlog was calculated through the income approach using the multi-period excess earnings methodology.

Supplemental Unaudited Pro Forma Information

The below unaudited pro forma financial information summarizes the combined results of operations for the Company and Ibeo as if the acquisition had been completed on January 1, 2022. The unaudited pro forma information presented below is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2022 or the results of our future operations of the combined businesses. Nonrecurring pro forma adjustments include:

Recognition of the bargain purchase gain as if incurred in the first quarter of 2022;
Acquisition-related costs of $1.1 million are assumed to have been incurred on January 1, 2022.

The following table summarizes the unaudited pro forma results (in thousands):

SCHEDULE OF BUSINESS ACQUISITION, PRO FORMA INFORMATION

         
  Year Ended December 31, 
  2023  2022 
Total revenue $7,808   6,957 
Net loss  (80,243)  (115,786)

4. REVENUE RECOGNITION

The following is a description of principal activities from which we generate revenue. Revenues are recognized when control of the promised goods or services are transferred to our customers, in an amount that reflects the consideration that we expect to receive in exchange for those goods or services. We generate all of our revenue from contracts with customers.

We evaluate contracts based on the 5-step model as stated in Topic 606 as follows: (i) identify the contract, (ii) identify the performance obligations, (iii) determine the transaction price, (iv) allocate the transaction price, and (v) recognize revenue when (or as) performance obligations are satisfied.

A contract contains a promise (or promises) to transfer goods or services to a customer. A performance obligation is a promise (or a group of promises) that is distinct, as defined in the revenue standard.

The transaction price is the amount of consideration an entity expects to be entitled to from a customer in exchange for providing the goods or services. A number of factors should be considered to determine the transaction price, including whether there is variable consideration, a significant financing component, noncash consideration, or amounts payable to the customer. The determination of variable consideration will require a significant amount of judgment. In estimating the transaction price we will use either the expected value method or the most likely amount method.

35


43

The transaction price is allocated to the separate performance obligations in the contract based on relative standalone selling prices. Determining the relative standalone selling price can be challenging when goods or services are not sold on a standalone basis. The revenue standard sets out several methods that can be used to estimate a standalone selling price when one is not directly observable. Allocating discounts and variable consideration must also be considered. Allocating the transaction price can require significant judgement on our part.

Revenue is recognized when (or as) the customer obtains control of the good or service/performance obligations are satisfied. Topic 606 provides guidance to help determine if a performance obligation is satisfied at a point in time or over time. Where a performance obligation is satisfied over time, the related revenue is also recognized over time.

Disaggregation of revenue

The following table provides information about disaggregated revenue by timing of revenue recognition, (in thousands):

   Year Ended December 31, 2020
      License and      
   Product  royalty  Contract   
   revenue  revenue  revenue  Total
Timing of revenue recognition:            
     Products transferred at a point in time $1,347  $1,718  $ $3,069 
     Product and services transferred over time      21   21 
     Total $1,347  $1,718  $25  $3,090 

SCHEDULE OF DISAGGREGATION OF REVENUE

 Product royalty Contract   
 Year Ended December 31, 2019 Year Ended December 31, 2023 
 License and    License and     
 Product royalty Contract  Product royalty Contract   
 revenue revenue revenue Total revenue revenue revenue Total 
Timing of revenue recognition:                 
Products transferred at a point in time $5,345  $99  $178  $5,622  $1,019   4,888   1,106  $7,013 
Product and services transferred over time   3,264  3,264   -   -   246   246 
Total $5,345  $99  $3,442  $8,886  $1,019  $4,888  $1,352  $7,259 

  Product  royalty  Contract    
  Year Ended December 31, 2022 
     License and       
  Product  royalty  Contract    
  revenue  revenue  revenue  Total 
Timing of revenue recognition:                
Products transferred at a point in time $           -  $664  $                   -  $664 
Product and services transferred over time  -   -   -   - 
Total $-  $664  $-  $664 

  Product  royalty  Contract    
  Year Ended December 31, 2021 
     License and       
  Product  royalty  Contract    
  revenue  revenue  revenue  Total 
Timing of revenue recognition:                
Products transferred at a point in time $         -  $2,500  $       -  $2,500 
Product and services transferred over time  -   -   -   - 
Total $-  $2,500  $-  $2,500 

44

Contract balances

The following table provides information about receivables, contract assets, and contract liabilities from contracts with customers (in thousands):

   December 31,
   2020  2019
       
       
Accounts receivable, net $ $1,079 
Accrued liabilities    432 
Deferred revenue    21 
Contract liabilities  7,765   9,755 

SIGNIFICANT CHANGES IN CONTRACT ASSETS AND CONTRACT LIABILITIES

  2023  2022  2021 
  December 31, 
  2023  2022  2021 
          
Accounts receivable, net $949  $-  $- 
Accrued liabilities  -   -   - 
Contract liabilities  300   4,601   5,265 

Under Topic 606, our rights to consideration are presented separately depending on whether those rights are conditional or unconditional. We present our unconditional rights to consideration as "accounts receivable"“accounts receivable” in our Balance Sheet.

36


Contract assets represent rights to consideration that are subject to a condition other than the passage of time and will be comprised primarily of costs and estimated profits in excess of billings on uncompleted contracts and estimated accrued sales-based royalty revenue.

Contract liabilities in the table below are presented as contract liabilities, deferred revenue, and a portion of accrued liabilities on the balance sheet. Significant changes in the contract assets and the contract liabilities balances during the period are as follows (in thousands, except percentages):

   December 31,  December 31,     
   2020  2019  $ Change % Change
            
Contract assets $ $ $ 
Contract liabilities  (7,765)  (10,208)  2,443  23.9 
Net contract assets (liabilities) $(7,765) $(10,208) $2,443  23.9 

SCHEDULE OF CONTRACT WITH CUSTOMER, CONTRACT ASSET, CONTRACT LIABILITY, AND RECEIVABLE

  December 31,  December 31,       
  2023  2022  $ Change  % Change 
             
Contract assets $                  949  $                       -  $949   - 
Contract liabilities  (300)  (4,601)  4,301   93.5 
Net contract assets (liabilities) $649  $(4,601) $5,250   114.1 

In April 2017, we signed a contract with Microsoft Corporation to develop an LBS display system; the contract terminated effective December 31, 2023. Under the agreement, we received an upfront payment of $10.0 million. As of December 31, 2022, we had applied $5.4 million against the contract liability. During the year ended December 31, 2020,2023, we applied $2.0the remaining $4.6 million against the contract liability with our April 2017 customer.this customer since we believe the likelihood of further deliveries under the contract is remote. We do not expect to recognize any further revenue in connection with this contract.

During 2019, we reached an agreement with the distributor in our Ragentek contract on the final transaction price of the units shipped to them. As part of the agreement reached in 2019, we agreed to return $432,000 of the original transaction price to our distributor and the amount was included in accrued liabilities at December 31, 2019. During the year ended December 31, 2020, payments totaling $332,000 were made to the distributor. In 2020, we settled all claims with Ragentek and our distributor. Per the terms of the agreement, the final $100,000 payment to our distributor was no longer required. As a result, we recognized $100,000 of product revenue during the year ended December 31, 2020 as an adjustment to the transaction price of products previously transferred to our customer.

Contract acquisition costs

We are required to capitalize certain contract acquisition costs consisting primarily of commissions paid when contracts are signed. We currently do not pay any commissions upon the signing of a contract; therefore, no commission cost has been incurred as of December 31, 2020.  2023.

In connection with our January 2023 acquisition of assets from Ibeo, we assumed contract liabilities totaling approximately $1.2 million. During the twelve months ended December 31, 2023, we recognized revenue totaling $1.0 million against the contract liability.

Transaction price allocated to the remaining performance obligations

The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The $10.0 million upfront payment received from a major technology company is being recognized as revenue as component sales are transferred to the customer. During the years ended December 31, 2020 and 2019, we recognized $2.0 million and $245,000, respectively, of the $10.0 million contract liability. We expect to apply an additional $3.2 million in 2021, and this amount is included in revenue below. Because there is uncertainty about the timing of the application of the remainder of the contract liability, it has been excluded from future estimated revenue in the table below. The $7.8 million contract liability is classified as a current liability on our balance sheet. Due to the uncertainty of the timing, it is possible that recognition of revenue may extend beyond the next twelve months.

The following table provides information about the estimated timing of revenue recognition (in thousands):

   2021  2022
       
License and royalty revenue $3,222  $

AdoptionSCHEDULE OF ESTIMATED TIMING OF REVENUE RECOGNITION

  2024  2025 
     
Revenue $300  $- 

5. INVESTMENT SECURITIES, AVAILABLE-FOR-SALE AND FAIR VALUE MEASUREMENTS

Our investment securities, available-for-sale are comprised of corporate debt securities. The principal markets for the debt securities are dealer markets which have a high level of price transparency. The market participants for debt securities are typically large money center banks and regional banks, brokers, dealers, pension funds, and other entities with debt investment portfolios.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three level fair value inputs hierarchy and requires an entity to maximize the use of observable valuation inputs and minimize the use of unobservable inputs. We use market data, assumptions and risks we believe market participants would use in measuring the fair value of the standards relatedasset or liability, including the risks inherent in the inputs and the valuation techniques. The hierarchy is summarized below.

45

Level 1 – Quoted prices in active markets for identical assets and liabilities at the measurement date that the reporting entity has the ability to revenue recognition hadaccess.

Level 2 – Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 – Unobservable inputs for which there is little or no impact to cash from or used in operating, investing, or financing activities on our statements of cash flows.

4. LONG-TERM CONTRACTS

In April 2017, we signed a contract with a major technology companymarket data, which requires us to develop an LBS display system. Underour own assumptions, which are significant to the agreement, we received an upfront paymentmeasurement of $10.0 million in 2017 and,the fair values.

The valuation inputs hierarchy classification for assets measured at fair value on a recurring basis are summarized below as of December 31, 2019, had also received $15.0 million, net of early payment discounts, representing all payment due for development work. The2023 and 2022 (in thousands). These tables do not include cash held in our money market savings accounts.

37


SCHEDULE OF FAIR VALUE HIERARCHY ASSETS AND LIABILITIES

 Level 1  Level 2  Level 3  Total 
As of December 31, 2023                
Assets                
Corporate debt securities $-  $8,471  $-  $8,471 
U.S. Treasury securities  -   20,140   -   20,140 
  $-  $28,611  $-  $28,611 

 Level 1  Level 2  Level 3  Total 
As of December 31, 2022                
Assets                
Corporate debt securities $-  $15,500  $-  $15,500 
U.S. Treasury securities  -   46,673   -   46,673 
  $-  $62,173  $-  $62,173 

original contract was for $14.0 million in fees for development work, but we and our customer agreed to add $1.1 million in additional work to total $15.1 million. After applying early payment discounts, we recognized revenue of $15.0 million in development fees over time based on the proportion of total cost expended (under Topic 606, the "input method") to the total cost expected to complete the contract performance obligation. For the year ended December 31, 2019, we recognized $2.9 million of contract revenue from development fees on this agreement.

Beginning in the fourth quarter of 2019, the $10.0 million upfront payment was being recognizedOur short-term investments are summarized below as revenue at the point in time that component sales were sold to the major technology customer. In March 2020, we entered into an agreement for our customer to take over production of the components we had been producing for them. The agreement provides that, beginning in March 2020, we will earn a royalty on each component shipped that is approximately equal to the gross profit we would have earned if we continued to produce and ship the components. Under the new arrangement, the royalties earned will be applied against the remaining $7.8 million prepayment that we had previously received from the customer until the prepayment is exhausted.

5. LONG-TERM DEBT

In April 2020, we received funds in the amount of $1.6 million pursuant to a loan under the Paycheck Protection Program of the 2020 CARES Act ("PPP") administered by the Small Business Administration. The loan has an interest rate of 0.98% and a term of 24 months. No payments are due for the first 10 months following the 24-week covered period, although interest accrues during that period. Thereafter, the loan is repayable in monthly installments over the next 18 months to retire the loan plus accrued interest. Funds from the loan may only be used for certain purposes, including payroll, benefits, rent and utilities, and a portion of the loan used to pay certain costs may be forgivable, all as provided by the terms of the PPP. The loan is evidenced by a promissory note, which contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. We may prepay the loan at any time prior to maturity with no prepayment penalties.

As of December 31, 2020, all2023 and 2022 (in thousands).

SCHEDULE OF UNREALIZED GAIN OR LOSS ON SHORT-TERM INVESTMENTS

           Investment 
  Cost/  Gross  Gross  Securities, 
  Amortized  Unrealized  Unrealized  Available- 
  Cost  Gains  Losses  For-Sale 
As of December 31, 2023                
Assets                
Corporate debt securities $8,466  $6  $(1) $8,471 
U.S. Treasury securities  20,119   21   -   20,140 
  $28,585  $27  $(1) $28,611 

As of December 31, 2022            
Assets                
Corporate debt securities $15,538  $-  $(38) $15,500 
U.S. Treasury securities  46,762   2   (91)  46,673 
  $62,300  $2  $(129) $62,173 

46

The maturities of the funds received under the PPP hadinvestment securities available-for-sale as of December 31, 2023 and 2022 are shown below (in thousands):

SCHEDULE OF MATURITY DATE OF AVAILABLE-FOR-SALE SECURITIES

     Gross  Gross    
 Amortized  Unrealized  Unrealized  Estimated 
 Cost  Gains  Losses  Fair Value 
As of December 31, 2023                
Maturity date                
Less than one year $28,585  $27  $(1) $28,611 
                 
As of December 31, 2022                
Less than one year $62,300  $2  $(129) $62,173 

The following table summarizes investments that have been usedin a continuous unrealized loss position for qualified purposes. We intend to applyless than 12 months and those that have been in a continuous unrealized loss position for partial forgivenessmore than 12 months as of the loan under PPP guidelines. Based on the terms of the PPP, we plan to apply for forgiveness of approximately $690,000, subject to approval by our lender in accordance with PPP guidelines.December 31, 2023 and 2022 (in thousands):

SCHEDULE OF UNREALIZED LOSS ON INVESTMENTS SECURITIES

  Less than Twelve Months  Twelve Months or Greater  Total 
     Gross     Gross     Gross 
  Fair  Unrealized  Fair  Unrealized  Fair  Unrealized 
  Value  Losses  Value  Losses  Value  Losses 
As of December 31, 2023                  
Corporate debt securities $1,488  $(1) $-  $-   1,488   (1)
U.S. Treasury securities  1,486   -   -   -   1,486   - 
  $2,974  $(1) $-  $-  $2,974  $(1)
                         
As of December 31, 2022                        
Corporate debt securities $12,295  $(38) $-  $-   12,295   (38)
U.S. Treasury securities  34,530   (91)  -   -   34,530   (91)
  $46,825  $(129) $-  $-  $46,825  $(129)

6. INVENTORY

Inventory consists of the following (in thousands):

   December 31,
   2020  2019
Raw materials $ $
Finished goods    192 
  $ $192 

We recorded inventory write-downs of $168,000 in 2020 and $2.2 million in 2019.

COMPONENTS OF INVENTORY

         
  December 31, 
  2023  2022 
Raw materials $1,574  $1,556 
Work in process  305   305 
Finished Goods  1,995   - 
Total inventory $3,874  $1,861 

7. ACCRUED LIABILITIES

Accrued liabilities consists of the following (in thousands):

   December 31,
   2020  2019
Bonuses $ $201 
Payroll and payroll taxes  361   425 
Compensated absences    448 
Warranty  49   38 
Prepayments from customers    432 
Other  85   501 
  $495  $2,045 

38


8. PROPERTY AND EQUIPMENT

Property and equipment consists of the following (in thousands):

   December 31,
   2020  2019
Production equipment $7,210  $6,969 
Leasehold improvements  913   913 
Computer hardware and software/lab equipment  6,226   6,165 
Office furniture and equipment  1,345   1,345 
   15,694   15,392 
Less: Accumulated depreciation  (13,811)  (13,543)
  $1,883  $1,849 

COMPONENTS OF PROPERTY, PLANT AND EQUIPMENT

  2023  2022 
  December 31, 
  2023  2022 
Production equipment $6,140  $6,140 
Leasehold improvements  3,843   3,789 
Computer hardware and software/lab equipment  12,149   10,515 
Office furniture and equipment  5,367   1,804 
Property and equipment, gross   27,499   22,248 
Less: Accumulated depreciation  (18,467)  (15,418)
Property and equipment, net  $9,032  $6,830 

Depreciation expense was $442,000 in 2020 and $1.1$3.1 million in 2019.2023, $0.7 million in 2022 and $0.9 million in 2021.

9.

47

8. INTANGIBLE ASSETS

Our

The components of intangible assets consist exclusively of technology-based purchased patents. The gross book value of our intangible assets was $951,000 in the years ended December 31, 2020 and 2019, respectively. were as follows:

SUMMARY OF COMPONENTS OF INTANGIBLE ASSETS

As of December 31, 2023 Gross Carrying  Accumulated  

Net

Carrying

  

Weighted

Average Remaining

 
(in thousands) Amount  Amortization  Amount  Period (Years) 
Acquired technology $20,172  $2,940  $17,232   12 
Backlog  26   23   3   - 
  $20,198  $2,963  $17,235     

As of December 31, 2022 

Gross

Carrying

  Accumulated  

Net

Carrying

  

Weighted

Average Remaining

 
(in thousands) Amount  Amortization  Amount  Period (Years) 
Acquired technology $951  $876  $75      4 
  $      951  $    876  $     75     

Amortization expense was $57,000$2.1 million in 20202023, $0.0 million in 2022 and $105,000$0.0 million in 2019. In 2019, we recorded an impairment amounting to $160,000 on 52 patents that we elected not to renew, and one patent abandoned in prosecution. 2021.

The following table outlines our estimated future amortization expense related to intangible assets held at December 31, 20202023 (in thousands):

Years Ended December 31,  Amount
2021 $49 
2022  40 
2023  32 
2024  22 
2025  14 
Thereafter  
  $164 

ESTIMATED FUTURE AMORTIZATION EXPENSE RELATED TO INTANGIBLE ASSETS

     Research and    
  Cost of  Development    
Years Ended December 31, Revenue  Expense  Total 
2024 $1,548   584  $2,132 
2025  1,548   54   1,602 
2026  1,548   25   1,573 
2027  1,508   -   1,508 
Thereafter  10,420   -   10,420 
 Total $16,572  $663  $17,235 

9. ACCRUED LIABILITIES

Accrued liabilities consists of the following (in thousands):

SCHEDULE OF ACCRUED LIABILITIES

  2023  2022 
  December 31, 
  2023  2022 
Bonuses $1,359  $537 
Payroll and payroll taxes  3,704   766 
Income taxes payable  2,111   - 
Accrued professional fees  236   378 
Liabilities to suppliers  885   130 
Other  345   247 
Total accrued liabilities $8,640  $2,058 

In addition, the accrued liability for Ibeo business combination on our balance sheet in the amount of $6.3 million includes $3.3 million that was withheld from the Purchase Price and held in escrow for a maximum period of 13 months post-Closing as partial security for potential claims arising out of or in connection with the Asset Purchase Agreement and $3.0 million holdback amount that is expected to be paid in first quarter of 2024.

10. COMMON STOCK

In December 2020,August 2023, we entered into a $13.0$35.0 million ATM equity offering agreement with Craig-Hallum. Under the agreement, we may, from time to time,are able, at our discretion, to offer and sell shares of our common stock having an aggregate value of up to $13.0$35.0 million through Craig-Hallum. As of December 31, 2020,2023, we had issued 1.0completed sales under such sales agreement, having sold 6.1 million shares for net proceeds of $6.1 million that was received in January 2021. The $6.1 million is classified as subscriptions receivable on our December 31, 2020 balance sheet and is not included in the cash balance as$15.5 million. As of December 31, 2020.2023, we have approximately $19.0 million available under this ATM agreement.

48

In November 2020,June 2023, we entered into a $10.0$45.0 million ATM equity offering agreement with Craig-Hallum Capital Group.Craig-Hallum. Under the agreement, we were able, to, from time to time, at our discretion, to offer and sell shares of our common stock having an aggregate value of up to $10.0$45.0 million through Craig-Hallum. As of December 31, 2020,June 30, 2023, we had completed sales under such sales agreement, having sold 4.910.9 million shares for net proceeds of $9.6$43.9 million. No further shares are available for sales under this agreement.

In December 2019,June 2021, we entered into a Common Stock Purchase Agreement$140.0 million ATM equity offering agreement with Lincoln Park granting usCraig-Hallum. Under the rightagreement we were able, at our discretion, to offer and sell shares of our common stock having an aggregate value of up to $16.0 million. Under the terms of the agreement, Lincoln Park made an initial purchase of 1.5$140.0 million shares of common stock for $1.0 million at a purchase price of $0.6531 per share. Subject to various limitations and conditions set forth in the agreement, we were able to sell up to an additional $15.0 million in shares of common stock, from time to time, at our sole discretion to Lincoln Park over a 24-month period beginning December 2019. In consideration for entering into the agreement, we issued 375,000 shares of our common stock, having a value of $277,000, based on the closing stock price at the date of grant, to Lincoln Park as a commitment fee. We incurred an additional $90,000 in issuance costs.through Craig-Hallum. As of December 31, 2020,2022, we had completed sales under such sales agreement, having sold 22.2 million shares for net proceeds of $15.6 million.

In July 2019, we raised $2.0 million before issuance costs of approximately $24,000 through a registered direct offering of 3.0issued 8.3 million shares of our common stock to a private investor.

39


In April 2019,for net proceeds of $81.8 million under this ATM agreement. During the quarter ended March 31, 2023, we raised $2.0 million before issuance costs of approximately $34,000 through a registered direct offering of 2.3issued 5.0 million shares of our common stock to a private investor.

In April 2019, we entered into a Common Stock Purchase Agreement with Lincoln Park granting us the right to sell sharesfor net proceeds of our common stock having an aggregate value of up to $11.0 million. Under the terms of the agreement, Lincoln Park made an initial purchase of $1.0 million in shares of common stock at a purchase price of $0.98 per share. Subject to various limitations and conditions set forth in the agreement, we were able to sell up to an additional $10.0 million in shares of common stock, from time to time, at our sole discretion to Lincoln Park over a 24-month period beginning April 2019. In consideration for entering into the agreement, we issued 250,000 shares of our common stock, having a value of $258,000, based on the closing stock price at the date of grant, to Lincoln Park as a commitment fee. We incurred an additional $92,000 in issuance costs. As of December 31, 2019, we had issued 15.7 million shares and raised a total of $11.0$12.5 million under thisthe agreement. No further shares are available forThe sales under this agreement.agreement was terminated in June 2023.

In January 2019, we raised $1.2 million before issuance costs of approximately $26,000 through a registered direct offering of 2.0 million shares of our common stock to a private investor.

11. SHARE-BASED COMPENSATION

We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award. The valuation of and accounting for share-based awards includes a number of complex and subjective estimates. These estimates include, but are not limited to, the future volatility of our stock price, future stock option exercise behaviors, estimated employee turnover, and award forfeiture rates.

Description of Incentive Plan

Our 20202022 Incentive Plan has 17.320.0 million shares authorized, of which 8.1includes 3.5 million shares not issued pursuant to any awards granted under the 2020 Incentive Plan. There were9.4 million shares available for awards as of December 31, 2020.2023.

Options Valuation Methodology and Assumptions

We use the Black-Scholes option valuation model to determine the fair value of options granted and use the closing price of our common stock as the fair market value of our stock on that date.

We consider historical stock price volatilities, volatilities of similar companies and other factors in determining estimates of future volatilities.

We use historical lives, including post-termination exercise behavior, as the basis for estimating expected lives.

Risk-free rates are based on the U.S. Treasury Yield Curve, as published by the U.S. Treasury.

The following table summarizes the weighted-average valuation assumptions and weighted-average grant date fair value of options granted during the periods shown below:

   Year Ended December 31,
   2020  2019
Assumptions (weighted-average)      
Volatility  111%  78%
Expected term (in years)  4.0   4.0 
Risk-free rate  0.3%  1.9%
Expected dividends  0.0%  0.0%
Pre-vest forfeiture rate  8.5%  8.5%
Grant date fair value of options granted $1.20  $0.37 

40


SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

  Year Ended December 31, 
Assumptions (weighted-average) 2023  2022  2021 
Volatility  0%  0%  120%
Expected term (in years)  -   -   4.0 
Risk-free rate  0.0%  0.0%  0.9%
Expected dividends  0.0%  0.0%  0.0%
Pre-vest forfeiture rate  0.0%  0.0%  8.5%
Grant date fair value of options granted $-  $-  $11.72 

49

Options Activity and Positions

The following table summarizes activity and positions with respect to options for the periods shown below (in thousands):

         Weighted-average   
         remaining  Aggregate
      Weighted-average  contractual  intrinsic
Options  Shares  exercise price  term (in years)  value
Outstanding as of December 31, 2018  4,646  $2.27   7.0  $
Granted   1,636   0.65   -    
Exercised    -    -    
Forfeited or expired  (1,178)  2.66   -    
Outstanding as of December 31, 2019  5,104   1.66   7.4   122 
Granted   68   1.60   -    
Exercised  (693)  1.44   -    
Forfeited or expired  (1,198)  2.20   -    
Outstanding as of December 31, 2020  3,281  $1.51   6.6  $12,784 
             
Vested and expected to vest as of December 31, 2020  3,193  $1.53   6.5  $12,379 
             
Exercisable as of December 31, 2020  2,086  $1.86   5.6  $7,413 

No options were exercised during the year ended December 31, 2019.

SCHEDULE OF VALUATION ASSUMPTIONS FOR STOCK OPTIONS

        Weighted-average    
        remaining  Aggregate 
     Weighted-average  contractual  intrinsic 
Options Shares  exercise price  term (in years)  value 
Outstanding as of December 31, 2020  3,281   1.51   6.6  $12,784 
Granted  8   14.04         
Exercised  (1,519)  1.75         
Forfeited or expired  (237)  1.23         
Outstanding as of December 31, 2021  1,533   1.37   5.6  $5,645 
Granted  -   -         
Exercised  (525)  1.38         
Forfeited or expired  (63)  3.00         
Outstanding as of December 31, 2022  945   1.26   5.7  $1,137 
Granted  -   -         
Exercised  (191)  0.92         
Forfeited or expired  (2)  0.28         
Outstanding as of December 31, 2023  752  $1.35   4.6  $1,083 
Vested and expected to vest as of December 31, 2023  752  $1.35   4.6  $1,083 
                 
Exercisable as of December 31, 2023  752  $1.35   4.6  $1,083 

The total grant date fair value of options vested during the years ended December 31, 20202023, 2022 and 20192021 was $604,000$0, $0.1 million and $801,000,$0.5 million, respectively. As of December 31, 2020, our2023, we have no unrecognized share-based compensation was $376,000 related to options, which options.

Restricted stock activity and positions

The following table summarizes activity and positions with respect to RSUs and PSUs for the three years ended December 31, 2023 (in thousands):

SHARE-BASED PAYMENT ARRANGEMENT RESTRICTED STOCK UNIT ACTIVITY

     Weighted-average 
  Shares  price 
Unvested as of December 31, 2020  1,983  $0.76 
Granted  4,179   12.92 
Vested  (2,380)  3.11 
Forfeited  (1,157)  11.97 
Unvested as of December 31, 2021  2,625   13.05 
Granted  9,180   2.46 
Vested  (1,391)  9.16 
Forfeited  (1,548)  6.42 
Unvested as of December 31, 2022  8,866   3.85 
Granted  3,491   3.89 
Vested  (1,872)  6.98 
Forfeited  (502)  7.47 
Unvested as of December 31, 2023  9,983  $3.09 

In 2023, we planissued 2.6 million PSUs to amortizenon-executive employees subject to the achievement of development goals. These shares are liabilities subject to mark-to-market accounting as the number of shares was not fixed when issued. One-third of these shares will vest in connection with 2023 achievement of the milestones and the remaining two-thirds will vest over two years from June 30, 2023.

In 2023, we issued 0.1 million shares for the partial achievement of internal performance milestones during the fourth quarter of 2022. These shares were valued based on the closing price of our common stock on the dates of grant and vest quarterly over two years. We had canceled 0.4 million PSUs in the fourth quarter of 2022 related to the same internal performance milestones.

In 2023, we issued 0.6 million time-based RSUs to non-executive employees for promotion, retention, and new hire grants. These shares were valued based on the closing price of our common stock on the dates of grant. These shares vest over three or four years from the date of grant.

50

In 2023, we issued 0.3 million time-based RSUs to independent directors for annual equity compensation. These shares were valued based on the closing price of our common stock on the dates of grant. These shares vest quarterly, with the final installment vesting the earlier of the one year anniversary of the grant date or the day before the next 1.2 years.annual meeting.

In 2020,June 2022, we issued 111,0006.0 million PSUs to our executive officers. The PSUs are subject to the achievement of performance goals and time-based vesting. The PSUs will become eligible to vest if the closing price of our common stock reaches or exceeds specified price thresholds for at least 20 consecutive trading days during the performance period through December 31, 2025. If the performance goals are met, the portion of the PSUs deemed earned will become subject to time-based vesting in equal quarterly installments over two years starting from the date on which the goal is achieved. These PSUs were valued using a Monte Carlo simulation model using the following inputs: stock price, volatility, and risk-free interest rates.

In 2022, we issued 2.4 million PSUs to non-executive employees subject to the achievement of development goals. These shares were valued based on the closing price of our common stock on the dates of grant. These shares vest quarterly over two years from the achievement of established performance criteria. We canceled 0.4 million PSUs in the fourth quarter of 2022 and re-issued 0.1 million PSUs in the first quarter of 2023 due to partial achievement of internal performance milestones.

In 2022, we issued 0.6 million time-based RSUs asto non-executive employees for promotion, retention, and new hire grants. These shares were valued based on the closing price of our common stock on the dates of grant. These shares vest over three or four years from the date of grant.

In 2021, an equity award was granted to the Chief Executive Officer in the form of 1.2 million restricted stock units. These shares were valued based on the closing price of our common stock on the dates of grant. On the date of grant, 0.3 million shares vested immediately, 0.3 million vested in April 2022 and subsequent grants of 0.3 million RSUs will be made on an annual basis in each of April 2023 and April 2024.

In 2021, we issued 1.5 million shares of performance stock units to non-executive employees. These shares were valued based on the closing price of our common stock on the dates of grant. TheseThe shares vest onone-eighth upon achievement of performance milestones with the earlier of a change of controlremainder vesting quarterly over the following seven quarters. In 2021, 1.1 million of the Companyperformance stock units were canceled because of modifications to or the one-year anniversary of the grant date.failure to achieve performance milestones.

In June 2020,2021, we issued 1.21.1 million RSUs to non-executive employees for promotion, retention purposes.and new hire grants. These shares were valued based on the closing price of our common stock on the datedates of grant. These shares vest on the earlier of a change of control of the Company or the one-year anniversary of the grant date.

In the fourth quarter of 2019, we issued 384,751 vested RSUsannually over one to our executives in lieu of cash for payment of short-term incentive bonuses earned in 2018.

On May 22, 2019, we issued 195,000 PSUs to our executive officers. The performance criteria for PSUs issued in May 2019 is the achievement of the Company's share price of $2.50 sustained for 60 of trailing 90 days before the PSUs are earned ("Earned PSUs").  To the extent the PSUs become Earned PSUs, the PSUs shall be eligible to vest as to one-third (1/3) of the PSUs subject to the Award on the each of the first three (3) anniversaries of May 22, 2019. If there are outstanding but unearned PSUs as of a vesting date and the PSUs become Earned PSUs prior to the next vesting date the Earned PSUs that would have vested on any earlier vesting date shall become immediately vested and deliverable.  The PSUs are valued using a binomial option pricing model using the following inputs: stock price, volatility, and risk-free interest rates.

We also issued 475,000 stock options to our executives on May 22, 2019, that vest one-third on each of the first three anniversaries of May 22, 2019.

On May 19, 2020 and May 22, 2019, we issued 120,000 and 180,000 RSUs, respectively, to members of the board, vesting ownership in the RSUs on the earlier of the day prior tofour years from the date of the Company's annual meeting of shareholders following the date of grant, or one year from the grant date, provided the member of the board continues to serve as a director on the vesting date. On November 11, 2019 we issued 163,734 RSUs to the members of the board in lieu of the annual cash fee. The members of the board vest ownership in the RSUs immediately.grant.

As of December 31, 2020,2023, our unrecognized share-based compensation related to RSUs was $5.0 million, which we plan to expense over the next 1.6 years, our unrecognized share-based compensation related to executive PSUs was $5.1 million, which we plan to expense over the next 1.8 years, and our unrecognized share-based compensation related to the RSUsnon-executive PSUs was $751,000$3.3 million, which we plan to amortizeexpense over the next 0.5 years. As of December 31, 2020, our unrecognized share-based compensation related to the PSUs was $5,000, which we plan to amortize over the next 1.0 years. year.

41


12. LEASES

12. LEASES

In February 2016, the FASB issued Accounting Standards Update 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires lessees to recognize a ROU asset and lease liability in the balance sheet for all leases, including operating leases, with terms of more than twelve months. Recognition, measurement and presentation of expenses and cash flows from a lease by a lessee have not significantly changed from previous guidance. The amendments also require qualitative disclosures along with specific quantitative disclosures. We adopted this guidance using the cumulative-effect adjustment method on January 1, 2019, meaning we did not restate prior periods. Current year financial information is presented under the guidance in Topic 842, while prior year information will continue to be presented under Topic 840. Adoption of the standard resulted in the recognition of an operating ROU asset of approximately $1.6 million, a lease liability of approximately $2.5 million, and a reduction in other short-term and long-term liabilities of $873,000. Adoption of the standard did not have a material impact on our Statement of Operations or Statement of Cash flows. Accounting for our finance leases remains substantially unchanged.

We lease our office space and certain equipment under finance and operating leases. Our leases have remaining lease terms of one to threeten years. Our office space lease contains an option to extend the lease for one period of five years. This extension period is not included in our ROU asset or lease liability amounts. Our office lease agreement includes both lease and non-lease components, which are accounted for separately. Our finance leases contain options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless we are reasonably certain to exercise the purchase option.

In September 2021, we entered into an office lease with Redmond East Office Park LLC, a Washington limited liability company, pursuant to which we will lease approximately 16,681 square feet of space located in Redmond, Washington that we will use primarily for general office space. The lease provides for an initial term of 128 months that commenced November 1, 2021. Pursuant to the lease, annual base rent was approximately $0.5 million for the first year and is subject to annual increases of 3.0%. In addition to base rent, we pay additional rent comprised of our proportionate share of any operating expenses, real estate taxes, and management fees. We have the option to extend the term for one ten-year renewal period, provided that the rent would be subject to market adjustment at the beginning of the renewal term. The total minimum lease payments related to this lease is $6.4 million.

51

In September 2021, we entered into a second office lease with Redmond East Office Park LLC, pursuant to which we will lease approximately 36,062 square feet of space located in Redmond, Washington that we will use primarily for product testing and lab space. The lease provides for an initial term of 120 months that commenced on December 1, 2022. Pursuant to the lease, annual base rent will be approximately $1.1 million for the first year and is subject to annual increases of 3.0%. In addition to base rent, we will pay additional rent comprised of our proportionate share of any operating expenses, real estate taxes, and management fees. We have the option to extend the term for one ten-year renewal period, provided that the rent would be subject to market adjustment at the beginning of the renewal term. The total minimum lease payments related to this lease are $13.0 million. During the quarter ended June 30, 2023, we received a payment of $3.0 million as an incentive to terminate our previous building lease. The gain is recorded as other income in our statement of operations.

In April 2022, we entered into an office lease with Universal-Investment-Gesellschaft mbH, a German investment company, pursuant to which we lease approximately 3,533 square feet of space located in Nuremberg, Germany that we use primarily for general office space for business development activities. The lease provides for a term of 60 months that commenced May 1, 2022. Pursuant to the lease, annual base rent is approximately $76,000 per year. The total minimum lease payments related to this lease is approximately $0.4 million.

In September 2022, we entered into a second office lease with Universal-Investment-Gesellschaft GmbH, a German investment company, pursuant to which we lease approximately 3,810 square feet of space located in Nuremberg, Germany that we use primarily for product testing for engineering and development activities. The lease provides for a term of 60 months that commenced November 15, 2022. Pursuant to the lease, annual base rent is approximately $92,000 per year. The total minimum lease payments related to this lease is approximately $0.5 million.

In connection with our January 2023 acquisition of assets from Ibeo, we assumed three leases in Hamburg, Germany covering approximately 51,000 square feet.

One lease is with IntReal International Real Estate Kapitalverwaltungsgesellschaft and covers approximately 5,511 square feet of space for IT network equipment through December 31, 2026. Pursuant to the lease, annual base rent is approximately $65,000 per year. The total remaining minimum lease payments related to this lease are approximately $0.3 million. During the quarter ended March 31, 2023, we recorded a right-of-use asset in the amount of $0.2 million on our balance sheet. A second lease is with Neuer Holtigbaum and covers approximately 32,529 square feet of office space and long-range laser testing space through August 2023. During the quarter ended September 30, 2023, we amended this lease and extended until August 2024. The total remaining minimum lease payments related to this lease are approximately $0.2 million. The third lease is with BG BAU Berufsgenossenschaft der Bauwirtschaft and covers approximately 13,127 square feet of garage space to house our test and demonstration vehicles through July 31, 2024. The total remaining minimum lease payments related to this lease are approximately $0.1 million.

In December 2023, we entered into a lease on approximately 60,000 square feet of space located in central Hamburg in Germany. This lease is intended to replace the office space described in the immediately preceding paragraph. The lease provides for a term of 60 months and will commence on the date the property is delivered to us, which is expected to occur between August 1, 2024 and December 31, 2024.

The components of lease expense were as follows:

   Year Ended December 31,
(in thousands)  2020  2019
Operating lease expense $464  $464 
       
Finance lease expense:      
     Amortization of leased assets  26   15 
     Interest on lease liabilities    
Total finance lease expense  29   21 
Total lease expense $493  $485 

SCHEDULE OF COMPONENTS OF LEASE EXPENSE

             
  Year Ended December 31, 
(in thousands) 2023  2022  2021 
Operating lease expense $2,625  $1,501  $513 
             
Finance lease expense:            
Amortization of leased assets  21   26   30 
Interest on lease liabilities  -   2   3 
Total finance lease expense  21   28   33 
Total lease expense $2,646  $1,529  $546 

52

Supplemental cash flow information related to leases was as follows:

   Year Ended December 31,
(in thousands)  2020  2019
Cash paid for amounts included in measurement of lease liabilities:      
     Operating cash flows from operating leases $656  $642 
     Operating cash flows from finance leases    
     Financing cash flows from finance leases  29   20 
       
Right-of-use assets obtained in exchange for new lease obligations:      
     Operating leases $ $1,638 

42


SCHEDULE OF CASH FLOW INFORMATION RELATED TO LEASES

             
  Year Ended December 31, 
(in thousands) 2023  2022  2021 
Cash paid for amounts included in measurement of lease liabilities:            
Operating cash flows from operating leases $2,500  $1,280  $762 
Operating cash flows from finance leases  -   2   3 
Financing cash flows from finance leases  21   26   28 
             
Right-of-use assets obtained in exchange for new lease obligations:            
Operating leases $1,338  $10,184  $5,322 

Supplemental balance sheet information related to leases was as follows:

   December 31,
(in thousands)  2020  2019
Operating leases      
     Operating lease right-of-use assets $946  $1,308 
       
     Current portion of operating lease liability  676   656 
     Operating lease liability, net of current portion  774   1,348 
     Total operating lease liabilities $1,450  $2,004 
       
Finance leases      
     Property and equipment, at cost $112  $66 
     Accumulated depreciation  (28)  (25)
     Property and equipment, net $84  $41 
       
     Current portion of finance lease obligations $31  $25 
     Finance lease obligations, net of current portion  44   
     Total finance lease liabilities $75  $34 
       
Weighted Average Remaining Lease Term      
     Operating leases  2.3 years   3.3 years 
     Finance leases  2.0 years   1.4 years 
       
Weighted Average Discount Rate      
     Operating leases  6.0%  6.0%
     Finance leases  6.3%  13.8%

SCHEDULE OF BALANCE SHEET INFORMATION RELATED TO LEASES

         
  December 31, 
(in thousands) 2023  2022 
Operating leases        
Operating lease right-of-use assets $13,758  $14,579 
         
Current portion of operating lease liability  2,323   1,846 
Operating lease liability, net of current portion  12,714   13,829 
Total operating lease liabilities $15,037  $15,675 
         
Finance leases        
Property and equipment, at cost $112  $112 
Accumulated depreciation  (97)  (80)
Property and equipment, net $15  $32 
         
Current portion of finance lease obligations $-  $21 
Finance lease obligations, net of current portion  -   - 
Total finance lease liabilities $-  $21 
         
Weighted Average Remaining Lease Term        
Operating leases  8.4 years   13.1 years 
Finance leases  -   0.5 years 
         
Weighted Average Discount Rate        
Operating leases  4.6%  9.0%
Finance leases  0.0%  6.3%

53

As of December 31, 2020,2023, maturities of lease liabilities were as follows:

   Operating  Finance
(in thousands)  leases  leases
Years Ended December 31,      
2021 $676  $35 
2022  696   25 
2023  175   21 
2024    
Thereafter    
Total minimum lease payments  1,547   81 
Less: amount representing interest  (97)  (6)
Present value of lease liabilities $1,450  $75 

SCHEDULE OF MATURITIES OF LEASE LIABILITIES

(in thousands) Operating  Finance 
Years Ended December 31, leases  leases 
2024  2,373   - 
2025  2,019   - 
2026  2,032   - 
2027  1,971   - 
Thereafter  9,663   - 
Total minimum lease payments  18,058      - 
Less: amount representing interest  (3,021)  - 
Present value of lease liabilities $15,037  $- 

13. COMMITMENTS AND CONTINGENCIES

Litigation

In March 2019,

Purchase commitments

During the quarter ended September 30, 2023, we filedentered into a Notice$9.3 million purchase commitment with a contract manufacturing partner for the production of Arbitration in Hong Kong against Ragentek asMOVIA sensor inventory to support direct sales to both automotive and non-automotive customers. We made a resultpayment of its failure$3.1 million during the third quarter and expect to perform its obligations under a purchase order with us. During 2019, we reached an agreement withmake the distributor in our Ragentek contract onremaining future payments by the final transaction priceend of the units shipped to them. As partsecond quarter of the agreement reached in 2019, we2024 based on an agreed to return $432,000 of the original transaction price to our distributor. During 2020, payments totaling $332,000 were made to the distributor and we settled all claims with Ragentek and our distributor. Per the terms of the agreement insensor delivery schedule.

43


Litigation

2020, the final $100,000 payment to our distributor was no longer required. Upon settlement we dismissed the arbitration.

We are subject to various claims and pending or threatened lawsuits in the normal course of business. We are not currently party to any legal proceedings that management believes are reasonably possible to have a material adverse effect on our financial position, results of operations or cash flows.

14. INCOME TAXES

A provision for

Components of income (loss) before income taxes has not been recorded for 2020 and 2019 due to the valuation allowances placed against the net operating losses and deferred(in thousands):

SCHEDULE OF COMPONENTS OF INCOME (LOSS) BEFORE INCOME TAXES

             
  Year Ended December 31, 
  2023  2022  2021 
          
United States $(86,730) $(53,091) $(43,200)
Foreign  5,034   -   - 
Total $(81,696) $(53,091) $(43,200)

Components of income tax assets arising during such periods. A valuation allowance has been recorded for all deferred tax assets. Based on our history of losses since inception, the available objective evidence creates sufficient uncertainty regarding the realizability of the deferred tax assets.expense (benefit) (in thousands):

SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)

             
  Year Ended December 31, 
  2023  2022  2021 
          
Current                        
Federal $-  $-  $- 
State  -   -   - 
International  2,061   -   - 
Total Current Tax Expense  2,061   -   - 
             
Deferred            
Federal  -   -   - 
State  -   -   - 
International  (915)  -   - 
Total Deferred Tax Expense  (915)  -   - 
             
Total Tax Expense $1,146  $-  $- 

The effective tax rate of our provision (benefit) for income taxes differs from the Federal statutory rate as follows:

   Year Ended December 31,
   2020  2019
Statutory rate  21.0%  21.0%
Net operating loss expiration  (47.5)%  (14.7)%
Tax credits  2.2%  2.8%
Change in valuation allowance  24.3%  (9.1)%
Total  0.0%  0.0%

SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION

  2023  2022  2021 
  Year Ended December 31, 
  2023  2022  2021 
          
Statutory rate  21.0%  21.0%  21.0%
Permanent Items and adjustments  0.1%  0.0%  0.0%
Compensation related  (0.4)%  (0.5)%  (8.2)%
Share-based compensation  (1.7)%  (2.2)%  25.1%
Net operating loss expiration  (6.3)%  (9.0)%  (16.2)%
Tax credits  1.0%  1.5%  1.4%
Change in valuation allowance  (15.0)%  (10.8)%  (23.1)%
Bargain Purchase gain  0.9%  0.0%  0.0%
Other  (1.0)%  0.0%  0.0%
Total  (1.4)%  0.0%  0.0%

54

Deferred tax assets are summarized as follows (in thousands):

   December 31,
   2020  2019
Deferred tax assets      
     Reserves $647  $610 
     Net operating loss carryforwards  83,289   85,282 
     R&D credit carryforwards  8,836   9,047 
     Depreciation/amortization deferred  15,862   16,978 
     Other  5,773   5,808 
Net deferred taxes before valuation allowance  114,407   117,725 
Less: Valuation allowance  (114,407)  (117,725)
Deferred tax assets $ $

AtSCHEDULE OF DEFERRED TAX ASSETS

       
  December 31, 
Deferred tax assets 2023  2022 
Reserves $632   $651 
Net operating loss carryforwards  97,254   92,469 
R&D credit carryforwards  10,114   9,628 
Depreciation/amortization deferred  26,079   19,787 
Operating lease liabilities  3,878   3,292 
Other  7,833   7,360 
Total deferred tax assets  145,790   133,187 
Deferred tax liabilities:        
Operating lease right-of-use assets  (3,272)  (3,062)
Total deferred tax liabilities  (3,272)  (3,062)
Net valuation allowances  (142,376)  (130,125)
Deferred tax assets $142  $- 

As of December 31, 2020,2023, we maintained a valuation allowance of $142.4 million for our deferred tax assets that we believe are not more likely than not to be realized.

As of December 31, 2023, we have net operating loss carryforwards of approximately $396.6$463.1 million for federal income tax reporting purposes. In addition, we have research and development tax credits of $8.8$10.1 million. During 2020, $28.42023, $23.1 million federal net operating losses and $512,000$0.3 million general business credits expired unused. A majority of the net operating loss carryforwards and research and development credits available to offset future taxable income, if any, will expire in varying amounts from 20212024 to 2040,2043, if not previously used.

Certain net operating losses arise from the deductibility for tax purposes of compensation under nonqualified stock options equal to the difference between the fair value of the stock on the date of exercise and the exercise price of the options. For financial reporting purposes, the tax effect of this deduction, when recognized, is accounted for as an income tax benefit.

In certain circumstances, as specified in the Internal Revenue Code, a 50% or more ownership change by certain combinations of our shareholders during any three yearthree-year period would result in limitations on our ability to use a portion of our net operating loss carryforwards.

44


We did not have anyhad no unrecognized tax benefits at December 31, 20202023 or 2019.2022.

We recognize interest accrued and penalties related to unrecognized tax benefits in tax expense. During the years ended December 31, 20202023, 2022 and 20192021 we did not recognize anyrecognized no interest or penalties.

We file income tax returns in the U.S. federal jurisdiction, Oregon and Oregon.in Germany. Due to our operating loss and credit carryforwards, the U.S. federal statute of limitations remains open for 1998 and onward. Tax years 2022 and forward remain open in Germany.

15. RETIREMENT SAVINGS PLAN

We have a retirement savings plan that qualifies under Internal Revenue Code Section 401(k). The plan covers all qualified employees. Contributions to the plan are made at the discretion of our Board of Directors. During the years ended December 31, 20202023, 2022 and 20192021 we contributed $213,000$0.5 million, $0.4 million and $393,000$0.3 million to the plan, respectively.

16. QUARTERLY FINANCIAL INFORMATION (Unaudited)

55

ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

The following table summarizes our unaudited quarterly financial information for the periods shown below (in thousands, except per share data):

   Fiscal Year 2020
   December 31,  September 30,  June 30,  March 31,
Revenue $395  $639  $587  $1,469 
Gross profit  395   639   588   70 
Net loss  (3,570)  (2,826)  (2,304)  (4,934)
Net loss per share, basic and diluted  (0.02)  (0.02)  (0.02)  (0.04)
             
   Fiscal Year 2019
   December 31,  September 30,  June 30,  March 31,
Revenue $4,605  $1,190  $1,240  $1,851 
Gross profit  1,179   (882)  (583)  608 
Net loss  (3,284)  (6,141)  (8,990)  (8,068)
Net loss per share, basic and diluted  (0.03)  (0.05)  (0.08)  (0.08)

For the quarter ended December 31, 2019, net loss included a reversal of previously accrued bonuses in the amount of $770,000.

17. SUBSEQUENT EVENT

In January 2021, we issued 1.1 million shares of our common stock for net proceeds of $6.6 million under the December 2020 ATM equity offering agreement with Craig-Hallum. In January 2021, we also received $6.1 million for the 1.0 million shares of common stock that were issued in December 2020. In total, we have issued 2.1 million shares of our common stock for net proceeds of $12.7 million under this ATM agreement. No further shares are available for sales under this agreement.

In February 2021, we entered into a $50.0 million ATM equity offering agreement with Craig-Hallum. Under the agreement we were able, at our discretion, to offer and sell shares of our common stock having an aggregate value of up to $50.0 million through Craig-Hallum. We have issued 2.5 million shares of our common stock for net proceeds of $48.7 million under this ATM agreement. No further shares are available for sales under this agreement.

45


ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

There have been no changes in or disagreements with accountants on accounting or financial disclosure matters during our fiscal years ended December 31, 20202023, 2022 and 2019.2021.

ITEM 9A. CONTROLS AND PROCEDURES

ITEM 9A.CONTROLS AND PROCEDURES

(a)Evaluation of Disclosure Controls and Procedures. Our Chief Executive Officer (CEO) and the Chief Financial Officer (CFO) evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e)) under the Securities and Exchange Act of 1934, as amended (the "Exchange Act"“Exchange Act”), prior to the filing of this Form 10-K. Based upon that evaluation, our CEO and CFO concluded that, as of December 31, 2020,2023, our disclosure controls and procedures were effective.


(b) Management'sManagement’s Report on Internal Control Over Financial Reporting. Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f). Our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on its evaluation under the framework in Internal Control - Integrated Framework (2013), our management concluded that our internal control over financial reporting was effective as of December 31, 2020.2023.

(c) Limitations on the Effectiveness of Controls. Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

(d) Changes in Internal Control Over Financial Reporting. ThereWe completed the acquisition of Ibeo assets on January 31, 2023. As part of the asset acquisition, we are in the process of incorporating our controls and procedures with respect to MicroVision GmbH’s operations, and we will include internal controls with respect to their operations in our assessment of the effectiveness of our ICFR as of December 31, 2024. Other than changes related to incorporating our controls and procedures with respect to MicroVision GmbH, there was no change in our internal control over financial reporting during the quarterperiod ended December 31, 20202023 which has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

56

Report of Independent Registered Public Accounting Firm

To the Shareholders and the Board of Directors of

MicroVision, Inc.

Opinion on Internal Control over Financial Reporting

We have audited Microvision Inc.’s (the “Company”) internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by COSO.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated balance sheets of Microvision Inc. as of December 31, 2023 and December 31, 2022, the related consolidated statements of operations, comprehensive loss, changes in shareholders’ equity (deficit) and cash flows for each of the three years in the period ended December 31, 2023, and the related notes and schedule (collectively referred to as the “consolidated financial statements”) and our report dated February 29, 2024, expressed an unqualified opinion on those consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting included in Item 9A. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

As discussed in Management’s Report on Internal Control Over Financial Reporting, in January 2023, the Company acquired certain assets of IBEO Automotives (Microvision GmbH). For the purposes of assessing internal control over financial reporting, management excluded Microvision GmbH, whose financial statements constitute approximately 10% of the Company’s consolidated total assets (excluding $18 million of intangible assets, which were integrated into the Company’s control environment) and approximately 5% of consolidated net loss as of and for the year ended December 31, 2023. Accordingly, our audit did not include the internal controls over the financial reporting of Microvision GmbH.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Moss Adams LLP

Seattle, Washington

February 29, 2024

We have served as the Company’s auditor since 2012.

57

ITEM 9B.OTHER INFORMATION

(a) None.

(b) During the three months ended December 31, 2023, none of our directors or officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).

ITEM 9C.DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

None.

PART III.

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

ITEM 10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Information regarding executive officers is included in Part I of this Annual Report on Form 10-K in Item 4A. The information required by this Item 10 of Form 10-K and not provided in Item 4A will be included under the caption "Discussion“Proposal One – Election of Proposals Recommended by the Board"Directors” and “Board of Directors & Governance Matters” in our 20212024 Proxy Statement and is incorporated herein by reference. Our 20212024 Proxy Statement will be filed with the SEC prior to our 20212024 Annual Meeting of Shareholders.

ITEM 11. EXECUTIVE COMPENSATION

ITEM 11.EXECUTIVE COMPENSATION

The information required by this Item 11 of Form 10-K will be included under the captions "Executive“Executive Compensation," "Compensation” “Compensation Committee Interlocks and Insider Participation," and "Director“Director Compensation for 2020"2023” in our 20212024 Proxy Statement and are incorporated herein by reference.

46


ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Information as of December 31, 2020,2023, regarding equity compensation plans approved and not approved by shareholders is summarized in the following table (in thousands, except per share data):

   Equity Compensation Plan Information
   Number of     Number of securities
   securities to be  Weighted-  remaining available for
   issued upon  average exercise  further issuance under
   exercise of  price of  equity compensation
   outstanding  outstanding  plans (excluding
   options, warrants  options, warrants  securities reflected in
   and rights  and rights  column (a))
Plan Category  (a)  (b)  (c)
Equity compensation plans approved by shareholders  3,281  $1.51   8,133 
Equity compensation plans not approved by shareholders    -    
     Total  3,281      8,133 

  Equity Compensation Plan Information 
 

Number of

securities to be

issued upon

exercise of

outstanding

options, warrants

and rights

  

Weighted-

average exercise

price of

outstanding

options, warrants

and rights

  

Number of securities

remaining available for

further issuance under

equity compensation

plans (excluding

securities reflected in

column (a))

 
Plan Category  (a)   (b)   (c) 
Equity compensation plans approved by shareholders          9,422 
Options to purchase common stock  752  $1.35     
Restricted stock units and performance stock units  9,983   -     
Equity compensation plans not approved by shareholders  -   -   - 
Total  10,735       9,422 

The other information required by this Item 12 of Form 10-K will be included under the caption "Information“Information about MicroVision Common Stock Ownership"Stock” in our 20212024 Proxy Statement and is incorporated herein by reference.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

58

ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

The information required by this Item 13 of Form 10-K will be included under the captions "Certain“Certain Relationships and Related Transactions"Transactions” and "Board Meetings and Committees"“Board of Directors & Governance Matters” in our 20212024 Proxy Statement and are incorporated herein by reference.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

ITEM 14.PRINCIPAL ACCOUNTING FEES AND SERVICES

The information required by this Item 14 of Form 10-K will be included under the caption "Independent“Independent Registered Public Accounting Firm"Firm” in our 20212024 Proxy Statement and is incorporated herein by reference.

PART IV.

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

ITEM 15.EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(A) Documents filed as part of this Annual Report on Form 10-K:

1. Consolidated Financial Statements

Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets as of December 31, 2023 and 2022
Consolidated Statements of Operations for the years ended December 31, 2023, 2022 and 2021
Consolidated Statements of Comprehensive Loss for the years ended December 31, 2023, 2022 and 2021
Consolidated Statements of Shareholders’ Equity (Deficit) for the years ended December 31, 2023, 2022 and 2021
Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021
Notes to Consolidated Financial Statements

47


59

2. Financial Statement Schedules

Schedule II

MicroVision, Inc.

Valuation and Qualifying Accounts and Reserves Schedule

(In thousands)

      Additions      
   Balance at  Charges  Charges     Balance
   beginning of  to costs and  to other     at end of
Year Ended December 31,  fiscal period  expenses  accounts  Deductions  fiscal period
2019               
Tax valuation allowance $115,313  $2,412  $ $ $117,725 
                
2020               
Tax valuation allowance $117,725  $ $ $(3,318) $114,407 

     Additions       
Year Ended December 31, 

Balance at

beginning of

fiscal period

  

Charges

to costs and

expenses

  

Charges

to other

accounts

  Deductions  

Balance

at end of

fiscal period

 
2021               
Tax valuation allowance $114,407  $9,973  $          -  $         -  $124,380 
                     
2022                    
Tax valuation allowance $124,380  $5,745  $-  $-  $130,125 
                     
2023                    
Tax valuation allowance $130,125  $12,252  $-  $-  $142,377 

All other schedules are omitted because they are not applicable, or because the information required is included in the consolidated financial statements and notes thereto.

60

48


3. Exhibits

The following exhibits are referenced or included in this Annual Report on Form 10-K.

Exhibit
Number

Description

3.1

2.1Asset Purchase Agreement, dated December 1, 2022, by and between Ibeo Automotive Systems GmbH and MicroVision GmbH(14)
2.2Amendment Agreement, dated January 31, 2023, to the Asset Purchase Agreement, dated December 1, 2022, by and between Ibeo Automotive Systems GmbH and MicroVision GmbH(14)
3.1Amended and Restated Certificate of Incorporation of MicroVision, Inc., as amended.(2)

3.2

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of MicroVision, Inc.(4)

3.3

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of MicroVision, Inc. dated June 7, 2018.(6)

3.4

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of MicroVision, Inc. dated October 8, 2020.2020.(8)

3.5

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of MicroVision, Inc. dated May, 18, 2023.(7)
3.6Amended and Restated Bylaws of MicroVision, Inc.(5)

4.1

Form of Specimen Stock Certificate for Common Stock.(1)

4.2

Description of Common Stock (filed herewith)(9)..

10.1

20202022 MicroVision, Inc. Incentive Plan, as amended.Plan.(9)(13)*

10.2

Third Amendment to Lease Agreement Concerning Office Premises between BRE WA Office Owner, LLC and MicroVision, Inc.Victoria Immo Properties I S.à r.l., dated July 25, 2017.(7)December 15, 2023 (covering approximately 60,000 square feet).

10.3

Change of Control Severance Plan.(3)*

10.4

Employment Agreement between MicroVision, Inc. and Perry MulliganSumit Sharma dated November 21, 2017.April 8, 2021. (7)*(11)

10.5

At-the-Market Issuance Sales Agreement, dated August 29,2023, by and between the Company and Craig-Hallum Capital Group LLC(10)
10.6Lease Agreement between Redmond East Office Park LLC and MicroVision, Inc. dated September 24, 2021 (covering approximately 16,681 square feet). (12)
10.7Lease Agreement between Redmond East Office Park LLC and MicroVision, Inc. dated September 24, 2021 (covering approximately 36,062 square feet). (12)
10.8Form of Performance-Based Restricted Stock Unit Agreement(13)*
10.9Form of Restricted Stock Unit Agreement(15)*
10.10

At-the-Market Issuance Sales Agreement, dated February 16, 2021,June 16,2023, by and between MicroVision, Inc.the Company and Craig-Hallum Capital Group LLC. (filed herewith)LLC(16).

23.1

21.1

List of Subsidiaries of the Registrant
23.1Consent of Independent Registered Public Accounting Firm - Moss Adams LLPLLP..

31.1

Principal Executive Officer Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 20022002..

31.2

Principal Financial Officer Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 20022002..

32.1

Principal Executive Officer Certification pursuant to Rule 13a-14(b) or Rule 15d-14(b) and Section 1350, Chapter 63 of Title 18, United States Code (18 U.S.C. 1350), as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 20022002..

32.2

Principal Financial Officer Certification pursuant to Rule 13a-14(b) or Rule 15d-14(b) and Section 1350, Chapter 63 of Title 18, United States Code (18 U.S.C. 1350), as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 20022002..

101.INS

97.1

Policy on Recoupment of Incentive Compensation
101.INSInline XBRL Instance Document

(the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH

Inline XBRL Taxonomy Extension Schema Document

Schema.

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

Document.

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

Document.

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

Document.

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase DocumentDocument.
104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

61

(1)Incorporated by reference to the Company’s Post-Effective Amendment to Form S-3 Registration Statement, Registration No. 333-102244.
(2)Incorporated by reference to the Company’s Form 10-Q for the quarterly period ended September 30, 2009.
(3)

Incorporated by reference to the Company’s Current Report on Form 8-K filed on May 24, 2022.

(4)Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 17, 2012.
(5)Incorporated by reference to the Company’s Current Report on Form 8-K filed on July 14, 2023.
(6)Incorporated by reference to the Company’s Amendment No. 2 to Form S-1 Registration Statement, Registration No. 333-222857.
(7)Incorporated by reference to the Company’s Current Report on Form 8-K filed on May 19, 2023.
(8)Incorporated by reference to the Company’s Form 10-Q for the quarterly period ended September 30, 2020.
(9)Incorporated by reference to the Company’s Form 10-K for the year ended December 31, 2020.
(10)Incorporated by reference to the Company’s Current Report on Form 8-K filed on August 29, 2023.
(11)Incorporated by reference to the Company’s Form 10-Q for the quarterly period ended June 30, 2021.
(12)Incorporated by reference to the Company’s Form 10-Q for the quarterly period ended September 30, 2021.
(13)Incorporated by reference to the Company’s Form S-8 filed on June 8, 2022.
(14)Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 3, 2023.
(15)Incorporated by reference to the Company’s Form 10-K for the year ended December 31, 2022.
(16)Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 16, 2023.

(1)    Incorporated by reference to the Company's Post-Effective Amendment to Form S-3 Registration Statement, Registration No. 333-102244.
(2)    Incorporated by reference to the Company's Form 10-Q for the quarterly period ended September 30, 2009.
(3)    Incorporated by reference to the Company's Form 10-K for the year ended December 31, 2011.
(4)    Incorporated by reference to the Company's Current Report on Form 8-K filed on February 17, 2012.
(5)    Incorporated by reference to the Company's Current Report on Form 8-K filed on November 27, 2013.
(6)    Incorporated by reference to the Company's Amendment No. 2 to Form S-1 Registration Statement, Registration No. 333-222857.
(7)    Incorporated by reference to the Company's Form 10-K for the year ended December 31, 2017.
(8)    Incorporated by reference to the Company's Form 10-Q for the quarterly period ended September 30, 2020.
(9)    Incorporated by reference to the Company's Form S-8 filed on October 9, 2020.

*Management contracts and compensatory plans and arrangements required to be filed as exhibits pursuant to Item 15(b) of this Annual Report on Form 10-K.

* Management contracts and compensatory plans and arrangements required to be filed as exhibits pursuant to Item 15(b) of this Annual Report on Form 10-K.

ITEM 16. FORM 10-K SUMMARY

None.

49


None.

62

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MICROVISION, INC.

MicroVision, Inc.

Date: March 15, 2021

By

By/s/ Sumit Sharma
Sumit Sharma
Date: February 29, 2024Chief Executive Officer and Director

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Sumit Sharma and Anubhav Verma, jointly and severally, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the following capacities on March 15, 2021.February 29, 2024.

Signature

Signature

Title

Title

/s/ Sumit Sharma
Sumit Sharma

Chief Executive Officer and Director
Sumit Sharma(Principal Executive Officer)

/s/ Stephen P. Holt
Stephen P. Holt

Anubhav Verma

Chief Financial Officer
Anubhav Verma(Principal Financial Officer and Principal Accounting Officer)

/s/ Simon Biddiscombe
Simon Biddiscombe

Director

Simon Biddiscombe

/s/ Robert P. Carlile
Director
Robert P. Carlile

Director

/s/ Judy Curran
Judy Curran

Director

Judy Curran

/s/ Yalon Farhi
Yalon Farhi

Director

/s/ Jeffrey HerbstDirector

/s/ Seval Oz
Seval Oz

Jeffrey Herbst

Director

/s/ Mark Spitzer
Mark Spitzer

Director

Mark Spitzer

/s/ Brian V. Turner
Director
Brian V. Turner

Director

63

50